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SUMMARY
Considerable circumstantial evidence suggested that
prostaglandins or prostaglandin-like substances might be
responsible for the diarrhoea associated with V. choleras and
heat-stable E. coli enterotoxins. The role of prostaglandins
in the secretion of fluid and electrolytes initiated by these
toxins was therefore investigated.
Cholera toxin was prepared from Vibrio cholerae strain
12r (Ogawa). The prostaglandin content of crude cholera toxin
(Wyeth lot 002 toxin) and crude E. coli strain BAA heat-stable
enterotoxin was determined. Neither contained sufficient
prostaglandin-like activity to account for their secretory
stimulant properties.
Prostaglandins of the E and A series were released from
rabbit intestine by cholera enterotoxin but it was demonstrated
by further experiment that this release was associated with
tissue trauma and loop distension. Indomethacin administered
systemically reduced the prostaglandin release markedly but did
not cause a significant reduction in fluid output by the intestine.
In in vitro studies it was demonstrated that purified cholera
toxin did not modify the synthesis of PGE and PGF compounds by
the small intestine.
In cats the effect of prostaglandin synthesis inhibitors
on fluid output by the lower and upper small intestine was
investigated. Neither systemic nor local application of
indomethacin nor systemic administration of aspirin prevented
the secretion of fluid by the intestinal mucosa following
intra-luminal challenge with cholera enterotoxin. Prostaglandin
release was modified by these drugs. The plasma levels of
indomothacin achieved by systemic therapy were monitored.
It was shown that levels of indomethacin attained in vivo were
sufficient to cause significant reduction in prostaglandin
biosynthesis by cat terminal ileum tissue in vitro.
+Tpy iV%.
The prostaglandin content of washings from E. coli infected
piglets and control healthy animals was assessed. It was found
that both healthy and infected material contained prostaglandin
E and F-like activity. There was no significant difference in
prostaglandin content between the two groups of samples.
The ability of E. coli toxin infected intestine and healthy
intestinal tissue to synthesize prostaglandin-like compounds was
investigated. PGEg-like and FGFg^ activity was detected. The
presence of ^ was confirmed by combined gas chromatography-
mass spectrometry.
The effect of intraluminal administration of PGS^ and PGA^
on net s&a and electrolyte movement across the intestinal mucosa
of piglets was studied. The changes in these parameters wrought
by the prostaglandins were compared to those initiated by heat-
stable Escherichia coli toxin.
Intra-arterial infusion of PGE^, PGA^ and FGF^ ^ into the
superior mesenteric artery of dogs had been demonstrated to initiate
fluid and electrolyte secretion by canine jejunum similar to that
> *
observed following cholera and Escherichia coli toxin administration.
The ability of intra-arterially administered prostaglandins to mimic
the secretory activity of E. coli toxin in calf intestine was
investigated.
No evidence was found to implicate prostaglandins or
prostaglandin-like compounds in the fluid and electrolyte losses
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Until the early 19th century cholera was a disease confined
mainly to India and the neighbouring countries of the East. With
the expansion of commerce and the opening up of new trading routes
to the East, the occurrence of cholera in other countries was
inevitable and in the period from 1817 to 1923 six pandemics
were to occur. In 1817 the Bengal outbreak spread rapidly to
China, and the disease reached Burma, Thailand and Indonesia
two years later. By 1822 Japan, Malaya and the Phillipines
had all experienced the effects of the vibrio. It was transmitted
to Arabia by the British expeditionary force which was sent from
India in 1821 and soon the countries on the Southern Mediterranean
coast, Zanzibar and East Africa were infected. The first reports
of a westward spread of the disease was in the pandemics which
scourged the world between 1326 and 1837. Europe experienced
its initial attack in 1829 and both England and Scotland were
ravaged by cholera in 1831. It was only after the appearance
of the disease in the western hemisphere that any real interest
in the scientific aspects of the illness wa3 taken. Sporadic
outbreaks of the disease have been reported in Europe in the
past decade and with these new incidents fresh interest has been
aroused into the o^thanisa of action of V. cholerae.
r~
As early as 1831, it was known that the treatment of cholera
necessitated fluid and electrolyte replacement (Q'Shaughnessy,
1831) and by 1837 Snow had postulated that the rice-water stool
was the effect of hypersecretion in the small intestine due to
the toxic substances which acted as potent irritants in the
gastro-intestinal tract (Snow, 1854). It was not for some
thirty to forty years that much headway was made, until Koch
in 1884. showed that the outbreak of cholera in Alexandria,
Egypt, during the previous year was attributable to the comma
bacterium. Koch postulated that the disease was not due to
the action of the vibrio itself but resulted from the effects
of toxic substances elaborated by the organism. He also
stated that the disease processes were confined to the small
intestine. Evidence to support the participation of toxins
came from the work of Nicata and Hietch (Nicata & Rietch,
1884.) who showed that week-old cultures of the vibrio caused
lethal poisoning when injected intravenously in dogs, a
property not shared by fresh cultures of the organism. In
1886 Cantoni found endotoxic activity associated with heat
killed cultures of V. cholera©. These reports were confirmed
in 1892 by Pfeiffer. Pfeiffer demonstrated that young,
aerobically incubated cultures of vibrio contained a toxic
substance which was resistant to the effects of heat, chloroform
and thymol, all of which resulted in the death of the bacteria.
Furthermore intraperitoneal injection of the cholera toxin
in guinea-pigs caused progressive hypothermia and was lethal
in large doses. Lesser doses caused severe incapacitation
but the animals generally recovered within twenty-four hours.
It should be noted however that these early reports are
probably describing the effects and properties of the endo
rather than the enterotoxic moieties associated with V. cholera®.
Advances in the mechanism of action of the vibrio were
retarded at this time due to the influence of Virchov. At
post mortem examination Virchow (Virchow, 1879) observed
that denudation of the intestinal epithelia had occurred in
specimens from deceased cholera patients. Thus in 1879 he
proposed that this loss of epithelial integrity was the cause
of the massive diarrhoea experienced by the choleraic patient.
Not even the evidence presented by Cohnheim in 1882 was able
to refute the claims made by Virchow. Cohnheim (Cohnheim,
1882) asserted that the denudation was a post-mortem
artefact and that, as the rice water stool contained so
little proteinaceous material, it was due to hyperactivity
of normal secretory mechanisms in the intestine, as had been
suggested by Snow some years earlier. The presence of
relatively high concentrations of amylase in the stools was
further evidence in favour of Cohnheim's hypothesis. Even
the fresh evidence put forward by Goodpasture in 1923
(Goodpasture, 1923) was insufficient to deter many members
of the medical profession from continuing to give credence
to the views of Virchow for some further forty years.
During the next half century interest was focused on
the nature of the toxic substances produced by V. cholerae,
and in particular in endotoxic moieties. At this time
bacterial diseases were believed to owe their symptoms to
endo-rather than exotoxins. Kolle and Schurman (1912)
and Kolle and Prigge (1928) had attested that the choleraic
syndrome was produced by exotoxins elaborated by the growing
e^
organisms. Wilson and Miles stated catagorically that no
true exotoxins were synthesized by the vibrio but that endo¬
toxins were released on autolysis or by the action of host
cells on the bacteria, suggesting that these bacteria were
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relatively easily lysed being similar to microcci in this
respect (Wilson & Miles, 194-6). Earlier work by Boivin and
Mesrobeanu in 1935 and 1936 had shown that V. cholerae did
produce endotoxin. These workers were able to extract glycolipid
endotoxic material from the organisms, a result confirmed by
Bernard and Gallut in 194-3 and by Burrows in the following year
(Burrows, 1944)* Gallut working together with Graber demonstrated
that V. cholerae produced at least two toxic substances (Gallut
& Graber, 1943, 1947). Banerjee (Banerjee, 1942) was able to
isolate a dialyzable toxin from vibrio cultures using
dialysis techniques. Freter confirmed the synthesis of
endotoxin in 1953 and later characterized the differences
between the endo-and exotoxic material in a more intensive
investigation (Freter, 1956). The situation became even more
complicated by the early 1960s when two further toxic moieties
were described. Huber and Phillips showed that a sodium
pump inhibitor was present in cholera stools during the
epidemic in Bangkok in 1960 (Huber & Phillips, 1962) and later
a capillary permeability factor was isolated by Basu, Malllck and
Ganguli and by Craig (Basu, Mallick & Ganguli, 1964; Craig 1965a).
Thus at least four toxic substances were implicated in the
choleraic syndrome.
In the late 1960s it became apparent that the problem was
in fact much simpler than had once been imagined. Exotoxins
produced by V. cholerae were capable of reproducing the effects
of vibrial infection in various experimental models and in human
subjects (see appropriate sections of Introduction) and thus the
question to be answered was how did the enterotoxic exotoxin
stimulate the fluid loss in cholera and how could this process
be interrupted.
The work of Ling (1965) and Finkelstein (Finkelstein, Sobocinski,
Atthasampimua, Charunmethee, 1966a) excluded the sodium pump
inhibitor as a causative agent of fluid production. The
participation of endotoxins was also excluded by the ability of
cell free fractions and supernatant from non lysed cell cultures
to mimic the effects of bacterial infection (see Latif, 1966,
Sheahan, 1972) and the inability of endotoxic material isolated
from choleraic stools to reproduce the syndrome in rabbits
(Finkelstein, Kukherjee & Rudra, 1963).
Experimental Models
(a) Rabbit Ligated Loop Models.
The first experimental model used to study V. cholerae —
induced diarrhoea was that of Metchnikoff. In 1892, Metchnikoff
(Metchnikoff, 1892) produced the symptoms of cholera in infant
✓
rabbits by allowing them to suckle from maternal teats smeared
with V. cholerae organisms. Because great emphasis was laid on
8 howing the problem of endotoxin versus exotoxin production,
animal studies on the intestinal aspects of cholera tended to
be neglected somewhat. In 1915 however, Violle and Crendiropoulu
developed the ligated intestinal loop model. Using a 10 cm
length of upper small intestine they were able to demonstrate
fluid production and denudation of mucosal epithelium (Violle and
Orendiropoulu, 1915). The infant rabbit model was revised in
1955 by Dutta and Habbu who used intra-intestinal inoculation
with V. cholerae cultures and obtained reproducible diarrhoea.
Later intragastric administration of cell" free filtrate (Dutta,
Panse, Kulkarni, 1959), or cell'freo ultrasonic lysate (Oza Sc.
Dutta, 1963) to infant rabbits was found to give similar results.
These results were confirmed by Finkelstein and his associates
(Finkelstein, Norris & Dutta, 1964.). In parallel
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with the development of the infant rabbit model, was the re-
introduction of the ligated loop model in adult rabbits (De
& Chatterjee, 1953)* The model has been used to study the
effects of vibrio cultures (De, 1959; De, Ghose & Sen 1960;
Formal, Kundel, Schneider, Kunev, Sprinz, 1961). Namioko,
Urushido and Sakazaki (1953) and Taylor and his associates
(Taylor, Maltby and Payne, 1953) used the loop model to
establish enteropathogenicity in a range of V. cholera©
strains. McNaught and Roberts also used the model but
reported that false positive responses could be elicited
(McNaught & Roberts, 1953).De and Ghose found that such
responses were only obtained when the volume injected exceeded
1 ml/10 era length of gut (De & Ghose, 1959). The model was
modified by Kasuga and his collaborators (Kasuga, Goda, Ushiba,
Ujiie & Kishimoto, 1963) and by Hattore's group (Hattore,
Misawa, Igarashi & Sugiya, 1965). These groups washed the
loops with saline to remove debris and mucin. Longer loops
were used by Leitch (1965) and Schafer and Lewis (1965) but even
they were unable to avoid false positive x*esults.
The suitability of other animal species has been investigated.
Monkeys and goats have both been used but there appears to be no
advantage over rabbit models (Fresh, Versage & Reyes, 1964).
Rat loops are not susceptible (De, 1961). The guinea-pig has
been reported to be a more sensitive preparation (Nikonov,
Yevsenyeva, Bibikova & Bichul, 1958).
Further sophietication of the loop technique has led to the
introduction of Thiry-Vella loops in dogs (Sack & Carpenter, 1969).
(b) Other Models
Although a certain amount of information is provided by
animal studies, changes in ion and water movement are perhaps
more easily studied in in vitro systems. Isolated strips of
guinea-pig and rabbit small intestine were used by Burrows,
Wagner & Mather in 19-44- to investigate the effects of cholera
toxin on fluid movement. An increase in the flow of Ringer —
Locke solution was induced by V. cholerae cells and could be
abolished by agglutinating these cells with antisera. Isolated
il£eal segment models have been employed to measure the magnitude
and nature of electrolyte and water fluxes in cholera (Field,
Frornrn, Wallace & Greenough, 1969; A1 Awqati, Cameron, Field,
Greenough, 1970a). Studies have been carried out principally
on human and rabbit ileum.
Greater confidence has been placed in experimental models
since Benyati reported the ability of cell-free material to produce
cholera in human subjects. (Benyati, 1966).
Preparation of Cholera Toxin
There are two characteristic features associated with almost
every toxin yet found: firstly, extreme potency - a minute
quantity of a pure toxin preparation is required to produce the
pathological effect associated with the toxin's presence; secondly,
specificity of site of action - cholera toxin shows remarkable
specificity for the gastro-intestinal tract. Introduction of
the toxin at other sites does not lead to the massive fluid
production associated with cholera.
Vibrio cholerae produces several toxic substances:
(l) a heat-labile, enterotoxin, which is non-dialyzable, occurs
intracellularly, diffuses into the culture medium, is not a cell
wall component and is responsible for the intestinal electrolyte
and water movement both in vitro and in vivo. It is also
responsible for increased capillary permeability in the skin and
cytotoxic effects on cell culture (for references see Reviews of
Craig, 1971; Burrows, 1968 and Monograph of Sheahan, 1972). This
toxin is also capable of stimulating adenyl cyclase activity in
a variety of tissues (see appropriate subsection of introduction
for references).
(2) A heat-stable, non-dialyzable factor seen in liquid cultures
after autolysis of the cells has occurred and contains mouse
lethal factor. This is probably an endotoxin (Craig, 1970;
Burrows, 1944-) •
(3) Heat-stable, dialyzable factors which inhibit sodium transport
in anuren epithelia, and para-amino hippuric acid uptake by
kidney tissues in vitro (Burrows, 1968; Sheahan, 1972).
This study is concerned only with the enterotoxin produced
by V. cholerae.
Most of the classical and El Tor strains of V. cholerae are
of low toxicity but V. cholerae 569B has been brought to high
virulence by serial passage in animals (Dutta and Habbu, 1955).
This strain grows with relative ease on a simple salt-containing
medium. Growth conditions leading to optimum toxin production
vary from strain to strain, but appropriate adjustment of salt
concentration, aeration, pH and temperature will generally lead
to toxin manufacture (Craig, 1971), (for references see Monograph
of Sheahan, 1972). The toxins obtained from the various strains
appear to be antigenically identical, and behave identically on
agar gel double diffusion precipitation testing (Finkelstein,
Sobocinski, Atthasampunna, Charunmethee, 1966b). Enterotoxin
is detectable in the medium during the log phase of growth and
reaches a maximum at the end of this phase and the beginning of
the stationary phase. (Richardson, 1969, Latif, 1966).
Richardson demonstrated that lysing of the cells prior to entry
into the exponential growth phase inhibited toxin production
completely (Richardson, 1969) and thus it seems as if the log
phase is of critical importance in the toxin cycle. The functions
of these toxins is obscure. It does not appear to be of metabolic
consequence for the bacteria. Richardson (1969) has suggested
that it may be a non-functional protein.
Purification of Cholera Toxin
Most assays in experimental models have been carried out
using relatively impure forms of toxin. Purification is a complex
multi-step procedure requiring ammonium sulphats precipitation,
DEAE cellulose chromatography and gel filtration (Finkelstein and
Lo Spalluto, 1969), or ultrafiltration through various membranes
and gel filtration through Sephadex-G75 (Finkelutein and Lo
Spalluto, 1972). This latter technique gives better yields
and has been used to prepare crystalline toxin and naturally
occurring toxoid (Finkelstein and Lo Spalluto, 1972). Other
modifications which have been introduced to provide high yields
of relatively pure, concentrated toxin, include an initial
adsorption on to aluminium hydroxide (Spyrides and Feeley, 1970)
but further chromatography has to be used to increase the purity
of the end-product (Finkelstein, Fujita and Lo Spalluto, 1971a,
Finkelstein, Peterson & Lo Spalluto, 1971b). Richardson, Evans
& Feeley, (1970) using a combination of dialysis, dextran sulphate
precipitation and elution, ammonium sulphate precipitation, gel
filtration and ion exchange chromatography obtained a pure toxin
from the activity point of view, but this preparation was found
to be contaminated with significant amounts of somatic antigen and
to stimulate the production of vibrocidal antibodies. Furthermore
a second band was found on immuno-electrophoresis of the protein
material.
Pure crystalline and non-crystalline forms of toxin are not
generally available for investigative work in experimental models,
thus caution must be exercised in analysing results and interpreting
differences obtained with toxins from different sources.
Properties of Cholera Toxin and Toxoid
Cholera toxin is not a stable bacterial product and even with
low temperature storage is found to lose its activity over a
period of months. At room temperature the process is very much
faster (Finkelstein, 1972, Van Heyningen, personal communication).
The deactivation mechanism is thought to represent the spontaneous
decomposition of toxin into its two subunits, the A fragment
of molecular weight 27,000 and the B fragment of approximately
56,000 molecular weight. The B fragment is antigenically
identical to the toxoid obtained in pux-ification procedures
(Finkelstein and Lo Spalluto, 1969, 1970, 1972),
Table 1 summarises the properties of cholera toxin and the






infant rabbit model 0.25 - 0.5 Jig —. oo
Skin-reactive dose
adult rabbit 0.6 x 10~^ - 0.1 x 10Jig 0.1 - 0.2 yug
Ileal-loop reactive
dose - adult rabbit 0.03 - 0.2 jig oo
Fat cell lipase 0.014 ug Inactive
Intravenous Lethal












Content <1* < 1%
►
Table 1. The properties of cholera toxin and its naturally
occurring toxoid. The table is modified from that of Finkelstein,
1972.
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Slto of Action of Cholera Toxin
Cholera toxin has a purely local effect on the gastro¬
intestinal tract. In order to produce the clinical symptoms of
cholera, the toxin must come in contact with the luminal side of
epithelial cells of the intestine. Injection into the wall can
produce an intense inflammatory response but cannot elicit fluid
accumulation in the gut lumen (Sheahan and Sprinz, 1971). Similarly
serosal application of toxin is ineffectual (Field, Fromm, Wallace
& Greenough, 1969)# Human studies (Banwell, Pierce, Mitra, Brigham,
et al, 1970), and canine Thiry Vella Loop model experiments
(Carpenter, Sack, Feeley & Steinberg, 1968) indicate that the
whole of the small intestine is suscept ible to attack by the
toxin. Evidence from experiments in neonate and adult rats
by Bayless and his co-workers (Bayless, Luebbers & Elliott, 1971)
indicate that the intestinal crypts may be the precise location
of toxin receptors. Neonatal rats which do not have mature
crypts are not sensitive to cholera toxin. Peterson, Lo
Spalluto & Finkelstein^ 1972) localized the toxin to the exterior
of the epithelial surface: They were unable to demonstrate
penetration of the mucosa by the toxin using immunofluorescent
and autoradiographic techniques. Elliott and his colleagues
(Elliott, Carpenter, Sack and Yardley, 1970) found toxin in
close association with the fuzzy coat of the brush border in
biopsy studies in dogs during experimentally induced cholera.
Again no penetration of mucosal tissue or crypt lumen was observed.
Thus the choleraic syndrome presents one with a peculiar problem -
how does the toxin cause the massive fluid loss? Evidence has
been presented very recently by Cuatrecasas in a series of
papers (Cuatrecasas, 1973, a, b, c, d) suggesting that interaction
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with a ganglioside component of the epithelial cell wall may be
the initial reaction which eventually leads to the pathological
manifestations of the disease. This work is supported by
similar studies of van Heyningen, and his collaborators,
(van Heyningen, WE, Carpenter, Pierce & Greenough, 1971)
and by van Heyningen using the ganglioside (van Heyningen,
S., 1974-). Leiteh and Glinkson (1972) observed a decrease in
the phospholipid, sialic acid, and cholesterol levels in
\
purified brush border preparations on exposure to cholera toxin.
The ratio of phospholipid (P.L.) to cholesterol (Cholesterol) was
» markedly altered - the ratio decreased from 1:4 (PL: Cholesterol)
to 1:2.
Mechanism of Action of Cholera Toxin
The initial step in producing diarrhoea appears to involve
an interaction between the 56,000 molecular weight component
of cholera toxin and some ganglioside component of the cell
membrane (van Heyningen,1974 and personal communication). The
smaller subunit, being essential to produce the toxic effects
once the binding step has been effected, has apparently no role
in toxin attachment to the membrane.
Several mechanisms have been postulated for the production
of fluid.
(1) increased vascular capillary permeability
(2) decreased absorption
(3) Hypersecretion - active secretion of electrolytes and water
(4) a combination of (2) and (3).
(1) Increased vascular permeability
Evidence both in favour and against the vascular permeability
theory has been found. In 1953 De and Chatterjee (De & Chatterjee
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1953) noted that fluid which had accumulated in the ligated
intestinal loop in rabbits following inoculation with V. cholerae
culture was rich in protein and that Evans Blue dye could be
detected in the fluid following the intravenous administration
of this plasma marker. Liebermeister stated that it was not
unusual to find variable numbers of red blood cells in cholera
stools giving the fluid a mucosanguinous or meat-broth like
appearance (Liebermeister, cited in Pollitzer, 1957). Keusch
and his co-workers (Keusch, Atthasampunna & Finkelstein, 1967)
found increased permeability to iiondextran complexes in mucosal
capillaries. In ultrastructural and anatomical studies (Fresh et al,
1964? Dalldorf, Keusch & Livingstone, 1969? Merrill and Sprinz
1966) dilatation of capillaries was found. Elliott et al, 1970
and Norris and Mayno (1965) were unable to confirm these results.
Love (1969) found the pore size of ileal loop mucosa had doubled.
Circumstantial evidence also supports this theory - the. time
course of cholerar-mediated fluid loss is very similar to that
of permeability changes in inflammation and thermal injury
(Formal et al, 1961, Schafer & Lewis, 1965, Wilhelm 1971, Leme,
Hamamura, Leite, Rocha e Silva, 1973). No increase in permeability
could be detected by Gordon (Gordon, 1969), nor by Rhode and
Chen (Rhode & Chen, 1972), and Hakim and Lifson concluded that
cholera toxin operated by a mechanism not involved with increases
in hydrostatic pressure in the interstitial tissue of the mucosa
(Hakim & Lifson, 1969). Protein loss is minimal (Weaver, Johnson
& Phillips, 194-8) and the ion concentrations in the diarrhoeic
fluid do not reflect those of plasma exactly (Carpenter, Barua,
Sack, Wallace, Mitra et al, 1966). Cholera toxin does cause
an increase in vascular permeability in skin in guinea-pigs
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(Kennedy & Richardson, 1972) and in rabbits (Craig, 1965a,
Latif, 1966). Injection of the toxin into the wall of the
intestine results in a narked inflammatory response (Sheahan
St Sprinz, 1971). Alteration in mucosal blood flow doss not
alter fluid secretion in cholera (Norris St Summer, 1971*
Carpenter, Greenough, Sack, 1969a).
(2) Impaired Absorption
Absorptive processes remain intact in cholera - neither
glucose absorption nor the lumen to plasma flux of sodium
appear to be reduced (Lovo, 1969; Banwall at al, 1968; Leitch
et al, 1968; Grady, Madoff, Duhamel, Moore St Chalmers, 1967;
Hirschorn, Kinnie, Sacher, Rorthurp et al, 1968; Iber, McGona^le,
Serebro, Luebbers et al, 1968; Carpenter et al, 1968), Anatomical
and ulstratructural studies indicate that the integrity of
the gut epithelium is maintained (Gangarosa, Reieel, Bonyajati,
'
Sprins & Piyaratn, 1960). Serebro et al showed that tho
absorption of glucose was independent of the net ion and
fluid movements due to cholera toxin. Enhanced sodium
absox'ption still occurs in the choleraic animal and man, as
it does in the healthy controls (Hirschorn et al, 1968;
Serebro et al, 1968).
There is a factor in crude preparations and in cell-free
culture fluid which is capable of inhibiting sodium uptake by
the intestine but Burrows has shown that this substance can
be separated from the enterotoxLn on the basis of the heat
lability and non-dializability (Burrows, 1968). This sodium
pump inhibitor is a mucinase enzyme. It is not known whether
it is important in cholera in human patients but it does not
appear to be essential in experimental models (Sheahan, 1972),
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It would therefore seem as if the theory postulated by
Fuhrman and Fuhrman and supported by other groups can be
discounted and that choleraic diarrhoea is not the result of
impaired absorptive mechanisms in the intestine (Fuhrman St
Fuhrman, 1959).
Active Secretion
Stimulation of active secretory processes seems to be the
most likely mechanism for producing fluid loss in cholera. Water
movement occurs against an osmotic gradient and must therefore
be coupled to the transport of electrolytes. The coupling has
to occur in a restricted space so that an appropriate osmotic
environment can be created. Field has proposed that the crypt
regions of the intestine are suitable sites (Field, 1971a).
Supportive evidence comes from the observation that cycloheximide,
which in the intestine is selectively cytotoxic to crypt cells
(Verbin & Farber, 1967), interferes with secretory mechanisms
and inhibits the effect of cholera toxin while leaving absorptive
processes intact. (Serebro, Iber, Yardley, Hendrix, 1969;
Grayer, Serebro, Iber St Hendrix, 1970; Harper, Grayer, Yardley
& Hendrix, 1970). Moritz, Iber and Moore showed that cyclo¬
heximide caused a reduction in sodium and bicarbonate ion secretion
and abolished that of chloride ions. Water movement was also
abolished (Moritz, Iber St Moore, 1971).
Field, (Field et al, 1969) found that cholera toxin
stimulated chloride ion secretion, increased short circuit current
and raised the potential difference across membranes in vitro.
Leitch and his colleagues found that in vivo cholera toxin not
only produced chloride ion secretion but also enhanced bicarbonate
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ion efflux (Leitch, Iwert, Burrows, 1966). A1 Awqati's group
confirmed the results obtained by Field in 1969 (A1 Avqati,
Cameron, Field, Greenough, 1970a). Bicarbonate ion flux probably
accounts for the residual ion flux that is not accounted for by
the movement of chloride and sodium ion3 in control tissues.
In vivo bicarbonate transport appears to be of greater
importance than that of chloride ions (Banwell et al, 1970,
Leitch & Burrows, 1967, Leitch et al 1966, Moore, Bieberdorf,
& Morawski, 1971). Field and his co-workers were able to
inhibit the effect of cholera toxin in rabbit ileum preparations
in vitro by replacing both the bicarbonate and chloride ions
in the Ringer solution with sulphate ions. If only one was
removed or if the sodium was omitted and choline substituted
for it, then the rise in short circuit current due to cholera
toxin was reduced. (Field, Plotkin & Silen 1968). Glucose-
independent transport of sodium is inhibited by the toxin
while the glucose-dependent pathway is unaffected. Glucose
perfusion of the intestine in animals and human patients is able
to increase sodium and water transport to such an extent that
the effect of cholera toxin is abolished (Serebro, Bayless,
Hendrix, Iber, McGonagle, 1968).
Pharmacological Modification of Choleraic Diarrhoea
Therapy in cholera has proved to be a difficult task
despite the simplicity of the treatment required to ensure
recovery in the majority of patients. Rehydration is essential
but the countries ravaged by cholera generally have inadequate
hospital facilities and trained staff to carry out this procedure.
The administration of antibiotics i3 of limited use as the
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choleraic syndrome is self limiting - the massive diarrhoea
serving to purge the intestinal tract of the causative agent
(Banwell and Sherr, 1973). Prophylactic vaccination is
difficult to execute on the scale required and as protection
is of limited duration, affords little hope, as yet, as a means
of controlling the disease. (Sheahan, 1972).
Attempts to interfere with fluid production in experimental
models of cholera have had mixed success. Ethacrynic acid
has been found to inhibit the effects of cholera toxin in
in vitro models (A1 Awqati, Greenough & Carpenter, 1969).
Cycloheximide prevents fluid secretion in rabbit intestine
when administered prior to toxin challenge (Serebro, Iber,
Yardley & Hendrix, 1969; Moritz, Iber, Moore, 1971) but the
doses required exclude its use in human therapy. Rats have
been shown to be insensitive to the drug (Strombeck, 1971).
Cycloheximide is thought to exert its inhibitory effects by
interfering with the enhanced sodium flux from plasma to lumen
due to cholera toxin. (Grayer, Serebro, Iber & Hendrix, 1970;
Harper, Grayer, Yardley & Hendrix, 1970).
Intraluminal administration of acetazolamide also reduces
the effect of toxin challenge (Norris, Curran & Schultz, 1969).
Salt solutions containing glucose perfused intralurainally are
also beneficial and when used in combination with acetazolamide,
are capable of abolishing fluid loss. These procedures may be
of limited application clinically as this treatment would
necessitate hospitalization and careful supervision of the
patient during therapy.
Erythose inhibits toxin production by V. cholerae (Chowdhury
K
& Datta, 1965). Its effect on toxin-induced diarrhoea has not
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been assessed. The use of this chemical in the prophylactic
treatment of cholera has not been investigated. It has been
shown to prevent diarrhoea in adult and infant rabbit models
challenged with viable V. cholerae organisms (Bhattacharja,
Chowdhury and Datta, 1965).
Loxomboom and his associates were able to inhibit the
inflammatory response induced by cholera toxin in the mouse
foot oedema model using protein synthesis inhibitors and
anti-inflammatory drugs. Aspirin was ineffectual and
tndomethacin was capable of reducing the response to cholera
toxin by 50$. (Loxomboom, Goth & Finkelstein, 1971).
Finkelstein was able to inhibit and reverse oedema in the
rat foot following toxin challenge using cycloheximide
(Finkelstein, Jehl and Goth, 1969).
Escherichia coli toxin-induced diarrhoea
The participation of E. coli in pathological processes in
the intestine has only been appreciated in the last twenty years.
Some strains of this bacterid can be isolated from the intestinal
tract of healthy individuals but there is a marked paucity of
their numbers in the upper small intestine. In disease states
the organisms populate the entire intestinal tract and the
upper bowel is particularly striking in this respect. This
alteration in distribution of the bacteria was first reported
by Thomson in 1955. It has boen suggested by Eanwell and Sherr
that the organisms may find their way into the small intestine
by retrograde spread from the lower regions of the gut as well as
by exogenous infection per os (Banwell & Sherr 1973).
Pathogenic strains of E. cold have been implicated in human
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adult and neonatal diarrhoeas (Neter, 1959J Ewing, Davis & Montague,
1963) in swine, piglet and neonatal calf diarrhoeas (Nielson & Sauter,
1968; Smith, 1962; Smith & Halls, 1967a, b). Sojka concluded
that most cases of neonatal diarrhoea in piglets were attributable
to coliform infection (Sojka, 1965, 1971) but in the calf, bacteria
are not the main cause of diarrhoea. Smith was able to
implicate E. coli in 7 of 127 unrelated cases of neonatal
diarrhoea that he investigated (Smith, cited in Bywater, 1974-) *
There is a sharp distinction between V. cholerae and E. coli
organisms with respect to their ability to initiate diarrhoea.
In the case of coliform organisms there are at least two
separate processes which can lead to the loss of fluid and
electrolytes from the intestine. Both invasive and non-invasive
strains of E. coli exist. The former induce secretory activity
and damage the intestinal epithelium at the same time. The
latter, however, are able to activate secretory mechanisms without
any concomitant disruption of mucosal cell integrity (Sheahan, 1972).
Some strains produce Salmonella-like and others Shigella-like
diarrhoeas (Sakazaki, Tamura & Saito, 1967). Invasive organisms
elicit inflammatory changes in the intestinal mucosa (Taylor et
/
al, 1958; Yahagaki, Goda & Sazaki, 1967). The effects are
seen within seven hours of infection (Ogawa, Nakamura & Sakazaki, 1963).
Non-invasive strains do not have this capacity.. De and his associates
and Taylor1s group were unable to demonstrate inflammatory
reactions with non-invasive strains (De et al, 1956j Taylor,
Wilkins, Payne, 1961). These organisms are believed to produce
their untoward effects via toxins (Gorbach, 1970). Thus the
non-invasive, toxin-producing strains resemble 7. cholerae in
the manner in which they stimulate fluid and electrolyte losses in
the intestinal tract superficially at least. Only one mechanism
is thought to be operative in choleraic diarrhoea, (see previous
section).
The Toxins of Escherichia:. Coli
There are several reports of cell-free material prepared
from cultures of E. coli being capable of exerting enterotoxic
activity in the small intestine in animals. Bywater observed
fluid and electrolyte loss in calf small bowel following challenge
with a heat-stable cell free fraction (Bywater, 1970, 1973a, b).
Pierce and Wallace stimulated secretory activity in dog and
rabbit intestinal loops by introducing similar crude toxin
fractions into the ligated loops (Pierce & Wallace, 1972).
The preparation was thought to contain both heat-labile
and heat-stable forms of the enterotoxin as the crude material
was only partially heat-stable.
As do other gram negative bacteria, E. coli produce
endotoxins but the importance of this toxin in producing diarrhoea
is somewhat obscure. This toxin cannot evoke secretory responses
if injected into intestinal loops in pigs (Smith & Halls, 1967a),
nor in calves (Bywater, 1970). Endotoxin can however elicit
hypersensitivity reactions in the intestine (Thomlinson, cited
in Bywater, 1974) and stimulate inflammatory responses in pig
gut (Kejfaworthy, 1974). Jacks and his associate^ were unable to
separate enterotoxic and endotoxic activities by various separative
techniques including gel chromatography and ultrafiltration when
they used a crude toxin preparation as the starting material (Jacks, Wu,
Braemer, Bidlach, 1973). Endotoxin is a lipopolysaccharide heat-sensitive
component of the bacterial cell. Two enterotoxic moieties have
been identified: a heat-stable and a heat-labile toxin (Gyles
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& Barnara, 1969: Smith & Gyles, 1970.P-). The heat-stable toxin
is associated with the extracellular medium when E. coli are grown
in culture whereas the labile form is only detectable in cell
lysate preparations. The latter toxin is a high molecular
6
weight compound (M Wt. 5 x 10 ) but the former is a much smaller
entity, its molecular weight being 1000-10000 (Banwell & Sherr,
1973! Bywater, 1970). The toxins also exhibit different
antigenic properties. Heat-labile material can be neutralized
by E. coli specific antisera in contrast to the heat-insensitive
forms which cannot. This was demonstrated by Rutter and Luther
in 1973. Rabbit loop sensitivity to the toxins is a further
means of differentiating between the two types of enterotoxin.
The model is susceptible to challenge by the heat-sensitive
toxin but not to the heat-stable form (Smith & Gyles, 1970b).
The onset of diarrhoea occurs earlier with the heat-stable
toxin and the effects are already apparent two hours after
infection. The heat-labile toxin does not produce any measurable
effects for a further one or two hours, (Larriviere ot al, 1972).
It has been suggested that the two forms of enterotoxin may, in fact,
be a single enterotoxic substance. There are several objections
to this hypothesis of Smith and Gyles (Smith & Gyles, 1970b).
Although all strains of E. coli investigated and found to be
enterotoxic in pigs are capable of synthesising the heat-stable
toxin, not all strains produce heat-labile forms. The possession
of the K 88 antigen appears to be associated with this property
of E. coli strains. Gyles and Barnum noted that more entero-
pathogenic strains produced heat-labile toxin alone. Heat-labile
toxin from one strain which was enterotoxic in pigs was a more
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potent stimulant of fluid secretion in the rabbit loop model than
the heat-stable toxin produced by the same strain (Smith & Gyles,
1970b). Heat-labile toxin is a much larger molecule than the
heat-stable toxin and causes death by endotoxic shock rather than
by dehydration which is the lethal factor in heat-stable toxin
syndromes. The work of Kohler has provided these results
(Kohler, 1971). It is feasible therefore that the larger
heat-labile toxin contains the endotoxic moiety in its structure.
In support of the single enterotoxin theory is the observation
that both toxins are transferred on the same ent-plasmid
during bacterial replication and both are resistant to the
effects of trypsin, and neither is adsorbed on to Violin nor
aluminium hydroxide (Sheahan, 1972). Skin permeability
enhancing activity is not associated with either toxin, although
one strain of E. coli (08: K87, K88a, B:H19) has been found
to possess such activity (Moon & Whip,.1971: Glew, Gorbach,
Sack & Wallace, 19695 Sack, Gorbach, Banwell, Jacobs St.
Chatterjee, 1971).
Toxins have been produced by various methods (Smith &
Halls, 1967b: Kohler, 1968: and Gyles & Barnura, 1969).
Experimental Models
(a) Rabbit Ligated Loop Model.
This model has been employed to assess the effects of cell-free
preparations of E. coli cultures on gastro-intestinal function.
Zinnaka and Carpenter investigated the nature of the fluid losses and
the electrolyte composition and protein concentration in the secreted
material (Zinnaka & Carpenter, 1972). De, Battacharya and Sarker
tested a wide range of E. coli strains for enteropathogenicity
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in this model and found good correlation between the ability
of the strains to cause diarrhoea and to stimulate fluid production
in the intestinal loops (De et al, 1956). All three strains
of coli isolated in infantile diarrhoea and fifteen of the
twenty strains obtained from adult intestine in patients with
acute diarrhoea were found to give positive loop lesions.
Taylor and Maltby together with Payne observed that the proximal
small intestine was more sensitive to the toxin than more
distal segments. (Taylor et al 1958). McNaught and
Roberts (1958) showed that positive loop lesions could be
elicited with coliform bacteria isolated from human patients
but Taylor, Wilkins and Payne were not able to confirm the
usefulness of the model when they tested the effects of E. coli
strains isolated from other animals and which had been shown
to be enteropathogenic in those species (Taylor, Wilkin3 and
Payne, 1961). Other interesting observations on the locus
of isolation of the organisms and their ability to stimulate
fluid production in this model were made by Namioka and his
colleagues (Namioka et al, 1958). Namioka demonstrated that
whereas fourteen of the fifteen strains isolated from the
ileum of pigs dying of transmissible viral enteritis were
able to cause fluid secretion, none of the ten obtained from the
\
colon were active. Larriviere has used the model to distinguish
the two different types of enterotoxin (Larriviere et al, 1972).
Rabbit jejunal loops have been used by Glews and by Sherr's
groups to investigate various aspects of E. coli-induced
diarrhoea (Glew, Gorbach, Sack & Wallace, 1969: Sherr, Banwell
& Hendrix, 1971).
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(b) Pig Intestinal Models.
Both ligated and perfused loop systems have been developed
to investigate the changes that occur in intestinal handling of
water and electrolytes (Bywater unpublished observations).
The ligated loop has also been used by Moon and his associates
(Moon et al, 1971).
(c) Thiry-Vella Loop Models.
These loops have been employed in dogs (Pierce and Wallace,
1972) and in neonatal calves (Bywater, 1970, 1973a) to follow
the changes in fluid and electrolyte behaviour after the
administration of E. coli toxin preparations.
(d) Ligated Intestinal Loops in Calves.
This type of experimental model has been used by Bywater
to follow the fluxes of water and inorganic ions at various
levels in the intestine in healthy and infected animals.
(Bywater & Jeffries in preparation, Bywater, 1973b).
Mechanism of Action of E. coli Toxin
Escherichia coli toxin resembles cholera toxin in that it
fails to produce any overt histopathological changes in the
intestinal mucosa either in animal or in human patients (Moon
et al., unpublished observations cited in Sheahan, 1972:
Kohler & Cross, 1969s Banwell, Gorbach, Pierce & Mitra, 1971).
It has been suggested that the K88 antigen secures the attachment
of the bacteria to the epithelial surface of the intestine by
penetrating the surface layer of mucus (Jones & Rutter, 1972).
Colonization of the upper small intestine and toxin production
are essential to the pathogenic mechanism (Sheahan, 1972).
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The nature of the fluid secreted in E. coli diarrhoea is
identical to that produced in response to cholera toxin challenge both
in ionic composition and in the relative absence of proteinaceous
material. It also shows the same isotonicity to plasma as the
choleraic fluid. These results were obtained in dogs (Pierce
& Wallace, 1972} and in rabbit and pig intestinal loop models
(Moon, Whipp, Engstrom & Baetz, 1970).
The similarity of the anatomical lesions or rather the lack
of them and the biochemical changes which occur in these bacterial
diarrhoeas is highly suggestive that the same mechanism is
responsible for the symptoms. Like cholera toxin, E. coli
toxin has been shown to stimulate adenyl cyclase activity in
the intestinal tissue (Guerrant, Chen & Sharp, 1972; Kantor,
Kao & Gorbach, 1974) .Further support for the hypothesis of a
common mechanism is afforded by the work of Sherr. He and
his colleagues were able to inhibit E. coli-induoed fluid loss by
cycloheximide pretreatment (Sherr, Banwell & Hendrix, 1971). Not
all the evidence appears to give support to this theory however.
Glucose absorption in some species is unaffected by exposure of the.
intestine to toxin^namely,in the calf (Bywater, 1970) and in the dog
(Pierce & Wallace, 1972) but in the rabbit gut as in the piglet
glucose absorption seems to be depressed by E. coli enterotoxin
(Sherr, Banwell, Rothfield & Hendrix, 1973; Bywater & Jeffries
in preparation). It is possible that these results reflect
species differences in the response to toxin challenge rather
than differences in the mode of action of the toxins per se.
The response of pig and rabbit intestine to cholera toxin with
regard to the effects on glucose absorption under the same
experimental conditions as the coliform challenge has
not been reported. Other evidence which casts doubt
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on this hypothesis is the difference in the time coarse of the
cholera and E. coli toxin effects. The response to E. coli
toxin i£"of much shorter latency and is more transient than that
to cholera toxin challenge. The fact that pretreatment of
tissues with cholera toxin reduces the response to E. coli
toxin is in favour of their having a common mechanism of action
(Pierce & Wallace, 1972).
Neither toxin has an immediate effect on adenyl cyclase
activity although the latent period is shorter in the case of
the E. coli toxin. It is conceivable, therefore, that both
these toxins may stimulate the release or synthesis and
subsequent release of a mediator or local hormone that is
more directly responsible for the fluid and electrolyte losses.
The putative mediator would, in addition to being locally
available, have to be capable of mimicking the effects of
toxin challenge and in general would have to fulfil criteria
similar to those which have to be met with by postulated
transmittor substances at neural endings (e.g. for acetylcholine).
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Fart 3. Prostaglandins and Bacterial Diarrhoeas
Nomenclature
C^q polyunsaturated fatty acids are the precursors of a
relatively new group of lipid hormones, the prostaglandins.
The parent compound is prostanoic acid, the structure of
which is shown in Figure 1.
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All prostaglandins are related to this acid and may be
named systematically on the basis of their relationship to this
structure (Nugteren, van Dorp, Bergstrom & Hamberg, 1966), although
they are more usually referred to by their trivial names. There
are eight series of prostaglandins that are known to occur in
mammalian tissues: the smooth muscle stimulant substance of
Goldblatt (Goldblatt 1933) and von Euler (1934-) containing
prostaglandins of the F and E series (PGF and PGE); PGA and PGB,
the products of alkali treatment of PGE compounds; the prostaglandin
intermediate FGC which is formed from PGA by the action of
prostaglandin A isomerase (Jones,1972); PGD, also the product
of an isomerase-mediated reaction but derived from PGR series
of prostaglandins (Foss et al, 1973); the two PGR groups of
compounds, 15 hydroperoxy PGR (also termed PGG) and PGR
(also named PGH - See Samuelsson, 1973) which were identified
by Nugteren and Samuelsson independently (Nugteren & Haselhof,
1973; Samuelsson, 1973).
With the exception of the R series, all prostaglandins
have two structural features in common namely, the ^^2-14.
double bond and the hydroxy group at C^. All of the
prostaglandins exhibit differences in the cyclopentane ring.








PGA PGC PGB PGR
FIGURE 2. Structural differences in
the prostaglandin ring.
There are two side chain units composed of C^_7 and
carbon atoms and these are referred to as the and the^ chains
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respectively. In the B prostaglandins the <chain is in the
transfiguration whereas it occurs in the cis position in all the
other series. In the PGF groups epimerization at the hydroxyl
position is found. This gives rise to the^Cand^ types of PGF.
Only the Fw» prostaglandins are known to occur naturally and are
thought to be biologically significant.
There are several centres of asymmetry in the prostaglandin
molecule. Thus a large number of isomers may be synthesised
chemically (Caton, 1972). Only one unusual isomer is known
to occur naturally, the IS-epi-PGA^ isomer (Weinheimer &
Spraggins, 1969).
There are 3 sub-divisions for each group of prostaglandins.
These are named according to the number of double bonds in the
side chain part of the molecule. In the 1 series only one such
bondr is present in the structure - the CL, i. double bond. In
\ 14
the 2 sub-group another is found at the ^ position, and in the
3 series the third is contained in the chain at ^g.
19 hydroxy prostaglandins of the A and B type are found in
human semen but whether these should be regarded as separate
groups or as metabolites of PGA and PGB is not known.
(Bygdeman & Samuelsson 1964-, 1966).
The structure of some of the naturally occurring prostaglandins








































FIGURE 3. Some naturally occurring prostaglandins.
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Synthegiia
Prostaglandin storage is not a widespread phenomenon. The
level of hormone found in tissues is much lower than that which
can be released by an appropriate stimulus. Thus a readily available
enzyme system together with an adequate supply of precursors is
of prime importance for prostaglandin synthesis.
The enzyme responsible for this synthesis is associated
with the microsomal fraction of cells and is present in a large
number of tissues from various organs (van Dorp, 1966). The
richest source is seminal vesicle tissue from sheep (Nugteren,
Beerthius, van Dorp, 1966 & 1967; Bergstrom, Danielsson &
Samuelsson, 1964) and ox (Wallach, 1965). Studies with these
preparations indicate that the type of prostaglandin formed and
the relative amount of each may be influenced by several factors:
The presence or lack of co-factors (Samuelsson, Granstrom &
Hamberg, 1967; Xashimoto, Ito & Tomita, 1970); the addition
of hormones, e.g. oestrogens and progesterone (Poyser, 1974),
catecholamines and biogenic amines (Foss, Sih, Takeguchi &
Schnoes, 1973). Giroud has shown that in inflammation the
ratio of PGE to PGF increases (Giroud et al, 1974). There is
circumstantial evidence that PGR may be the unstable active
principle of rabbit aorta contracting substance (Gryglewski &
Vane, 1972; Samuelsson & Hamberg, 1973) released from traumatized
guinea-pig lung (Piper & Vane, 1971). The mechanism whereby
polyunsaturated fatty acids are converted into prostaglandins
has been elucidated (see Review by von Euler, 1967; Gorton, 1972
and Caton, 1972). Tissues from different sources show preference
in the type of prostaglandin they synthesize normally.
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Distribution
Prostaglandins are widely distributed in animal tissues
and in fluids including intestine, lung, heart, smooth muscle,
endometrium, skin, brain, iris, semen and menstrual fluid (see
Reviews and Monographs - Bergstrom, Carlson & Weeks, 1968^
Horton 1969, 1972, Karim 1972 and Cuthbert 1973). The
Gorgonian coral i3 the only non-mammalian, non-amphibian source
of prostaglandin - it has been found to contain significant
quantities of 15-epi and its methyl ester. (Weinheimer
& Spraggins, 1969; Bundy, Lincoln, Nelson, Pike & Schneider,
1971).
Release
Spontaneous and evoked release of prostaglandins has been
observed in a wide variety of tissues in many species (see Table 1).
A physiological milieu is not a prerequisite for prostaglandin
release, and release of these compounds is often found in
pathological conditions. Thus in some inflammatory conditions
e.g. uveitis and conditions resembling uveitis produced by
mechanical stimulation in rabbits, and uveitis in man (Ambache,
Kavanagh and Whiting, 1965; Eakins, Whitelocke, Perkins, Bennett
and Unger, 1972; Eakins, 1973), allergic dermatitis and
inflammatory skin conditions (Greaves, McDonald-Gibson and
S^ndergaard, 1971) prostaglandins are released in greater amounts
into perfusates as compared to the amounts found in the perfusate
of normal uninflamed tissues. Burn injuries in man and
experimental animals are associated with enhanced output of PGE
predominantly into blister fluid and lymph draining from the
affected site (Jonsson and Hamberg, 1973) The PGE-like material
was conclusively identified as PGE£ by gas chromatography-mass
- 34 -









Bennett et al, 1967, 1
Ramwell St Shaw, 1968a, 1
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Stomach Serosa 1) Spontaneous, vagal
transmural stimulation
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Volta 4 Wolfe, 1967, 1
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Skin Inflammation Caraghenin Willis, 1969
. Lung Air Embolus Alabaster & Bakhle, 1970
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Piper & Vane, 1971, 2, 8
Vogt et al, 1969, 3
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Stirring Palmer, Piper, Vane, 1970a
Uterus Distension Poyser, 1971
Dog Spleen Particulate material Gilmore, Vane, Wyllie,1969
Bladder Distension Gilmore, 1968





Ambache et al, 1965
Eakins, Whitelocic, Perkins,
Bennett and Unger, 1972
Epigastric
fat pad
Hormonal Lewis & Matthews, 1969
Intestine Spontaneous, diarrhoea Thesis Section 1
Leukocytes Phagocytosis Higgs & Youlten)1972
Human Thyroid Carcinoma Sandler et al, 1969,
Williams et al, 1968.
Uterus Partuition Karira, 1968





Human Eye 1) Uveitis
2) Acute angular glaucoma
Eakins et al, 1972






Greaves et al, 1971
Jonsson & Hamberg, 1973
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spectrometry by Arturson, Eamberg and Jonsson (1973)• -Tumours
of the thyroid and certain other tumours of the fore and mid-gut
are thought to release prostaglandins into the blood stream
and it is possible that some of the side effects experienced
by patients may be attributable to this (Sandler, Karim and Williams,
1968; Sandler, Williams and Karim, 1969). Conclusive
identification of the prostaglandin, which resembles
in its thin layer chromatographic and biological activity, is
however lacking. Prostaglandin release from rat stomach has been
demonstrated by Bennett and his colleagues and by Pace-Asciak,
Morawska, Coceani and Wolfe (Bennett, Friedmann and Vane, 1967;
Pace-Asciak, Morawska, Coceani and Wolfe, 1968a). Mucosal
release exceeds that of the serosal and muscle tissues (Wolfe,
Coceani, Pace-Asciak, 1967).
Prostaglandins and the Gastro-intestinal tract
Prostaglandins are found throughout the entire length of
the gastro-intestinal tract in man, pigs, rats, guinea-pigs and
rabbits (Table 3). Little is known about the relative distribution
in the individual layers of the gut wall, although Bennett and
his associates found that in human stomach, the highest
concentrations are contained in the mucosal layer (Bennett,
Murray and Wyllie, 1968a). It is likely that strain and species
differences occur in the type and relative amounts of prosta¬
glandins present in the gut. Coceani and Pace-Asciak together
with Wolfe detected PGE1 , PGE„, PGF1 and PGF- in perfusates• I iX. <. ,X
following response to nerve stimulation of rat stomach (Coceani,
Pace-Asciak and Wolfe, 1968). Bennett found PGE^ and some PGF^
only in a series of experiments in which the release of
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prostaglandins into luminal perfusates of rat stomachs during
nerve stimulation was investigated (Bennett, Friedmann and Vane,
1967). The characterization of the prostaglandin was by thin-
layer chromatography and biological assay in both instances.
Shaw and Ramwell observed release of PG3., PGF„ and PGF_ , from1 loC 2 {X.
stimulated rat stomach (Shaw and Ramwell, 1967).
Prostaglandin compounds affect motility and secretory
activity in the gastro-intestinal tract.
- 39 -
Site Species Reference
Stomach Man Bennett, Murray & Wyllie,
1968a
Rat Bennett et al, 1967
Coceani, Pace-Asciak,
Volta, Wolfe, 1967
Intestine Frog $ogt, Suzuki & Babilli,
1966








Guinea pig, rabbit Ambache, Brummer, Rose
& Whiting, 1966
Large intestine Man, rat,
guinea pig
Bennett & Fleshier, 1970
Pig, calf M. Dlugolecka, unpublished
observations
Pig Miyazaki, 1968
Table 3. The occurrence of prostaglandins in the gastro¬
intestinal tract.
Prostaglandins and Gastro-Intestinal Motility
In vitro PGE and PGF contract whole segments of intestine
in most species investigated, although in guinea-pig colon and
rat jejunum relaxation may precede contraction (Bennett &
Fleshier, 1969; Bergstrom, Duner, von Euler, Pernow & Sjovall,
1959). Circular muscle responds to PGE^ and PGS^ by relaxing
or by inhibiting the effect of other stimulants, e.g. acetyl¬
choline (Bennett, Eley & Scholes, 1968b; Bennett & Fleshier, 1970).
PGF causes contraction of both longitudinal and circular muscle
in guinea-pigs, rat, and man (Bennett & Fleshier, 1970), and in
dogs (Vanasin, Greenough, Schuster, 1970). PGE contracts
longitudinal muscle in human stomach (Bennett et al, 1968a).
The contractions produced by PGE and PGF compounds differ
qualitatively; that of the F series being slower in onset and
taking longer to reach the peak height at a given dose (Horton
& Main, 1965). Opposite effects are observed with these two
prostaglandins on peristaltic activity induced by increasing
intraluminal pressure. PGE^ inhibits peristalsis when applied
serosally whereas PGF enhances peristaltic contraction of circular
muscle (Bennett & Fleshier, 1970).
In vivo intravenous injection of a mixture of prostaglandins
causes an increase in intestinal motility in rabbits and mice
(von Euler, 1966). PGE^ and PGE^ given by either intravenous
or intra-arterial injection to rats contract intestinal muscle and
increase intraluminal pressure (Bennett, Eley & Scholesf1968c)
but in dogs inhibition of vagally induced contraction occurs
(Chawla & Eisenberg, 1969). A similar inhibitory effect is seen
in rats (Main, unpublished observations, Main 1972). Intra-arterial
injection of *^2^ in dogs, via the Superior Mesenteric artery,
«• 41 *•
produces contraction of the jejunum.
In man, intravenous infusion of PGE results in abdominal
cramps in the subjects (Bergstrom et al, 1959; Carlsson, Ekelund
& Oro, 1968). Horton et al noted increased intestinal motility
in human volunteers given doses of PGE^ totalling 0.8-3.2 mg
orally. Sensations of mild colicky pain and enhanced motility
were experienced by the participants (Horton, Main, Thompson
& Wright, 1968). Misievicz carried out objective investigations
and observed that there was a delay of 30-120 min. in onset of
effects and that their duration was of the order of 1-6 hours.
There was marked increase in contractile activity of both the
small and large intestine. The decrease in transit rate could
have been attributable in part to the increase in volume of
intestinal content - secretion of watery fluid occurred
contemporaneously. (Misiewicz, Waller, Kiley & Horton, 1969).
Diarrhoea in carcinoma patients can, in some cases, be correlated
with the enhanced levels of prostaglandin in peripheral venous blood
(Williams, Karim and Sandler, 1968),
Prostaglandin and Gastro-Intestinal Secretions
The effect of prostaglandins on secretory activity in the
gastro-intestinal tract depends on the region that is being
investigated. In the stomach PGE^ inhibits the secretion of
gastric acid, an inhibition of adenyl cyclase activity being
implicated in the response (Robert, 1968; Shaw & Ramwell, 1967).
There are reports both favouring and disputing the involvement of
3'5' cyclic adenosine mono phosphate (Wilson, 1972). An
inhibitory effect of prostaglandins on the adenyl cyclase system
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is also found in toad bladder, renal tubule and lipocytes
(Or Ioff, Handler, Bergstrom, 1965; Orloff & Grantham 1967;
Steinberg & Vaughan, 1967 and Hittelman & Butcher, 1972).
In the intestine Fierce and his collaborators found that PGE^
reduced the absorption of fluid and electrolytes in a dose «
dependent manner when applied to the luminal aspect of
Thiry-Vella loops. Doses of 2ug-24;Ug/minute or 1ug-12ug/ml
were used. Injection via the Superior Mesenteric artery had
similar results but the dose required to elicit a maximal «
secretory response was very much lower - 24ug/min. PGA^
and qualitatively similar effects as PGE^ although
PGF^ was more potent and enhanced the protein content of the
intestinal secretions. The response to cholera toxin was
studied in these animals and compared with that to prostaglandin
administration (Pierce, Carpenter, Elliott & Greenough, 1971).
A direct mucosal interaction was likely because isolated ileal
mucosa can be induced to secrete chloride ions and diminish the
absorption of sodium ions by adding either PGE^ or PGA^ to the
bathing fluid (A1 Awqati, Field, Pierce & Greenough, 1970b;
Greenough, Pierce A1 Awqati & Carpenter, 1969). PGE^ has
similar effects on ion secretion in isolated mucosa from rabbits
and man to theophylline, dibutyryl CAMP, and cholera toxin
(A1 Awqati, Cameron, Field, Greenough, 1970a). Prostaglandins
stimulate adenyl cyclase activity in the gut (Kimberg, Field,
Johnson, Henderson, Gershon, 1971; Sharp & Hynie, 1971).
Matuchansky and Bernier demonstrated that perfusion of isolated
segments of intestine with PGE^ inhibited the absorption of
water and electrolytes (Matuchansky & Bernier, 1971).
The ability of prostaglandin compounds to mimic the effects
of cholera toxin in the gut and the observation that intestinal
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adenyl cyclase activity is enhanced by E. coli toxin (Raskova,
1974), cholera toxin and prostaglandins might have been
indicative of prostaglandin involvement in the diseases
associated with V. cholerae and E. coll infection.
Anti-Inflamratorv Drags and Prostaglandins
Steroids and non-steroidal anti-inflammatory agents suppress
inflammatory processes by independent mechanisms. That modified
by steroid drugs remains a mystery but the mechanism of action
of non-steroidal compounds is better understood. These latter
agents are believed to ameliorate inflammatory states by
interfering with prostaglandin biosynthesis. Prostaglandins
are involved in the later stages of inflammation in earageenin—
induced oedema in rats (Willis, 1969). PGE^ activity increased
after a latency of several hours, reaching peak levels at about
16 hours after administration of the irritant.
Prostaglandin synthetase activity is suppressed or inhibited
anti-inflammatory agents in dog spleen (Ferreira, Moncada & Vane,
1971* Flower, Gryglewski, Herbacinska-Cedro & Vane, 1972),
guinea-pig lung (Vane, 1973) and uterus (Poyser, 1974.), in rabbit
brain (Flower St Vane, 1970) and kidney (Davis, 1971} Davis &
Horton, 1972), in human skin (Greavee.&McDonald -» Gibson, 1972}
Ziboh, McElligot St Hsia, 1972), and in platelets (Smith & Willis,
1971). ' Synthesis is abolished or at least markedly reduced in
bovine seminal vesicles (Tomlinson, Ringold, 9ures':ii and Forchielli,
1972). Vane (1971) has suggested that the beneficial effects
A
of Aspirin and Indomethacin is due to the suppression of
prostaglandin synthesis.
The sensitivity of all the above tissues is not identical
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with respect to the actions of the anti-inflammatory drugs but
there appears to be a good correlation between the order of
potency of the drugs as prostaglandin biosynthesis inhibitors
and their clinical effectiveness (Flower, et al, 1972). In
dog spleen a variety of drugs was studied and their ability
to inhibit inflamination was found to reflect their anti-
, t
prostaglandin activity. The ID^ of anti-inflammatory drugs
was observed to be lower than the plasma concentration likely
to be achieved on a therapeutic dose regime in most instances,
even allowing for plasma protein binding (Flower et al 1972).
Very high doses of prostaglandins are themselves capable
of exerting anti-inflammatory actions. It has been suggested
that steroid release may be involved in this situation
(Glenn & Rohloff, 1972).
There is much circumstantial evidence to implicate prosta¬
glandins in the initiation of fluid and electrolyte loss observed
in clinical and experimental diarrhoea in man and in animals.
This thesis was embarked upon with the intention of testing
this hypothesis. The scheme envisaged for prostaglandin
mediation of the bacterially induced diarrhoeas is outlined in
Figure 4- • Toxins prepared from V. cholerae strains and E. coli
heat-stable toxin were employed to simulate the clinical condition
in several experimental models and the answers to the following
questions were sought:
(l) Is prostaglandin release associated with the fluid and
electrolyte secretion induced by the bacterial toxins of V. cholerae
and E. coli or is it a reflection of non-specific trauma incurred
by the intestinal epithelium?
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(2) Do the toxins contain prostaglandins or do they enhance
7
the synthesis of prostaglandins.
(3) Is the fluid secretion induced by the toxins blocked by
inhibitors of prostaglandin synthesis and particularly
?
Indomethacin.
(4) Is a reduction in prostaglandin synthesis related in a
dose-dependent manner to the reduction in the diarrhoeic response
to toxin challenge;
(5) Can prostaglandins miraic the effects of toxins on the pattern
of ion and water movement in the small intestine? (This
aspect was only investigated in the case of E. coli toxin).
If prostaglandins are^mediators of the enteropathogenic effects
of the non-invasive enterotoxins then the changes in ion and
• water movement across the intestinal mucosa should be identical.
To prove that prostaglandins were causally related to the
bacterial toxin induced diarrhoeas would afford new approaches to
the clinical treatment of the syndrome which might be more
effective than those tried hitherto. (Bennett (1971) has
suggested that a trial of aspirin in the treatment of cholera
would be worthwhile). To exclude their participation would also
be of value in that it would serve to redirect therapeutic


















































Section 1. Part 1. The toxins used to simulate cholera in
experimental animals.
The production of toxin by V. cholerae is thought to be
essential to their enterotoxic effects although not all the
strains isolated from human patients during outbreaks of
cholera have been observed to elaborate toxins in in vitro culture.
This probably reflects the specificity of their growth requirements
rather than the absolute inability of that particular strain
to produce enterotoxin (Craig, 1971} Sheahan, 1972). Some
strainsof vibrio, like V. cholerae 569B^appear able to
synthesize toxins under a relatively wide range of growth
conditions whereas others like V. cholerae strain 12 r (Ogawa)
have much more stringent requirements (Latif, 1966? Sheahan, 1972).
The toxins used to investigate the role of prostaglandins in
toxin-induced diarrhoea and in particular choleraic diarrhoea
in experimental animals included two which were ready prepared,
solid toxins. These were reconstituted as required. The
third toxin preparation was produced by growing live vibrios
in vitro. The solid toxins were crude Wyeth lot 002 toxin
and highly purified freeze-dried toxin prepared from V. cbolerae
strain 225B. Wyeth toxin was donated by Dr. J. Seale, N.I.A.I.D.,
National Institute of Health, Bethesda, Maryland and was
obtained by growing V. cholerae strain 569B on Richardson's TRY
medium (Richardson, 1970). The lyophilized culture filtrate
contained 2, 650,000 Bd (blueing doses) per gram solid material.
Each 100g of the solid was prepared from approximately 8.45 litres
of crude culture. The rabbit skin permeability test (Craig, 1965b)
was used by the manufacturers (Wyeth Laboratories) to assess the
potency of the material. The purified toxin was a gift from
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Dr. Ungar, W.H.O.., Switzerland and was produced by growing V.
cholerae strain 225B on 3% peptone broth at pH 7.0 - 8.0.
The -culture filtrate was subjected to extensive purification using
protein precipitation and chromatographic techniques. This
material contained 1Bd per 12.5-15 jag purified solid and the unit
of rabbit loop toxicity was contained in 100 jag of the purified
toxin (Dr. Ungar - personal communication).
The third toxin used in these studies was that synthesised by
V. cholerae 12r (Ogawa) grown on 5% Difco BactoPeptone medium
containing 0.5& sodium chloride. This toxin was prepared during
the course of the experimental work and, unlike the other two
toxins, was stored as a liquid rather than as a solid. A
method is described for the preparation of this toxin. The
effects of incorporating antibacterial agents into the crude
toxin-containing filtrate on the toxic activity are reported. An
approximate estimate of toxin potency was obtained by comparing
the volumes secreted by intestinal loops following challenge
with the crude material and highly purified 225B toxin. The
crude toxin solution contained 4«5 loop toxic units per
millilitre - a 1.5 ml volume being equivalent to 600~800^ug
purified toxin. Slight variation between batches of crude toxin did
occur.
The preparation of enterotoxin from Vibrio cholerae strain
12r (Ogawa) and the incorporation of antibacterial agents into
the crude toxin-containing filtrate.
The method used to prepare the enterotoxin from V. cholerae
strain 12r (Ogawa) was based on that described by Latif for the




Vibrio cholerae strain 12r (Ogawa), isolated from a human
patient in East Pakistan by Dr. J. Feeley and freeze-dried after
serial passage through a suckling rabbit was redeemed from
Latif's freeze-dried stock stored on Dorset egg slopes, and
was used to seed a tube of Nutrient Broth Oxoid No. 2. The
broth was incubated static at 37°C for 6 hours. This culture
was then checked for growth of the organisms by phase contrast
microscopy and subculture on Agar plates. The organisms were
characterized as described by Latif in 1966. Subculturing
also enabled the presence of other contaminating bacteria to be
detected and to be eliminated by appropriate measures if
necessary.
Difco-Bacto Peptone medium was prepared as a 5% solution
containing 0,5% sodium chloride in volumes of 300 ml (Latif, 1966).
The pH of the medium was adjusted to pH 7.4 with sodium hydroxide
solution and any over-alkalinisation was corrected by the addition
of hydrochloric acid.
A Winchester Quart bottle containing 200 ml of the above
medium was seeded with a 5 ml aliquot of the Nutrient broth
culture and was incubated at either 37 or 30°C for 18 hours.
Constant movement of the culture was ensured by incubating in
a Gallenkampf shaking water bath or by using a magnetic stirrer.
The incubates were then centrifuged at 4,000 rpm for 40 minutes
at 4°C in an MSE major angle head centrifuge and the supernatant
was filtered through Sartorius membranes at 4°C. The sterility
of the filtrate was checked by incubating 1 ml aliquots in Autrient
broth for 20 hours at 37°C. The remainder of the filtrate
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was maintained at 4°C during this period.
In order to minimise the time interval between preparation
and use of the toxin solution it was decided to incorporate
anti-bacterial agents into the crude filtrate, provided that this
procedure did not result in significant loss of enterotoxicity.
The agents tested were Neomycin (l00^ug/ml) and chlorhexidine
as Hibitane solution (1:2000). This procedure rendered the final
sterility check superfluous as both Neomycin and chlorhexidine
were bactericidal in the concentrations used.
Control medium consisting of 5% Difco BactoPeptone medium
containing 0.5% sodium chloride was autoclaved at 121°C for
20 minutes and allowed to cool. The sterility of the solution
was checked by subculture techniques.
(b) Assay Systems
(1) The Rabbit Intestinal Loop Model
The rabbit ligated loop model has been used extensively
to investigate the enterotoxic effects of crude cholera toxin
preparations (Latif, 1966^ Sheahan, 1972) and purified toxin
(Ungar, personal communication). The technique has been described
in detail (Latif, 1966^ De and Chatterjee, 1953). A total of
8 rabbits was employed in this study: 5 were New Zealand White
rabbits and 3 were Brown and Black Lops. The group included
animals of both sexes and their weights ranged from 2.3 to 3.8 kg.
All were deprived of food in the 24. hour period prior to toxin
challenge. This procedure had the advantage of increasing the
sensitivity of the animals to the effects of the toxin (Craig, 1971)
as well as reducing the amount of food debris present in the small
intestine. The rabbits were anaesthetised by the intravenous
injection of sodium pentobarbitone, 40 mg per kg. At laparotomy the
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small intestine was exteriorized and sections of terminal ileum 10
to 15 cm in length were tied off by means of Mersilk ligatures.
A total of 8 to 12 loops was made in each animal, the last of
these loops extending to a point some 15 cm proximal to the
tip of the appendix. The rationale behind the use of this
section of small bowel as opposed to other regions is discussed
by Latif and Craig (Latif, 1966; Craig, 1971). Alternate loops
were inoculated with 1.5 ml of toxin and control solutions but the
maximum number of toxin-containing loops used in any one animal
was 5 in order to ensui'e maximal secretory responses (Craig, 1971).
The intestine was returned to the abdominal cavity taking care that
the loops were not traumatized further. The incisions in the
linea alba and the skin were sutured and the animals were allowed
to recover from the anaesthetic. The rabbits were transferred to
experimental cages for the remainder of the post-operative period.
No food was given during this time. Animals were re-anaesthetized
9 to 24 hours after toxin challenge and the abdomen was incised
once more. The small intestine was withdrawn very carefully
and the loops were examined for signs of haemorrhagic necrosis.
Any fluid present in the loops was aspirated and stored at -4°C or
-15°C. The volume of the choleraic fluid was noted.
(b) Skin Induration Assay
The method is given in detail by Latif and described by
Craig (Latif, 1966; Craig, 1965b). The fur on the rabbits' backs
was shaved as close to the skin as possible. An area approximately
8 cm by 12 cm was marked out and subdivided into 4 sections.
Intradermal injections of 0.1 ml and 0.2 ml toxin solution and
control medium were made, each of the toxin and control doses being
administered in diagonally opposite quadrants. The size of the
lesion at 8-12 hours after injection was noted. cUaav^y- o\. \w. \ea^>v
rf ft ^ ,/i CA, i«/vv <V\ .
Results
(a) The production of enterotoxin
Only filtrates obtained from peptone cultures incubated at
30°G were found to be enteropathogenic and to cause skin reactions
on intradermal injection. None of the batches of toxin produced
by incubating V. cholerae strain 12r at 37°G in peptone broth
was able to stimulate fluid secretion in the ligated ileal loop
in rabbiis. Some of the material did, however, possess skin
reactive substances - induration was detected following intracutaneous
injection of 0.1 ml and 0.2 ml crude filtrate in 3 rabbits. A
total of eight rabbits vaati injected with the toxin. Toxin
prepared by incubating at 30°C for 18 hours (T30 toxin) was twice
as potent a stimulant of induration as that prepared at 37°C (T37
toxin). An injection of 0.1 ml of T30 toxin produced a region of
induration of 0.7 cm in diameter whereas injection of an equal volume
of the T37 toxin resulted in a lestion of up to 0.5 cm in diameter.
None of the three batches of T37 toxin was able to stimulate fluid
production during the 9 to 24. hour experimental period. By
contrast, the loops challenged with T30 toxin were found to be
markedly distended with fluid by 10-12 hours and haemorrhagic
necrosis of the intestinal wall was invariably present at 24 hours
after toxin administration.
These results are summarized in Table 4«
(b) The effect of Incorporating Neomycin (lOO^ug/ml) and chlorhexidine
(1:2000 v/v) into crude cholera toxin filtrate.
Because T30 toxin alone was enterotoxic in ligated rabbit ileal
loops, the effects of neomycin (100yug/ml) and chlorhexidine (1:2000 v/v)
were investigated using this toxin. A blind trial method was used
Table 4. The Skin Reactivity and Enterotoxicity of V. cholera





























0.1 ml = +
0.2 ml = ++
LOP 2.6 kg
NZW 2.6 kg
T 37 C 0.1 ml = +
T 30°C 0.1 ml = ++











Key. 1. (a), (b), (c) refers to batches of toxin prepared
separately by 37°G incubation of 5$ Difco BactoPeptone
cultures.
2. NZW refers to New Zealand White and LOP to Lop strains
of animals respectively.
3. In skin reactivity estimations n+" indicates a lesion
of 0.5 cm in diameter.\ "++" records a lesion of more
than 0.7 cm maximum diameter. n-M indicates no lesion
detectable.
4. "++" indicates fluid secretion of more than 5 ml fluid
at 22 hours and the presence of haemorrhagic necrosis.
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to assess the potency of toxin solutions containing these agents and
comparing the activity with that of ordinary T30 toxin. No
difference was detected in the ileal response to T30 toxin, T30
toxin containing neomycin and T30 toxin containing chlorhexidine.
Neither chlorhexidine nor neomycin were able to stimulate fluid
secretion independently when given by intraluminal injection
to the ligated loop. i'he toxins were assessed in 2 rabbits.
Discussion
Only two previous reports of enterotoxin production using Ve
cholerae strain 12r (Ogawa) organisms have been encountered. Latif
in 1966 used this strain to produce and study the skin permeability
toxin in particular. In these investigations, significant amounts
of enterotoxic activity were obtained by incubating the organisms
in 5% Difco-BactoPeptone/0.5# saline medium at 37°C for 13 hours
(Latif, 1966). Attempts to reproduce this method of toxin
production were not successful. It is known that even slight
variations in medium composition, pH and other parameters like
surface to volume ratio and aeration, can greatly alter the amount
of toxin produced (Evans & Richardson, 1968; Latif, 1966). Under
the conditions of the experiment it was necessary to reduce the
temperature to 30°C to obtain reasonable quantities of enterotoxic
material. That total inhibition of toxin elaboration did not
occur at higher temperatures can be seen from the ability of
fresh T37 toxin to induce changes in skin permeability. Skin
permeability factor, which is responsible for induration, is
thought to be identical to enterotoxin possessing the same physical,
chemical and antigenic properties as enterotoxin (Craig, 1971;
ft>4, CkjJL h/vfC' Ui/VH
Sheahan, 1972). The pH appears to be critical in determining the
release of enterotoxin into the medium. Evans and Richardson (1968)
stated that a low initial pH was required for toxin production.
Callahan and Richardson demonstrated that only when the pH of
the medium rose to pH 7.4 did significant release of toxin
material occur (Callahan & Richardson, 1973). The initial pH tyTW
used was pH 7.4, therefore, release of toxin should not have been
impeded by an acidic medium nor was it too alkaline to suppress
toxin synthesis. It is possible that although significant
toxin production occurred at 37°C, that the toxin rapidly
deteriorated in the medium at this temperature. Cholera
enterotoxin is unstable and activity falls off very quickly at
such temperatures (Latif, 1966). A combination of high temperature
(37°C) and initial alkaline medium (pH 8,0 or more) suppresses
toxin production (Evans & Richardson, 1968).
The addition of neomycin 10Cml or chlorhexidine (1:2,000)
does not diminish toxin potency. Neomycin, an antibacterial
agent synthesized by Streptorayces fradiae is effective against
both gram negative and positive organisms (Wilson & Schild, 1968)
and thus would inhibit any residual V. choleras growth and also
kill any contaminating organisms in the intestinal loop itself.
case of cholera toxin, no significant decrease in enterotoxin
activity was found (Smith & Halls, 1967b). Neomycin itself was
unable to stimulate fluid secretion and, therefore, the fluid
we+e.
losses from the intestine in rabbits was directly attributable
to the effects of cholera enterotoxin. Neomycin is a protein
synthesis inhibitor (Wilson & Schild, 1968). It is intriguing
that other protein synthesis inhibitors like cycloheximide are
This drug has been used in Escheri/ahia coli enterotoxin filtrates
(U
in concentrations In this preparation, as in the
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capable of interfering with the secretory processes stimulated by
cholera toxin (Serebro et al, 1971; Moritz et al, 1971). Neomycin
is poorly absorbed from the gastro-intestinal tract (Wilson &
Schild, 1963). It is possible that its inability to modify
choleraic secretions is due to the failure of the drug to reach
intracellular sites in the intestinal mucosa. Like neomycin,
chlorhexidine is also bactericidal. This compound is an organic
halogen which in low concentrations is non-irritant to mucosal
epithelium (Wilson & Schild, 1968). Thus it would not be likely
to interfere with the secretory response of the intestine to
cholera toxin by causing epithelial cell damage.
Crude cholera toxin and stool filtrates from human cholera
patients are capable of causing induration and increasing skin
capillary permeability in guinea-pigs and rabbits (Craig, 1965b).
Induration and enhanced permeability are probably two manifestations
of the same underlying vascular defect. Induration is probably
as satisfactory a method of estimating toxin potency as the blueing
effect seen after intravenous injection of Evans Blue dye at the
site of toxin injection. Both techniques have been used to assess
toxicity in V. cholerae strain 569B and 12r (Ogawa) toxins by
Latif (Latif, 1966). In this series of experiments only skin
induration was studied. Latif showed that there was a very good
correlation between induration and blueing effects produced by
the same dose of toxin in guinea-pigs (Latif, 1966).
The use of skin induration as an index of toxin production
appears to be a very sensitive method of gauging toxicity of crude
filtrates. Although the time course is different from that seen
with the skin blueing lesion size, it is also a good means of comparing
the toxic abilities of different solutions. The blueing response
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reaches its maximum size over a 1£ to 8 hour interval, the lesion
increasing from 2 to 8 mm, but the intensity of blueing continues
to develop until 13 to 24 hours after the inoculation. Skin
induration, however, caused by the same dose of crude filtrate
shows a more gradual progression and the peak effect is seen at
18-24 hours. Figure 5 shows the relationship between induration
and blueing and is adapted from Craig, 1971. It is in fact
probably easier to compare the size of lesion at a given time
than the intensity of the colour reaction in vivo.
diameter of induration
blueing (mm), . index.y colour
time (hours)
Figure 5.
Figure 5. The time course of enhanced capillary permeability and
induration following intracutaneous injection of 0.1 ml of 1:20
diln of cholera stool filtrate in guinea-pigs (from Craig, 1971).
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This technique was therefore used to indicate the presence
of toxin activity in crude filtrates prepared from V. cholerae
12r (Ogawa).
Conclusions
(1) The production of enterotoxin by V. cholerae strain 12r (Ogawa)
requires lower rather than higher temperatures under the conditions
used to incubate live vibrio?.
(2) The incorporation of neomycin or chlorhexidine did not appear
to detract from the enterotoxicity of crude toxin filtrates.
The incorporation of neomycin (l00ug/ml) into such filtrates
adopted as a standard procedure to ensure bacterial sterility.
(3) Skin induration gives a sensitive index of toxin production.
The size of the lesion is dependent on the dose of toxin filtrate
" used and shows a good correlation with the enterotoxic activity
of the filtrate preparation under investigation.
SECTION 1. PART 2 - 59 -
Experiment 1
The Release of Prostaglandins in the rabbit ligated loop model of
cholera.
The ileal, ligated loop in rabbits has been widely used in
cholera research. It has the advantage of ieing a simple model
to prepare, gives reproducible results (De et al, 1960; Jenkin
& Rowley, 1959; Pierce & Wallace, 1973), and the fluid which
accumulates in the loops resembles that secreted in human cholera.
The model is analogous in some respects to certain tissue injuries
e.g. burns and local inflammatory conditions in that fluid
accumulation due to trauma occurs in a confined region. In both
burn and inflammatory skin lesions prostaglandin release occurs
(Jonsson & Hamberg, 1973; Greaves et al, 1971). It is possible
therefore that in the ligated loop model, prostaglandin release
into the pathologically produced fluid also occurs. This theory
was tested.
Methods
Eleven rabbits, of both sexes, weighing 1.7 to 3.5 kg
were deprived of food in the 24 hour period prior to the operation
but were allowed free access to water. The animals wei'e anaesthetized
with pentobarbitone sodium, 4-Omg/kg, given by intravenous injection.
The intestine was exposed at laparotomy and the terminal small
intestine was exteriorized. A maximum of 8 loops each 10 to 15
cm long were created in the distal ileum by means of raorsilk ligatures,
the last loop reaching a point 15 cm proximal to the tip of the
appendix.
Toxin solution, prepared either from V. cholerae 12 r and
containing approximately 4-.5 blueing units of activity per ml or
purified V. cholerae 2253 toxin containing 1 blueing units/15 Ag
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solid material and made up in stock solutions of 600-800 yug/ral
in 0.9% saline, were used to challenge intestinal loops. Control
loops, which were alternated with toxin-treated loops, were
inoculated with either sterile control Difco-Bactopeptone medium
or inactive toxin solution. Inactive toxin solutions were those
solutions prepared by growing V. cholerae at 37°C and which contained
\
no detectable skin induration activity in the animals receiving V.
cholerae 12 r toxin. If V. cholerae 225B toxin was the secretory
stimulant, then 0,9% saline injections were administered to the
control segments. The volumes injected were 1.5 ml of the V.
cholera 12 r toxin and appropriate control solutions, and 0.1 ml
of V. cholerae 225B toxin solution and normal saline.
After inoculation, the intestine was returned to the abdominal
cavity and the incision was sutured. Animals were allowed to recover
from the anaesthetic and returned to their cages. No food was given
in the ensuing period but water was allowed. Animals were killed
8-12 hours after toxin challenge (5 animals) and 22-24. hours after
toxin administration (6 animals). The fluid which had accumulated
in the toxin loops was collected on ice and either extracted
immediately or stored at -15°C until extraction could be carried out.
The appearance of the intestinal wall was noted and the presence of any
haemorrhagic necrosis was recorded.
Extraction of Samples
Standard techniques based on those described by Bergstrom and
Samuelsson (1963) and Horton and Main (1967) were employed. Two
methods (Method A and Method B) were used to extract prostaglandin-
like material from the fluid samples. The procedures are outlined
in Figures 6a and 6b.
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Figure 6(a). The Extraction of Prostaglandins from Fluid. Samples
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Residue stored at -15°C.
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Method A
Samples were acidified to pH 3.5 to pH 4.0 using either 10%
citric acid or 10% acetic acid, after the volume had been measured.
The acidified fluid was then partitioned twice with two times an
equal volume of redistilled ethyl acetate and the organic phases were
pooled, evaporated to a small volume (20-25 ml) and then partitioned
with twice equal volumes of phosphate buffer, pH 8.0. This phosphate
buffer partition was performed twice. The buffer fractions were
combined and acidified to pH 3.0 to 3*5 using 10% acetic or citric
acid. A second ethyl acetate partition followed; again using
U5Jr^ K Cvw.
Wtee equal volumes and two partitioning steps. The inorganic phase
was discarded and the ethyl acetate fractions were combined, and
evaporated to dryness under reduced pressure. The residue was
dissolved in 25 ml 61% ethanol and shaken with ,15 ml heavy
petroleum spirit. This petroleum phase was discarded and the
ethanolic material treated similarly with a second 15 ml volume of
petroleum spirit. The ethanol solution was then evaporated to
dryness and desiccated. The residue was stored at -15°C prior to
silicic acid chromatography or thin layer chromatography purification
and separation of the prostaglandin-containing extract.
Method B
Samples were extracted into ethyl acetate as described in
Method A. The ethyl acetate fraction was evaporated to a small
volume (20-25 ml) and washed with 10 ml distilled water (pH less
than 5.0). The washed ethyl acetate was evaporated to dryness under
reduced pressure and the water phase was discarded. The residue
was dissolved in (fl% ethanol (25 ml) and the extraction of
prostaglandins and prostaglandin-like material was completed as
in Method A.
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The results obtained by Methods A and B were not significantly
different but the latter method had the advantage of being less time
consuming.
Silicic Acid Chromatography:
The use of this technique to separate the different series of
prostaglandin compounds was first described by -BergstfOa itnd'
Samuelsson (1963).
Silicic acid 4*5 g SIL-R, 100-300 mesh or Bio-Rad SIL A,
100-200 mesh Batch 6910, was weighed out, dried and activated by
heating at 100°C for 1 hour. After cooling the silicic acid, a
slurry was made by adding petroleum spirit and this was then poured
into a 10 cm long glass column 1 cm in diameter. The column was
washed with 10$ ethyl acetate in toluene. The solvent system
used varied with the batch of silicic used: in the case of the
Sigma silicic acid an ethyl acetate-toluene solvent system was
found to be satisfactory but when Bio-Rad silicic acid was used,
the addition of methanol was required. Increasing percentages of
ethyl acetate in toluene were used to elute prostaglandins of the
A and E series. The systems used to elute the PGA and PGE-like
material in the fluid samples are outlined in Table 5. Poyser
(1971) had shown that PGE compounds were eluted in 65$ Methanolic
Ethyl Acetate and 60$ Ethyl Acetate-Toluene Mixtures with these
batches of silicic acid. Prostaglandins of the A series were
eluted in the 30$ Ethyl Acetate-Toluene fractions. This was
' 3-
demonstrated by running standard columns using H-labelled PGA^
and following the elution of the radioactive material by scintill¬
ation counting techniques.
The samples were dissolved in 10$ Ethyl acetate in benzene
and added dropwise to the top of the silicic acid column, using
a Pasteur pipette. The flask was rinsed carefully with aliquots
Table 5
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(a) Solvent Systems used to elute prostaglandins from Bio-Rad
SIL-A, 100-200 mesh Batch 6910, columns.
Fraction Volume Solvent Content - Percentages
Number (ml) Methanol Ethyl Acetate Toluene
1 AO 0.05 19.95 80
2 100 0.10 29.90 70
3 20 0.10 29.9D 70
A AO 0.25 39.75 60
5 130 0.60 6A.A 35
6 20 0.60 6A.A 35
7 130 2.5 77.5 20
9 AO 100 "" —
(b) Solvent System used to elute prostaglandins from Sigma SIL-R*
100-300 mesh silicic acid.
Fraction Volume Solvent content - Percentages
Number (ml) Ethyl Acetate Toluene
1 AO 30 70
2 AO AO 60
3 AO 60 AO
A 110 60 AO
5 20 60 AO
6 150 80 20
7 AO 100 -
8 AO Methanol
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of the first fraction and these were also added to the column.
The columns were eluted at a rate of 1 ml/minute under negative
pressure. Eluate fractions were collected and evaporated to
dryness under reduced pressure. They were then stored at -15°C
until biological assay could be performed. The original flask
was also evaporated to dryness and stored similarly for
biological assay of the residual content.
Silica Gel Thin Layer Chromatography
A detailed account of the preparation, loading and running of
thin layer, silica gel, glass plates is given by Horton and Main
(1967).
Grooved plates, 5 cm wide and 20 cm long were coated with a
0.25 m m thick layer of silica gel G (Merck). They were then
dried and activated by heating at 100°G for 1 hour. The prepared
plates were stored in a desiccator until required.
Samples which contained tritiated standard PGE^ (0.1 yuCi) wUfe-ve.
a«i applied as a narrow band to the plates using an Agla micrometer
syringe. The flasks were rinsed with 2 x 0.1 ml methanol and these
fractions were also applied to the plates.
Thin layer plates were developed in the AI solvent system of
Green and Samuelsson (1964-) and subsequently in the AVII solvent
system (Green and Samuelsson, 1964). If, however, the extracts
were highly pigmented, they were developed twice in the G.C.M.
solvent system described by Hensby (1974). Before the second
solvent run, the origin zone of the first run was carefully scraped
off and the plates were run from a new base line.
Plates were scanned using a Panax Radio TLC plate scanner.
The sensitivity was set at 100 mV and the chart speed was 12 cm
per hour. The time constant was 10 seconds and the range 10-30 cps.
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Zones corresponding to the regions occupied by the standard
prostaglandins were scraped from the plates and eluted with 2x5
ml methanol. The methanol fractions were evaporated to dryness
under reduced pressure and stored at -15°C until bioassay on the
appropriate tissue could be carried out.
Biological Assay
(a) The Rat Fundal Strip. The PGE-containing fractions from
silicic acid columns and the corresponding zones from thin layer
plates were assayed on the rat fundal strip preparation as described
by Vane (1957). Only one longitudinal cut was made in the fundus
giving a shorter, broader strip of tissue. The preparation was
suspended in a 5 ml organ bath in Tyrode's solution at 37°C and
was gassed with oxygen. Contractions elicited by doses of the
samples were compared quantitatively and qualitatively with
responses to standard PGE^, Stocks of standard PGE^ solution
containing 100 ng/ml PGE^ were prepared. Doses of 5 to 10 ng
were injected, giving a final bath concentration of 1-2 ng/ml.
A three minute dose cycle, with a drug contact time of /5 to 60
seconds was used for standard and sample doses. 'The samples
were dissolved in 1 ml distilled water for assay on this preparation.
(b) Kitten Blood Pressure Assay
PGA samples from chromatographic procedures were dissolved
in 1 ml 0.9^ saline.
Kittens weighing 1.0 to 1.8 kg, of either sex, were
anaesthetized with pentobarbitone sodium /O mg/kg injected intra-
peritoneally. Anaesthesia was maintained by slow intravenous
infusion of pentobarbitone sodium solution 6 mg/ml at rates of
0.05 to 10 ml per hour. Carotid blood pressure was recorded on
a Grass Polygraph. Standard PGA^ was injected as a bolus into
i
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the femoral vein and was washed in with 0.2 ml 0.9^ saline
(llort.on & Jones, 1969). Doses of standard PGA^ were injected
(stock solutions - 250 ng/ml and 500 ng/ral). A ten to twelve
minute dose cycle was used and the response to a sample injection
was compared to that of standard PGA^ for vasodepressor activity.
Preparations were only used to assay samples if they were sensitive to
30 - 50 ng standard PGA^.
Gas Chromatography-Kass Spectrometry
Samples remaining after biological assay were not sufficient
to allow for gas chromatographic-mass spectrometric analyses
to be performed.
Statistical Evaluation of Results
Statistical analysis of the samples was carried out. Using
the student 1t1 test, the significance of the difference of the
mean values obtained for the 8-12 hour and 22-24 hour PGE^ and
PGA.J output, and the rates of output were assessed.
Results
(a) Animals killed at 8 to 12 hours after toxin administration
No haemorrhagic necrosis was found in the small intestine wall
in animals killed 8 to 12 hours after toxin challenge when either
crude or purified toxin preparations were used. Fluid had
accumulated in the ligated toxin-challenged loops but marked
distension of the gut was not observed. Estimates of the prosta¬
glandin content of the fluid were made. In 5 animals the mean
output of PGE^-like material was 1.1 ng/ml fluid secreted in the
observation period. In the case of 3 of the 5 rabbits no
detectable PGA^-like activity was contained in the fluid samples.
The lower limits of detection in these experiments were 1.0, 0.5
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and 0.5ng PGA^ equivalents per millilitre of fluid secreted. In
two samples PGA^-like material was present. The total activity
contained in these was 0.6ng/ml and 0.4ng/ml respectively. The
mean hourly rate of prostaglandin production was also determined.
The rate of release of PGE^-like activity was 0.1ng/ml per hour
while in the case of the PGA^ fractions the release was 0.06ng/ml
per hour using the limits of the assay as the output in the
three experiments where no PGA^ material appeared to be released,
(b) Animals killed at 22 to 24 hours after toxin administration
In all animals killed at 22 to 24 hours after toxin
challenge, significant haemorrhagic necrosis of the intestinal
wall in the loops inoculated with active toxin was observed.
All of these loops were markedly distended with fluid. Traces
of blood were present in some of these samples. The prostaglandin
levels in the fluid aspirated in these experiments were determined
by biological assay. The prostaglandin output by this group
of animals was significantly greater than that observed in the
8 to 12 hour experimental group (e < 1$). The mean output of
PGE^-like material was 13.6 ng/ml and the corresponding PGA^ output
was 15.0 ng/ml. The mean hourly rates of prostaglandin release
were also calculated. The rate of PGE^ release was 0.59 ng/ml
per hour and that of PGA^ was 0.64 ng/ml per hour. These values
are considerably greater than those obtained in the experiments of
shorter duration. The difference in both the PGE and PGA release
per hour are statistically significant at the 1$ level in the case
of the PGE samples and at the 0.1$ level for the PGA samples.
The rate of PGE and PGA production did not differ significantly
from each other in the 22 to 24 hour group of rabbits.
The results of both groups of experiments are contained in
Tables 6 and 7 and in figures 7 and 8.
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Table 6. The output of prostaglandins into fluid secreted by
the rabbit' small intestine following challenge of the ligated
ileal loop with cholera toxin.



















1 60 60.0% 8 2.2 N.D. 1ng/ml
2 128 69.0% 10 0.5 N.D. 0.5ng/ml
3 112 59.0% 9.5 0.88 N.D. 0.5ng/ml
h
U 135 59.0% 12 1.05 0.6
5 100 59.0% 12 0.90 0.4
Mean Values 6%.2% 10.3 1.11 + 0.29 0.6 + *
Ratio PGE^/A ^ mean output 11 : 6
* The figure represents the mean of the two values obtained in experiments
in which PGA- activity wa.s detected plus those in which limit of detectittft
values were obtained. In Table 6b the mean value was calculated from the t
-experiments in which the recoveiy of exogenous prostaglandin was more than b0%.
















1 32 10.2$ 24 3.3 N.D. 1ng/ml
2 35 51.6% 24 4.9 13.5
3 37 45.0$ 24 17.2 17.6
4 44 53.8$ 24 10.8 19.6
5 35 54.4% 23 19.0 14.2
6 40 40.0$ 22 16.3 10.5
Mean Values
Ratio PGE : .PGA output







Table 7. The rate of prostaglandin production by the rabbit small
intestine and release into fluid accumulated in the ligated ileal
loop following cholera toxin challenge.
The hourly rate of PGE^ and PGA^ is estimated from the
mean output in the 8-12 hour (5 animals) and 22-24 hour (6 animals)
experiments tabulated in Table 4* The statistical significance
of the difference between the results of the 8-12 hour and






















experiment 1.11 + 0.3 0.1 0.6 + 0.1 0.05 • n = 5
22-24 hour






values 12.5 + 6.1 0.5 14.5 + 3.6 0.65
Student 1t1
test p.
values PC1% p< 1% P<1% p< 0.1%
Fluidconc0 ng/ml. 20 15 10 5 0
P<1% J^L PGE
P<17* L PGA
Rateofrelease ng/ml/hr.8-12hr 0-8•P<17o 0*6•I 0-4 0-2■ 0J PGE
24hrlI 7p<o-i°/o PGA
Figure7.Thecomparisonfprostaglandinrel sef om rabbitintestinewithtime.V lu srepresentMeaof6 22-24hrand58-1 hrexperiments1S.EM.
Fluid
n
cone ng/ml 20- 15-1 10 5-
0
1
PGA(0 PGE,IZ2J P<1% B






Prostaglandins are released from the small intestine into
fluid which accumulates in the ligated segment of the gut following
cholera toxin administration. The release of prostaglandin-like
activity is greater at 22 to 21+ hours than at 8 to 12 hours after
toxin challenge. This difference is statistically significant
at the Y/> level and corresponds to the onset of marked haemorrhagic
necrosis and distension of the ligated intestine. The mean PGA^
output at 8 to 12 hours after toxin administration appears to be
approximately half of that observed for PGE.j-like activity.
The release being 1.1ng/ml for the latter and 0.6ng/ml in the case
of the former (the lower limits of detection being used as estimates
of the PGA content of fluid in which no actual activity could be
detected). By 22 to 21+ hours the release of PGA was equal if
not greater than that of PGE^-like material. The amounts of PGE
and PGA being released at this point being equivalent to 13.6 + 5.8
output was shifted from 2:1 to 9*10 for PGE : PGA release at 8 to
12 hours and 22 to 21+ hours respectively. Why such a shift should
occur is not immediately apparent. There are several possible
explanations which might account for the changes. At 12 hours
the peak secretory activity has been achieved in the toxin challenged
intestine. Thus it is feasible that the decrease of PGE release in
favour of PGA is a reflection of the operation of some patho-physio-
logical mechanism in the small intestine which is responsible for
limiting fluid secretion. A second possibility is that the
enhanced PGA content of the secreted fluid is an artefact and merely
reflects the increased general release of PGS compounds due to
tissue damage and distension of the intestinal wall. The augmented
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PGE output with its subsequent dehydration to the corresponding
PGA compound in the alkaline environment,such as is encountered
in the lumen of the intestine, giving rise to the difference.
Because the PGA present is more readily detected it only appears
that there has been some alteration in the respective amounts of
PGE and PGA released from the intestine after 22 to 24 hours have
elapsed from the time of toxin administration. A third point
must also be considered. The release of prostaglandin need not
necessarily be limited to the intestinal tissue itself. It is
possible that V. cholerae toxin itself or by interacting with the
other microorganisms, causes prostaglandins to be released.
Conclusion
Prostaglandins are released into the fluid which accumulates
in the ligated intestinal loop in response to cholera toxin challenge.
The amounts present at 22 to 24- hours are significantly greater than
those detected in fluid samples from animals killed at 8 to 12 hours
after toxin administration. This increase coincides with the
development of marked haemorrhagic necrosis and distension of the
intestinal wall of cholera toxin-challenged loops.
Several questions are posed by these series of experiments.
(1) What contribution does the crude toxin itself make to the fluid
content of prostaglandins?
(2) To what extent is the 8 to 12 hour output of prostaglandins
a reflection of the enhanced secretory activity of the small intestine
induced by cholera toxin? How much of the output is due to the onset
of tissue damage and increasing pressure on the intestinal wall due
to fluid accumulating in the loop.
(3) Is the enhanced output observed in the 22 to 24 hour group of
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rabbits attributable solely to the tissue damage and distension.
Could the enhanced output be indicative, even partly, of the
operation of a pathophysiological mechanism which limits fluid
production in the intestine challenged with cholera toxin;




The prostaglandin content of Wyeth lot 002 crude cholera toxin
In e xperiments using impure cholera toxin it was possible that
prostaglandin activity detected in the fluid secreted by the small
intestine in response to cholera toxin challenge, might have
originated from the toxin solution. In addition it was desirable
to evaluate the relative contribution of toxin "prostaglandin" and
intestinally produced prostaglandins to the total prostaglandin content
of the intestinal secretions. Experiments were therefore undertaken
to establish whether or not crude toxin solutions contain prosta-
glandin-like material or not. ■'•he toxin investigated was Wyeth
lot 002 crude toxin. Previously Horton and Collee (unpublished
observations) tad been unable to detect any su^h-activity in crude
A
filtrates of toxin preparations obtained from V. cholerae strain, 12r
(Ogawa). Therefore it was not investigated.
Methods
In four experiments, the prostaglandin content of Wyeth 002
toxin was determined. One gram of crude toxin was weighed out and
dissolved in 10 ml salt solution (Pierce et al, 1971). The pH was
adjusted to pH /+.0 -4.5 with 10% acetic acid. The following standard
tritiated, high specific activity prostaglandins were added prior to
extraction: PGE2 (0.1 ^Ci : 49.6 ng cold ?GK^/p.Ci), PGF2^(0.1 yuCi:
36.5 cold ng/^uCi) and PGA2 (0.1 juCi : 2.5 ng cold FGA^/fiCi).
Extraction Procedure
The acidified samples were partitioned with 30 ml ethyl
acetate twice and the organic phases were pooled, washed with 10 ml
distilled water (pH^ 5.0) and evaporated to dryness under reduced
pressure. The residue was redissolved in 25 ml 67% ethanol and
shaken with 10 ml heavy petroleum spirit. This partition was
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performed twice. The petroleum fraction was discarded and the
67/o ethanol phase was evaporated to dryness as before and desiccated.
It was stored at -15°C prior to thin layer chromatography.
Thin layer chromatography
Samples were dissolved in 0.2 ml methanol and applied as
a narrow band on to 0.25 mm thick Kerck Silica Gel G prepared
plates 5 x 20 cm in size. The plates were developed in a multi-
ran chromatographic development system. The initial run was
performed using the F VI solvent system of Andersen (Andersen,
1969) while the second development of the plates was carried out
in the GCM solvent system as dfescribed by Hensby (Hensby, 197-4)#
The solvent front on both runs was 15 cm. from the origin.
The plates were scanned using a PANAX radio thin-layer
chromatographic plate scanner. The sensitivity setting was 100 mV
for the chart recorder, and 30 counts per second range ^nd a time
constant of 10 seconds on the detector. The chart speed was
120 mm per hour. A typical scan is shown in figure 9*
From the scan picture obtained it was possible to mark out
the PGE, F and A containing zones of the plates and scrape them off
the plates into test tubes containing methanol (5 ml). The
methanolic fractions were centrifuged for 10 minutes using a bench
centrifuge (at approximately 750g) and the supernatant was decanted
off. The residue was resuspended in a further 5 ml methanol and
recentrifuged. The methanol was collected and pooled with the
initial methanol eluates. The combined eluates were evaporated
to dryness and redissolved in 1 ml methanol. An aliquot (0.1 ml)
was removed for recovery estimations while the remainder was
evaporated to dryness and stored at -15°C until biological assay
could be performed.
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origin PGF PGE PGA solvent
front
Figure 9. Thin-layer radiochromatographic scan of an extracted
sample of Wyeth lot 002 toxin, containing approximately 0.1 yuCi of
standard tritiated prostaglandins, ^^2 anc* ^**2
development of the plate in FVI and GCM solvent systems.
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Recovery Estimations
The percentage recovery of exogenous prostaglandin was
determined by using liquid scintillation counting techniques.
The 0.1 ml samples removed after thin layer chromatography were
counted in 10 ml toluene ethoxyethanol based scintillant (Toluene-
ethoxyethanol-DMPPOPOP-PPO (2000,4-00,0.22,8.52, v/v/w/w). Counting
efficiency was 35-4-0$. Correction for quenching was made by the
use of the external standard channels ratio method and a quench
calibration curve constructed for the scintillation mixture.
Biological Assay
(a) Rat Fundal Strip
Samples containing PGS and PGF-like activity were assayed
in terms of standard PCE^ and PCF^. Stock solutions containing
100 ng/ml of these standard prostaglandins were prepared. The
rat fundal strip was suspended in Tyrode's solution at 37°G and
gased with oxygen. The responses of the tissue to standard PCE^
and PCF^^ were recorded and the responses to the samples was
compared qualitatively and quantitatively with those of the
appropriate standard. The preparation was sensitive to 0.5 ng/ml
PGE2 and 3 ng/ml PGF^. With PGE-j a dose cycle of 3 minutes'
duration and a drug contact time of 4.5-60 seconds was employed.
In the case of PGF. , standard and samples, a longer cycle was
required. A 3k minute cycle and 60-90 minute drug contact time
were used.
(b) Kitten Blood Pressure
The kitten blood pressure preparation was used to estimate the
PGA content of cholera toxin extracts. Standard PGA^ was given as a
single intravenous injection (0.2 ml stock solution) and was washed
in with 0.9$ saline (0.2 ml). Stock solutions containing 100-500 ng
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PGAj were prepared. A dose cycle of 8 to 12 minutes vas required.
The preparation was sensitive to 30 ng PGA^/kg. PGA eluates from
thin layer plates were redissolved in 0.5 ml or 1.0 ml 0.9% saline
for injection. The vasodepressor activity of aliquots of these
samples was assessed in terms of standard PGA^.
Results
No PGE2 or p0F2o, activity was detected in toxin extracts
when assayed on the rat fundal strip. The lower limit of detection
of P0E2 indicated that the samples contained less than 12.5 ng
PGE^-like activity and less than 25 ng PGF^-like material per
gram crude toxin. No PGA^-like material was found. The maximum
amount which could have been present and not detected by biological
methods was less than 90 ng PGA^/g crude toxin.
Discussion
The absence of prostaglandin-like activity in crude cholera
toxin preparations from two different strains of V. cholerae, namely
V. cholerae 5&9B used to prepare Wyeth 002 toxin, as reported in
this experiment, and from V. cholerae strain 12r (Ogawa) investigated
by Horton and Collee (unpublished observations) would seem to indicate
that-any prostaglandin contained in the fluid secreted in response
to cholera toxin challenge is unlikely to originate from the crude
toxin itself. Purified cholera toxin and crystalline toxin
contain less than Yjo lipid material and protein moieties (Finkelstein
& lo Spalluto, 1969; 1970^ Finkelstein & Lo Spalluto, 1972j
Finkelstein, 1972). Gas liquid chromatographic analysis of the
lipid content of V. choleraetoxin has shown the presence of
saturated and unsaturated fatty acids (Kaur et.al, 1970). Kaur,
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Konig, Martin and Barrows were investigating enterotoxin from V.
cholerae 569B and found only C^, °16- °18 fatty acids in this
preparation. Prostaglandin precursors are polyunsaturated C^q
fatty acids. Removal of the lipid material did not result in a
loss of enterotoxic activity of the toxin preparations (Kaur
fQ ^et al, 1970). This evidence, together with the results cited
in this experiment do not favour a contribution to the prostaglandin
activity of fluid samples from the toxins themselves and suggests
that all prostaglandins are likely to be of intestinal origin.
Conclusion
Crude cholera toxin does not contain prostaglandins. Any
prostaglandin found in fluid accumulating in the small intestine




The effect of indomethacin on fluid secretion and prostaglandin
release in the ligated ileal loop model of experimental cholera
in rabbits
There are several possible approaches to the problem of
determining the role of prostaglandins in the ligated ileal loop
model of cholera. One is to study the effect of prostaglandin
synthesis inhibitors on fluid secretion following cholera toxin
challenge.
Indomethacin, which inhibits the incorporation of molecular
oxygen into prostaglandin precursors in the bio-synthetic pathway
(Tomlinson et al, 1972) and thus suppresses the formation of
prostaglandins, was used as a tool to investigate the function
of these hormones in the secretory processes in the ligated ileal
loop model of experimental cholera in rabbits.
Methods
Nine rabbits, weighing 1.5 to 3.3 kg were used in this study.
The animals were New Zealand White stock of both sexes. Six animals
were pretreated with the drug, indomethacin, while three served as
untreated controls. Three different dose regimes were employed.
The experimental procedure for loop preparation and handling of the
animals during the pre-and post operative period was exactly as
described in the previous experiment. (Experiment 1, Methods
Section: Experimental Model).
Drug Treatment
Group A. There were two animals in this experimental group.
The rabbits each received a single injection of 10 mg/kg indometh¬
acin intravenously 40 minutes prior to toxin challenge. Two
further doses of the drug (each of 10 mg/kg), were given to
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the rabbits at two to four hourly intervals during the eight hour
period following toxin challenge. Thus the total dose received
by the rabbits comprising Group A was 30 trig/kg indomethacin.
Group B. The three rabbits in this group were pretreated with
indoraethacin given in a dose regime which was commenced three
days prior to toxin challenge. Each animal was given a loading
dose of 80 mg/kg indomethacin subcutaneously injected on the
afternoon of the first day of treatment. On the next two days
the rabbits received doses of 4-0 mg/kg indoraethacin per day
divided into two doses, each of 20 mg/kg, which were injected
in the morning and in the evening respectively. On day four, the
day of the experiment, animals were given the usual injection of
indomethacin (20 mg/kg) prior to toxin challenge and were given
further injections of 4-0 mg/kg amounts of the drug at four and
eight hours after toxin challenge. The total dose given to each
rabbit was 260 rag per kg indomethacin.
Group C. Two rabbits were each injected with a 20 mg/kg intravenous
dose of indomethacin forty minutes prior to inoculating the
intestinal loops with toxin. This dose, 20 mg/kg, wa3 then
administered at four hours and again at 8 hours after toxin
challenge. These animals received a total of 60 mg/kg indomethacin.
Group D. The animals in group D were not given indomethacin
injections. They were only challenged with cholera toxin as in
Experiment 1 rabbits.
The animals in Groups, B, C and D were killed at 8-12 hours
after toxin challenge. The two rabbits in Group A were allowed
to survive for 24 hours.
Fluid was collected from the loops as described in Experiment 1
and either subjected to prostaglandin extraction procedures
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immediately or were stored at -15. C until extraction could be
carried out.
Extraction. Purification and Separation of Prostaglandins
Samples from Groups B, C and 2 animals in Group D were pooled.
Fluid from Group A animals and the third rabbit in Group D were
treated separately. Samples were extracted by Method B outlined
in the Methods Section of Experiment 1, and Figure 6b. Separation
of the PGE and PGA content of the samples was achieved by thin
layer chromatography using the A I and A VII solvent systems
of Green and Samuelsson (Green & Samuelsson, 1964-) and described
in the previous experiment (Methods Section: thin-layer
chromatography). Samples were scraped from the plates and
eluted from the silica Gel as described in the previous experiment
and stored at -15°C until biological assay could be performed.
Biological Assay
The estimation of the PGE and PGA-like activity contained in
the thin layer eluates was performed on the rat fundal strip and
the kitten blood pressure preparations as described previously
(Experiment 1, Methods Section: Biological Assay).
Results
The effect of indomethacin pretreatment on fluid production
and prostaglandin release in the ligated loop model are summarized in
Table 8 and in Figure 10.
Group A
These 2 rabbits were allowed to survive for 24 hours. The
fluid output was 60 ml and 38 ml in 4 a^d 3 toxin treated loops
respectively. This was a comparable output to animals receiving
no indomethacin (Results Section, Experiment 1). The prostaglandin
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output was diminished compared to prostaglandin concentrations
detected in the 24 hour fluid samples in Experiment 1 animals
which received no drug treatment. The PGE^ concentration in the
two Group A rabbits was 3.0 ng and 1.7 ng/ml. No PGA^ activity-
was detected. The limit of the assay was 60 ng PGA^ for each of
the samples. Thus there was less than 1 ng/ml and less than 1.6
ng/ml in the 60 ml and 38 ml samples respectively. In Experiment 1,
the mean PGE output in the 24 hour fluid was 13.6 ng/ml and the
PGA concentration was 15.0 ng/ml. No haemorrhagic necrosis was
observed in the intestine of these animals.
Group B
The fluid from these three animals had been pooled and
extracted, purified and assayed as a single sample. The PGE
output was 0.7 ng/ml but no PGA^ activity could be detected. The
limit of assay was 90 ng PGA^ for the total sample. Thus the
concentration was less than 0.6 ng/ml in the PGA fraction of
the pooled fluid.
Group C
Fluid collected from the two animals in this group was
also pooled and treated as one sample. The volumes were 45 ml
and 31 ml respectively from 3 loops in each animal. The PGE^
concentration in the pooled material was 9.65 ng/ml. Again no
PGA.J was detected. The limit of sensitivity of the assay method
for PGAwas 90 ng PGA^ for the total sample. Thus the PGA^
concentration in the choleraic fluid was less than 1.2 ng/ml.
Group D
The control animals' fluid was pooled in the case of two
of the rabbits. The fluid output was 54 ml and 83 ml in 4 loops
and 5 loops respectively. In the third animal a total of 44 ml
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was recovered from 3 toxin challenged loops. The fluid was not
pooled with the combined samples of the other two rabbits. The
mean output of PGE^ was 1.8 ng/ml in the 9 hour period. No PGA^
activity was found. The limit of sensitivity of the PGA^ assay
was 90 ng PGA^ total for each of the two samples. Thus the
concentration of PGA^ was less than 0.7 ng/ml and less than
2 ng/ml in the pooled control and unpooled control samples
respectively. xhe mean output was higher than that detected
in Experiment 1 control 8-12 hour animals' fluid but the range
of output in these animals was quite large and thus the
discrepancy in mean figures is probably a reflection of the
fewer numbers of animals used in this experiment.
Discussion
Indomethacin treatment in the doses described is capable
of reducing the prostaglandin output into fluid which accumulates
in the ligated ileal loop of the rabbit intestine following cholera
toxin challenge. The reduction was more marked in the 24- hour
animals than in the 8-10 hour group of animals. This, together
with the notable absence of haemorrhagic necrosis of the
intestinal wall of the 22 to 24 hour group of^, rabbitq^suggests
that the main contribution to the prostaglandin release may in
fact be tissue destruction. The fluid output was not suppressed.
The residual prostaglandin levels may therefore be attributable to
distension of the intestinal loops by this accumulation of fluid.
It is not however possible to exclude the possibility that this
remaining prostaglandin output may be involved in the secretory
processes initiated by cholera toxin.
Further experiments, in which the element of distension is
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Table 8
The Effect of Indoraethacin pretreatment on Prostaglandin Output and
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A = 24 hour control
B = 8-12 hr control
C = 24 hr indomethacin





Figure 10. The release of PGE-like compounds from rabbit ligated
intestinal loops following indomethacin pretreatment. Values for
Column A are taken from Experiment 1, Table 7; those for groups
B, C and D from Table 8. Values represent mean results + S.E.M.
where appropriate.
- 90 -
also absent are required in order to determine whether the residual
release is due to stretching of the epithelial cells and intestinal
wall or is essential to fluid secretion in response to cholera toxin.
Conclusion
Indomethacin in the dose regimes outlined caused a marked
reduction in prostaglandin output into fluid accumulating in the
ligated loops of animals killed at 22-24. hours. The output at
8-12 hours was also reduced. It is not clear whether the residual
prostaglandin release is essential to the secretory process or is
a reflection of the loop distension. Further experiments are
required to clarify this point.
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Experiment 3
The release of prostaglandins from the luminally perfused rabbit
small intestine, in response to cholera toxin challenge.
The use of ligated intestinal loop models of cholera had two
disadvantages. The first of these was the inability to compare
the output of prostaglandins by non-toxin treated intestine as no
secretion of fluid occurred in the ligated control loops. ^he
second disadvantage was the presence of other factors likely to
lead to prostaglandin release, in themselves. Distension of the
tissue stimulates the production and release of prostaglandins
(Poyser, 1971) and trauaatization of tissue also causes prostaglandin
release (Piper & Vane, 1971).
In experiments in which the ligated loop model was employed
to study fluid secretion induced by V. cholerae toxin, it was not
possible to dissociate the prostaglandin release due to distension
of the intestine from that due to the effect of the toxin on the
secretory processes. By using a luminally perfused intestinal
loop model it was possible to eliminate the prostaglandin release
arising from the distension of the intestine. It was intended to
investigate the release of prostaglandins into the luminal
perfusate from the toxin-challenged and control loops and so define
the role of prostaglandins in the secretion of fluid stimulated
by the toxin.
Methods
Seven rabbits, New Zealand White and Brown and Black Lop animals
of both sexes were used in this series of experiments. The rabbits,
weighing between 1.8 and 3.9 kg, were anaesthetised with pentobarbitone
sodium, 4-0 mg/kg administered by intravenous injection. Anaesthesia
was maintained by the infusion of pentobarbitone sodium solution, 5 mg/ml,
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via the external jugular vein. •'■'he abdomen was incised and the
small intestine was exteriorized and two loops were tied off in the
terminal small intestine by means of Kersilk ligatures. ■''hese loops
were longer than those used in the ligated loop model, being of 25 to
35 cm in length. This was because it was more practical to perfuse
only two loops in any one animal. An unperfused segment of
intestine 4- to 6 cm long was left between the two perfused sections
of gut. The test (toxin challenged) loop and the control (non-
toxin treated) loop were cannulated at their upper and lower ends and
fluid was circulated through the lumen of these loops at a rate of
1.5 to 2.0 ml per minute. The perfusate was 0.9$ saline warmed
to 37°C prior to use. Cholera toxin either 0.1 ml purified
225B toxin or 1.5 ml crude V. cholera 12r/T30/N100 (Section 1,
Part 1, Methods section: Preparation of cholera toxin), was
introduced into the lumen of the test loops and the inflow and
outflow cannulae were clamped off from their respective reservoirs
for one hour. Control loops were inoculated with an equal volume
of 0.9$ saline (225B toxin treated animals) or control sterile
Difco BactoPeptone water medium or inactive toxin solution prepared
by incubating the V. cholera strain at 37°C and allowing the supernatant
to stand at room temperature for several days. This resulted in the
loss of any residual toxic activity in the fluid. The loops receiving
these last-mentioned control fluids were those in animals being
challenged with toxin prepared from V. cholerae strain 12r. Control
loops were also clamped off in a similar manner to the toxin-treated
loops. After the hour-long incubation period, perfusion of the lumen
was begun and was continued for a period of to 5g" hours. ^he
fluid was collected on ice and extraction of the samples was either
carried out immediately or the material was stored at -15°C until
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the extraction could be performed.
Treatment of Fluid Samples
The perfusate from toxin and control loops of two rabbits was
pooled separately in six of the seven animals used in this series of
experiments. Thus there were three samples for toxin and control
loops from these rabbits. The material obtained from the seventh
animal was treated independently and although subjected to exactly
the same extraction, purification and separation techniques as
the pooled samples, contained standard tritiated prostaglandins in
tracer amounts to enable estimates of the recovery of endogenous
prostaglandin-like material in the perfusate to be made. The amounts
3 3
of H-PGE^ and H-PGA^ added to the unpooled material were 0.1 ^.Ci
of each but the amount of non-radioactive prostaglandin present
was 150 ng in the case of the PGE^ and 100ng PGA...
Extraction. Purification and Separation of Prostaglandins
The technique used to extract, purify and separate the prosta¬
glandin-like activity in the intestinal fluid have been described
previously (Section 1, Part 2: Experiment 2).
Recovery of Exogenous Prostaglandin Activity
Aliquots of the PGE^ and PGA^ fractions of the unpooled sample
(0.1 ml)were taken after dissolving the residue obtained following
thin-layer chromatography in 1 ml methanol. The amount of radio¬
activity contained in these aliquots was then determined by
scintillation counting. The 0.1 ml samples were added to 10 ml
toluene scintillant fluid and the tritium content was measured
using a Nuclear Chicago Scintillation Counter. The remainder of
the sample was evaporated to dryness and subjected to biological
assay as were the other samples.
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Biological Assay
The estimation of the prostaglandin content of the perfusate
was made by assaying the PGE and PGA-containing zones on the rat
fundal strip and the kitten blood pressure preparation respectively,
as described in Experiment 1 (Section 1, Part:2.Experiment 1).
Results
The prostaglandin-like activity in the samples was estimated
in terms of the PGE^ and PGA^ equivalents for toxin and control
loops. The results are summarized in Table 8.
(a) The unpooled sample
The recovery of prostaglandin activity in the sample was
67$ and 50.8$ for the control and the toxin-treated loops respectively.
Fluid from the toxin challenged loop was contaminated with blood
and this is very probably responsible for the much lower recovery
of exogenous prostaglandin. The total PGE^-like content of the
fluid from the control loop was 130ng PGE^ equivalents and that of
PGA.J was 115ng PGA^ equivalents as determined by biological assay.
The fluid obtained from the toxin*treated loop contained very
different amounts of these prostaglandins. The PGE^-like activity
amounted to only 50 ng whereas the amount of PGA^-like material
present in the extracted and purified PGA^ zone was estimated to be
190 ng. The presence of blood in the perfusate may account for this
result.
(b) Pooled Samples
No prostaglandin-like activity was detected in any of the samples.
The limits of the assays were 20 ng and 75 ng for the PGE^ and PGA^
content of these samples respectively.
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Table 9. The release of prostaglandin-like activity in toxin —
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Discussion
Ho prostaglandin-like activity was detected in the purified
extracts of luminal perfusion fluid collected from rabbit intestinal
loops challenged with cholera toxin. No prostaglandin-like
material was present in control perfusates either. The lumen
of the intestinal loops was perfused for 4-2" to 5s" hours. The
small intestine of other species has been found to contain prosta¬
glandin dehydrogenase activity (Anggard, Larsson & Samuelsson, 1971).
Parkinson and Schneider (1969) have demonstrated that approximately
7 to 12^ of a luminally perfused dose of (1 - ^C) PGE^ is removed
from the perfusion fluid in one hour by the intestine. Thus it
was possible that some inactivation of released prostaglandin did
occur. Prostaglandin output would have to be continuously
maintained if cholera toxin-induced diarrhoea was dependent on
prostaglandin compounds (see Pierce et al, 1971). Each sample
assayed was prepared from the intestinal perfusate of two separate
loop perfusion experiments. PGE^like content was estimated by
the rat fundal strip technique. This preparation could detect
5 ng standard PGE^. The PGE^-like material in these samples ranged
from less than 0.06 ng to less than 0.16 ng per ml perfusion solution.
The PGA.j-like activity was assessed on the kitten blood pressure
preparation, which was sensitive to 25 ng standard PGA^. It was
observed that the samples contained less than 0.2 ng to less than
0.6 ng PGA^-like activity per ml perfusate. These values represent
the total output of PGE^-like and PGA -like activity during the
entire perfusion period. Even allowing for metabolism to the
extent of 20a>, it would appear that negligible amounts of prosta-
i
glandin-like material were being released. Born blister fluid has
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been found to contain approximately 1.4 ng PGE^ equivalents (Arturson,
Hamberg, Jonsson, 1973) per ml fluid. Greaves and his colleagues
detected prostaglandin E-like activity in perfusates of inflammatory
lesions in skin. The PGE^-like material was in the region of
1ng PGE^ equivalents per millilitre of perfusates. This contrasted
to levels below 0.2 ng/ml perfusate in control samples (Greaves
et al, 1971). The results would therefore seem to indicate that
cholera toxin did not induce prostaglandin production. In the
absence of more sensitive assay techniques it was not however
possible to eliminate prostaglandin involvement in the fluid
production completely. Exogenous administration of prostaglandin
in large amounts does stimulate fluid secretion (Pierce et al, 1971).
However sensitive the assay might be, it is unlikely that one
could be absolutely certain that prostaglandin-like compounds
did not mediate, at least in part, the effects of cholera toxin
with negative findings in studies of similar nature to these
experiments.
Conclusion
It is unlikely that prostaglandins are the mediators of the
effects of cholera toxin in the intestinal mucosa. The output of
prostaglandin E-like and A-like material into intestinal perfusates
was negligible and was not detectable by biological assay.
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Experiment A
The effect of local administration of indomethacin on the
secretory response of.the perfused rabbit ileal loop to cholera toxin.
In the prec@3ding experiment no PGE^-like nor PGA^-like
material could be detected in extracted purified samples of
intestinal perfusate following cholera toxin administration. It
was considered unlikely that prostaglandins were involved in the
pathogenesis of fluid loss but taken by itself, the results of
these experiments were not conclusive enough, to exclude prosta¬
glandin participation entirely. Therefore, it was decided to
investigate the effect of indomethacin on fluid production in the
perfused loop model in rabbits subsequent to toxin challenge.
Local administration of indomethacin to the spleen (Ferreira &
Moncada, 1971; Ferreira, Moncada & Vane, 1971) caused a significant
reduction or total inhibition of prostaglandin i*elease in response
to hormonal and nervous stimulation. Indomethacin is not
selectively concentrated by the intestine of several species examined
(Hucker, Zacchei, Cox, Brodie and Cantwell, 1966) and thus intestinal
levels of the drug following systemic administration are dependent
on the total dose administered, various reservations,it was 1
hoped that local administration would ensure j
that high mucosal epithelial concentrations of the drug were achieved.
If prostaglandins were vital to the secretion of fluid, then by local
administration of indomethacin in high concentration, it should have
been possible to reduce the fluid output observed in response to
cholera toxin challenge.
Methods
Seven New Zealand White rabbits, weighing between 1.8 and
3.8 kg were anaesthetized with pentobarbitone sodium, 4-Omg/kg,
injected intravenously. Anaesthesia was maintained by infusing a
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solution of pentobarbitone 6 mg/ml intermittently into the external
jugular vein. A mid-line abdominal incision was made and the small
intestine was exteriorized. Two loops, each of 25 to 35 cm in
length were tied off in the terminal ileum and a polythene cannula
was inserted at each end of the loops. The remainder of the small
intestine was returned to the peritoneal cavity, ensuring that these
prepared loops were not disturbed. The exposed gut was kept moist
with warmed saline throughout the experiment. Toxin solution,
either 1.5 ml V. cholera 12 r toxin solution (prepared as described
in Section 1, Part 1) or Wyeth lot 002 toxin solution (0.2 ml)
containing 500 mg toxin per ml, was injected into the test (toxin-
challenged) loops and 1,5 ml saline or heatrinactivated Wyeth
002 toxin (0.2 ml of a 500 mg/ml stock solution) was injected into
the corresponding control loop. Indomethacin was administered prior
to toxin or control solutions as indicated below. The loops
were clamped off from inflow and outflow cannulae for 1 hour following
toxin administration.
The loops were then perfused for 5 to hours with saline
(V. cholerae 12 r toxin loops) or salt solution as prepared by
Pierce (Pierce et al, 1971)(Wyeth lot 002 toxin treated loops). The
volume secreted or reabsorbed during each hour of the perfusion was
measured. The loops were perfused at a rate of 1.5 - 1.9 ml per
minute.
Indometh'acln Treatment-
The seven animals were divided into three groups on the basis
of toxin and drug treatment schedules. The dose of indomethacin
used was 100 fig per cm of intestinal tissue. Two factors were
considered when this dose was selected for pre-treating the
intestinal loops. Firstly, the dose had to be such that the amount
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of drug absorbed by the epithelial cells was sufficient to reach
the microsomal prostaglandin synthetase enzyme and cause appreciable
if not total inhibition of the enzyme. The second factor was the
potency of indomethacin as a prostaglandin synthetase inhibitor.
Flower and his associates (Flower, Gryglewski, Herbaczynska-Cedro
& Vane, 1972) demonstrated that the of splenic synthetase in
dogs was 0.06 \ig. The assay was performed with purified enzyme and
the dose was approximately equivalent to 0.06 jig per gram wet weight
whole spleen. Lung synthetase also exhibits great sensitivity to
this drug, being inhibited 50% by a dose of 0.27 jug indoraethacin
per ml partially purified enzyme. This was a 0.75ydM solution
of indomethacin, (Vane, 1971). The dose of indomethacin used in
these experiments in rabbit perfused loop models of cholera was
3mg per loop which was approximately a dose of 100yUg per gram wet
weight of intestine. It was therefore felt that, even allowing
for the possibility that intestinal prostaglandin synthetase might
be less sensitive than those in lung and spleen, and that absorption
of the drug by the epithelial cell might be poor, marked depression
of fluid secretion was likely to be achieved with this dose of
indomethacin if prostaglandins were an essential link in the chain
of events initiated by cholera toxin which led to fluid secretion in
the small intestine.
Group A
3 rabbits were used as controls. The two intestinal loops
were not treated with either indomethacin or polyethylene glycol (the
vehicle used for drug administration). One loop was inoculated
with 1.5 ml V. cholera 12 r/T30/N100 toxin or 0.2 ml Wyeth 002
cholera toxin (0.5g/ral). The control loop was injected with either
1.5 ml saline or 0.2 ml boiled, inactive Wyeth 002 toxin, depending
Rabbit Ileal Loop
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Table 9a. The effect of indomethacin on the action of cholera toxin
in the perfused ileal loop model of cholera in rabbits.
T = Toxin. Wyeth 002/vc12r
I = Indomethacin. 3mg/ml/loop
5% Difco Bactopeptone Water
C = Control. Boiled Wyeth 002/ Salt solution from vc12r medium
Note. Values given are the mean + S.E. of 5 experiments for
toxin only treatment, 4 for control only, 2 for control + indoraethacin
and 4 for toxin + indomethacin. oU/wobe-s secrc.\r&A J — ^oUvv*^
bed .
Volume (ml) Volume (ml) Volume (ml) Volume (ml)
Perfusion








1 -4.3 + 0.7 -5.33 + 0.9 -2.25 + 1.3 -6.0 + 2
•2 +0.7 + 1.2 -1.66 + 1.70 -3.25 + 0.85 -6.5 + 3.5
3 +1.9 + 0.33 +1.0 + 2.5 -3.75 + 1.03 -3 ± 1
4 +2.5 + 0.67 +1.3 + 1.7 -4.25 + 0.25 -1.5
5 +2.8 + 0.37 +2.8 + 0.17 -2.13 + 0.83 -0.5























































Figure 11. The effect of indomethacin 3 mg/loop on intestinal
handling in toxin-treated and control perfused ileal loops in
rabbits. Values represent the mean figures +, 3.E.M. For details
see Table 9a.
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on the volume and nature of the active toxin used in that particular
animal.
Group B
As in Group A one of the two loops was used for the injection
of cholera toxin while the other served as a control. The two
animals in this group received local indomethacin in the toxin loop
and in the control loop. The dose of indomethacin used was 3 nig/
loop, which was approximately 100 jag/g wet weight of intestine. The
drug was dissolved in 0.1 ml polyethylene glycol. The injection of
indomethacin was given 4-0 minutes prior to toxin challenge.
Group C
There were two animals in this experimental group. Both loops
were inoculated with cholera toxin. One was pretreated with
indomethacin 3 mg, the other received 0.1 ml polyethylene glycol,
the vehicle for indomethacin, 4-0 minutes before toxin challenge.
Results and Discussion
The results of indomethacin treatment in this series of
experiments are summarized in Table 9a and Figure 11.
In all of the loops, both those receiving cholera toxin and
those receiving control solution showed a net absorption of fluid
during the first hour of the perfusion. The volumes adsorbed
were 4-«8 ml + 0.7 ml (mean of 5 observations + SEM), 5.3 + 0.9 ml
(mean of 4- observations + SEM), 2.25 ml + 1.3 ml (mean of 4-
observations + SEM) and 6.0 ml (average of 2 readings) for toxin
treated loops, toxin loops pretreated with indomethacin, control
and control loops pretreated with indoraethacin respectively.
Thereafter toxin treated loops showed a tendency to secrete fluid.
In the second hour the loops treated with toxin alone secreted
0.7 ml + 1.2 ml (mean + SEM of 5 results) and toxin loops pretreated.
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with indomethacin absorbed 1.7 ml + 1.7 ml (mean of 4 results + SEM).
The difference was not statistically significant (p> 5%) when
statistical analysis using the Student 1t1 test was carried out.
During the 3rd, 4-th, 5th and 6th hours both sets of toxin loops were
observed to secrete fluid. Control loops absorl&luid throughout
the entire experimental period. In the case of indomethacin pretreated
control loops, fluid secretion was observed in 1 loop during the
second hour of perfusion. False positive results have been reported
in ligated loops (McNaught & Roberts, 1958). The abrupt nature of
this response together with the magnitude of the absorption in the
first and third hours (-5.5 ml and -6.5 ml) suggest that the secretion
of 1,5 ml is likely to be artefactual, rather than a real response
to indomethacin treatment.
Conclusion
Local administration of indomethacin, 100 Aig/g wet weight
intestine, to the lumen of the intestine forty minutes before toxin
challenge, did not inhibit the secretory response of the intestine.
At this dose the ability of the intestine^ did not appear to be
compromised during the 1st and the 3rd to 6th hours of perfusion.
During the second hour the intestine was observed to secrete fluid
in one rabbit. This was attributed to artefact rather than a real
response.
* The actual value for p was 1% 5when the Bessel correction was applied




The in vitro synthesis of prostaglandins by rabbit intestine and
the effect of cholera toxin on this synthesis
It had been observed that in the ligated loop model of
experimental cholera, that prostaglandin release did occur
following cholera toxin challenge. No such release was obtained
in the perfused loop model. Indomethacin did not inhibit the
secretory activity in either of these models, which strongly
suggested that prostaglandins did not have an obligatory role
in the fluid secretion stimulated by cholera toxin. It was
considered possible, though not very likely., that cholera toxin
might stimulate prostaglandin synthetase activity which was
resistant in some way to the effects of indomethacin. In this
experiment and in the following experiment it was intended to
investigate this possibility. In this experiment the effect of
cholera toxin on the in vitro synthesis of PGE-like and PGF-like
compounds was studied. In the subsequent experiment the effect
of indomethacin on the biosynthesis was observed.
Methods
Terminal ileum was removed from 12 rabbits at death. The
tissue was handled as little as possible and kept on ice whenever
this was feasible in the period prior to incubation. After
freeing the intestine from mesentery, fat and blood vessels, the
section of gut was chopped into small pieces and weighed. It was!washed and
then transferred to conical flasks containing ice-cold Tyrode
solution. The volume of Tyrode used in all experiments was 10 ml
per gram wet weight of tissue. The preparation was gassed with
oxygen and incubated at 37°C for three hours.
Purified cholera toxin solution containing 75 mg-150 mg
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2253 cholera toxin was added to the flasks to give a final
concentration of 75 yug-150 yug per 100 ml Tyrode's solution. Six
flasks were incubated with active toxin. The control flasks were
inoculated with an equal volume of 0.9% saline, the solution in
which the toxin had been dissolved.
The reaction was terminated by plunging the flasks and
contents into an ice-bath and acidifying the incubate to pH 3.5-
4.0 with 10% acetic acid. The supernatant was harvested and
subjected to prostaglandin extraction procedures as described in
earlier experiments.
Extraction, purification and separation of prostaglandins
The extraction of samples was achieved using method B
described in Experiment 1. The dried residue obtained after the
69% ethanol extract was evaporated to dryness under reduced
pressure was stored at -15°C until column chromatography was
performed. It was necessary to modify the solvent systems used
to elute the silicic acid columns because freshly sieved batches
of Sigma SIL R, 100-200 mesh and Bio-Rad SIL A, 100-200 mesh batch
6910 silicic acid were used. The solvent systems employed to achieve
discrete separation of PGE and PGF compounds on chromatography
with the new batches of acids are shown in Table 10a and Table 10b.
Standard prostaglandins were dissolved in 30% ethyl acetate in
toluene and applied to the top of the columns as described in the
Methods Section of Experiment 1. The columns were eluted at a rate
of 10-15 drops in 20 seconds which corresponded to a flow rate of 1 ml
per minute. The fractions were collected separately and evaporated
to dryness. They were redissolved in 1 ml distilled water and
assayed on the rat fundal strip. Using the solvent systems
described, PGE was eluted in the 65% ethyl acetate fraction of 130 ml
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and 160 ml volumes and PGF was present in the 80$ ethyl acetate
fraction only.
Biological Assay
Stock solutions of standard PGE^ and containing 100ng
ml of the respective prostaglandin were prepared. The rat fundal
strip was used to estimate the PGE and PGF content of the desiccated
column eluates. The fractions were dissolved in 1.0 ml distilled
water and assayed against standard PGE^ and P^F^^ in the case of
the PGE and PGF fractions respectively. Contractions of the fundus
to standard PGE^ and PGF^ were obtained and the responses of the
tissue to aliquots of the samples was compared to these. A three
minute dose cycle was employed for the PGE assay and the drug
contact time was 4-5-60 seconds. When PGF2^ was the stimulant of
contraction it was necessary to lengthen the dose cycle to 3i~4
minutes and to allow 60 - 90 seconds drug contact time. The method
of estimation was the same as in previous experiments.
Statistical Analysis
The statistical significance of the results was assessed
by student ' t' test.
Results
The prostaglandin synthesized in the presence and absence
*
of cholera toxin by rabbit terminal ileum, in vitro, was
estimated in terras of PGE. and PGF. equivalents. This does
not exclude the synthesis of other prostaglandins in the E and F
series. The mean PGE synthesis in toxin-treated tissue was
42.2 + 8.1 ng/g wet weight tissue for three hours. Control
tissue synthesis was 46.5 +, 17.3 ng/g PGE^ equivalents wet weight
tissue per three hour incubation period. The difference was
not statistically significant. Synthesis of prostaglandin F-like
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Table 10 (a). The solvent system developed for use with Signa-











1 4-0 30 70 -
2 AO 40 60 -
3 20 65 35 -
4 160 65 35 -
5 20 65 35 -
6 160 80 20 -
7 50 100 - -
8 50 — - 100
Table 10 (b). The solvent system developed for use with Bio Rad -












1 40 19.9 80 0.1
2 40 29.8 60 0.2
3 130 64.3 35 0.7
4 20 64.3 35 0.7
5 130 79 20 1.0
6 40 99 - 1.0
7 40 - - 100
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material also showed no significant alteration when cholera toxin
was added to the incubate, during the three hour incubation (p >5%).
In the presence of the toxin the POF,,^ -like activity detected in
the supernatant was 21.3 ± 0.7 ng per wet weight of tissue whilst the
corresponding figure for tissue containing no cholera toxin was
23.3 ±3.1 ng/g wet weight tissue/three hour incubation period.
The results of this experiment are summarized in Table 11 and
Figure 12.
Conclusion
Purified cholera toxin prepared from Vibrio cholera 225B
did not appear to influence the in vitro synthesis of PGS^-like
and PGF_ . -like compounds by rabbit terminal ileum.
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1 71.0 23.66 57.1 21.4
2 64-. 0 29.07 39.4 21.1
3 30.0 20.0 32.7 20.0
4 38.8 22.2 39.2 21.6
5 30.5 21.4 41.6 22.2
6 44.5 23.2 42.9 21.4
Mean 46.46 23.33 42.15 21.28
S.E.M. 7.09 1.27 3.32 0.29
S.D. 17.3 3.10 8.12 0.72
"p" tox-





Figure.12 The in vitro synthesis of
prostaglandins and the effect of purified




The inhitibition of in vitro prostaglandin biosynthesis by
indomethacin in cholera toxin*challenged and control segments
of rabbit terminal ileum
The doses of indomethacin used in the in vivo experiments
were 10-4.0 mg/kg body weight, in the case"of systemic administration
of the drug. Local administration doses were approximately 100 jag/g
wet weight intestine. The peak plasma levels achieved with
systemic indomethacin were estimated to be of the order of 8 to
30 ^ug/ml plasma, assuming total body water distribution of the
drug. In two experiments the effect of incubating tissue with
10yag/ml and 15 jug/ml indomethacin was investigated in toxi;y—
treated chopped intestine. The effect of 15 ug/ml indomethacin
on prostaglandin production by control tissue was also studied
in one experiment.
The procedure was exactly the same as that adopted in the
previous experiment with the exception that indomethacin (10 jag
or 15 fag per ml of incubate) was added prior to incubation and
before toxin or control medium was added to the flasks.
Extraction. Purification and Separation of Prostaglandins
Prostaglandin E and F containing fractions were obtained by
the methods outlined in Experiment 5.
Biological Assay
Samples were assayed on the rat fundal strip as described
in Experiment 5 in terms of standard PGE^ and PGF^ .
Results
Indomethacin produced marked inhibition of prostaglandin bio¬
synthesis when added in doses of 10 jug and 15 fig per ml to the
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intestinal incubate. Both toxin treated and control tissue synthesis
was affected. The lower dose of indomethacin inhibited PGE synthesis
by 66.8% and PGF synthesis by 82,5% as estimated in terms of standard
PGE.J and PGF^ . Indomethacin 15 jag/ml caused a further reduction
in prostaglandin production. The percentage inhibition was
77.5% and 83.7% for PGE^ and PGF^ respectively in the toxin
challenged preparations. Control intestine biosynthesis was
reduced by 76.7% in the case of PGE. and by more than 65% for PGF0r,
with a dose of 15 ;ug/ml indoraethacin. There was no detectable
PGF2(X -like activity contained in the sample. The limit of the
assay was 7ng PGF^per gram of tissue. The results are contained
in Table 12.
Table 12. The effect of indomethacin on the in vitro synthesis








Toxin 39.4 21.1 66.8^ 82.5%
Toxin + Indom.
10pg/ml 13.1 3.7
Toxin 57.1 21.4 77.5% 83.7%
Toxin + Indom.
15jig/ml 12.9 3.5





Prostaglandin synthetase in toxin-treated tissue is not
resistant to the effect of the prostaglandin synthetase inhibitor
indomethacin. Indomethacin in concentrations liable to be
present in rabbit plasma following the intravenous injection of
doses of 10-4.0 mg/kg in vivo is capable of causing significant




Experiment 7. The Selection of Doses of Wyeth 002 Toxin for use in
the luminally perfused Ileal Loop Model of Cholera in Cats
The rabbit models had to be abandoned for reasons beyond
the writer's control. It was therefore decided to pursue the
investigations on the role of prostaglandins in cholera using
another experimental animal. The cat was selected because it had
been observed to be sensitive to the effects of cholera toxin and
secreted water and electrolytes in response to intraluminal
injection of the toxin in the small intestine.
Before embarking on a long series of experiments using this
model it was essential to select a dose of toxin that would be
capable of stimulating fluid secretion. The toxin which was to
~ be used in these animals was the Wyeth crude cholera toxin Wyeth
lot 002 that had been used in some of the rabbit experiments
previously described (Experiments 3 and 4-> Section 1, Part 2).
The ligated intestinal loop model is a useful preparation in which
to study the sensitivity of the small intestine to the toxin.
It has been used in rabbits where a dose dependency of the response
has been observed following challenge with other toxin preparations,
(for references see Introduction}.
Methods
One young male cat weighing 2.0 kg was anaesthetised with
pentobarbitone sodium 4.0 mg/kg. During the course of the experiment
anaesthesia was maintained by supplementary intravenous injections of
the anaesthetic. Tracheostomy was performed and the blood pressure
was monitored using a Grass Polygraph connected to a Stantham
pressure transducer which registered carotid arterial blood pressure.
A midline abdominal incision was made and the small intestine
was carefully exteriorized. Four ligatod loops were tied off using
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raersilk ligatures in the terminal small intestine. Each was 10-12
cm in length and was separated from the next by a gap of 2-3 cm in
length. The loops were injected intraluminally with the toxin in
doses of 50 mg, 100 mg, 500 mg and 1g respectively. The volume
used for the injections was the same for all loops and was 2 ml.
The toxin was dissolved in 0.9% saline. The intestine was restored
to the abdominal cavity and the incision was lightly sutured.
The loops were examined three hours later and the presence of fluid
in the lumen was noted.
Results
No fluid accumulation was observed in the loops challenged with
the 50 rng and 100 mg doses of toxin. The section of intestine which
had been injected with the 500 mg dose of Wyeth toxin did contain
fluid, as did the loop challenged with 1 g crude toxin material.
The volumes secreted were 2.8 ml and 3.5 ml respectively.
Discussion
The 50 mg and 100 mg doses of toxin were ineffective and did
not appear to cause any change in gastro-intestinal function as
far as the handling of water and electrolytes was concerned. Cholera
toxin is known to be a potent stimulator of fluid secretion in
the small intestine (see Introduction). The toxin used in
this series of experiments had been stored for some considerable
time (6 months) and was therefore likely to have lost some of its
activity. That a complete loss of enterotoxic activity had not
occurred was evident from the secretion of fluid in the loops
challenged with the higher doses of toxin, namely 500 mg and 1 g
toxin. A longer interval between toxin administration and observation
of the secretory response of the small intestine to the toxin
might have resulted in a positive response occurring in loops
receiving the lower doses of toxin. The purpose of the experiment
was not however to determine the absolute level of sensitivity of
the cat intestine to cholera toxin but to select a dose of toxin
which would give a clearcut secretory response in a loop of
terminal ileum within a 5-6 hour perfusion period. ^or this
to occur it is necessary that the onset of secretion should
occur in the first or second hour of exposure to the toxin.
The doses of 500 mg and 1 g of toxin fulfilled these conditions
and were therefore suitable for use in this series of experiments.
Conclusion
The cat small intestine shows a dose-dependent secretory
response to cholera toxin challenge. Low doses of crude toxin
(50 and 100 mg) are not capable of stimulating fluid secretion
in the small intestine of cats within three hours. Higher
doses of toxin (500 mg and 1 g) elicit a secretory response from
intestinal tissue in this time interval and are therefore suitable
doses for investigating the effect of cholera toxin on prosta¬
glandin release and fluid production in the cat perfused loop
model of cholera.
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Experiment 8. The stimulation of fluid secretion in the cat small
intestine by cholera toxin
In the previous experiment doses of 500 mg and 1 g Wyeth
crude, 002 toxin was found to stimulate fluid production in the
terminal small intestine in cats. The ligated loop was not
considered to be the most useful model for investigating the
role of prostaglandin release in fluid secretion during cholera
due to the effects of loop distension and haemorrhagic necrosis on
prostaglandin release by the intestinal mucosa. A perfused
loop model similar to that used in the rabbit (Experiments 3 and A)
was therefore used and a dose of 1g cholera toxin was selected.
Methods
Four young cats and kittens were used. Anaesthesia was
induced with pentobarbitone sodium, 4-Omg/kg, intravenously
administered^ and was maintained by a continuous intravenous
infusion of pentobarbitone sodium (6mg/ml) at rates varying
between 0.075-6.6ml/hr. The anaesthetic solution contained
heparin 100iu/ml. The right common carotid^was cannulated for
blood pressure recording on a Grass polygraph. Tracheostomy vras
performed and the animals were artificially ventilated if respiration
became unsatisfactory. The right femoral vein or external
jugular vein was used to inject anti-inflammatory drugs in later
experiments and was therefore cannulated in this series of animals
although it was not used.
A mid-line abdominal incision was made and the terminal small
intestine was exteriorized. Three loops were made using Mersilk
ligatures in the small intestine. The last of these extended to
a point 15-20 cm proximal to the ileo-caecal junction. Both the
/
first and the third loops were approximately 30 cm in length while
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the second was 5-8 cm long. The longer loops were cannulated
at both ends and challenged with toxin or control solution. The
intervening loop was not operated on as it was merely intended to
separate the perfused segments of gut.
One gram of crude Wyeth 002 cholera toxin was dissolved
in salt solution (10 ml) and injected into the test loop. Control
loops were challenged with an equal volume of salt solution. The
salt solution used in this series of experiments was prepared
according to Pierce and his associates (Pierce et al, 1971).
The loops were clamped off from the inflow reservoir for one hour.
The clamps were removed and the loops were perfused at a rate
of 1.0-1.7 ml/minute for five hours. The fluid was collected
at the end of each hour of perfusion and the net amount either
secreted or reabsorbed was determined. The fluid was stored at *
-15°C until a prostaglandin extraction could be carried out after
each perfusion period and fresh salt solution was circulated
through the loops. In each pair of experiments the test and
control loops were reversed in position relative to the ileo-caecal
junction in a cross-over design thus ensuring an equal number of
test and control values for a given region of gut.
Results
The effect of cholera toxin on the small intestine was
investigated in 4 cats. The results are summarized in Table 13
and Figure 13. The toxin-challenged loops exhibited a secretory
response to the toxin throughout the 6 hours of perfusion. The
average output varied from 1.3 ml per hour to 7.1 ml per hour.
The mean output was 4-.5 ml per hour over the perfusion period.
Control loops, by contrast, did not secrete fluid but absorbed
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Table 13. The effect of cholera toxin on gastro-intestinal tract
handling of salt solution perfused through the liimen of loops in the
lower small intestine in cats













1 6.8 + 1.0
(n = 4)
0.5 1 - 13.5 + 13.6
(n = 4) 6.8
2 7.1 + 3.6
(n = 4)
1.8 2 - 5.9 + 4.2
(n = 4)
2.1
3 5.0 + 2.4
(n = A)
1.2 3 - 3.0 + 2.5
(n = 4) 1.2
4 3.8 + 4.3
(n = 4)
2.1 4 - 5.5 + 4.6
(n = 4) 2.3
5 1.3 (av. of 2) 5 - 7.5 + 7.0
(n = 37 4.1
6 3 (one obser¬





hour 4.5 ml - 7 ml
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Control Experiment. The effect of cholera toxin





Points represent mean values (see Table 13) + S.E.M.
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water and electrolytes from the solution perfusing the lumen of
the loop. Reabsorption of 3 to 13.5 ml per hour occurred. The
average reabsorption per hour was 7 ml per hour.
There was considerable variation between different animals in
the extent of fluid secretion and reabsorption but the general trend
of the response was always the same: toxin challenge causing
fluid loss; lack of toxin resulting in fluid absorption.
Conclusion
These experiments clearly established that cholera toxin
stimulates fluid secretion in terminal small intestine loops in
cats. The effect is localized to the loop receiving toxin as
is seen from the continued reabsorption of perfusate in the
unchallenged loop. The effect seen is similar to that observed
in rabbits using purified cholera toxin .225B and crude V.
cholerae 12r/T30/W100 toxin (Experiments 3 and 4-).
- 123 -
Experiment 9
The effect of prophylactic administration of indomethacin and aspirin
on fluid production in response to cholera toxin
In rabbits indomethacin pretreatment failed to abolish the
secretory response of the intestine to cholera toxin. It was
therefore of interest to see if cats, which also respond to
cholera toxin intestinal challenge by secreting water electrolytes,
A
were sensitive to systemic and local drug application and showed
a decreased fluid output following drug administration. The
effects of aspirin (25 mg/kg) were also investigated. Aspirin,
like indomethacin, is an inhibitor of prostaglandin biosynthesis
(Vane, 1971).
Methods
Seventeen cats weighing from 1.3 to 3#75 kg were pretreated
with either indoraethacin or aspirin. The experimental procedure
was exactly the same as in experiments where no drug treatment
was given. The drugs were administered either by intravenous
injection (for indomethacin and aspirin) or by local injection
into the lumen of the small intestine (indomethacin).
Indomethacin was dissolved in 0.2 ml polyethylene glycol
and the volume was made up to 2.5 ml with saline (0.9$) for
intravenous injection. When local administration of indomethacin
was carried out, the drug was dissolved in polyethylene glycol
only. The doses of indomethacin employed in these experiments
were: 10rag/kg, 50tng/kg and 100mg/kg given by the intravenous route
to 5, 3 and 1 animal respectively. Three animals received local
injections of 600 jig per loop of the drug into the lumen of the
small intestine. Only one dose of aspirin was used - 25 mg/kg
and this was given as a single intravenous injection, as was
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indomethacin, except in 2 cats when the initial 10mg/kg dose was
supplemented by 2 further 10mg/kg doses at 2 and 4 hours after
toxin challenge.
The drugs which were administered systemically were injected
slowly over a two minute period ten minutes before the toxin
was administered. Local indomethacin was delivered to the loop
twenty minutes before toxin or control solution was introduced
into the loop.
Fluid was circulated through the toxin and control loops
\
as described in the previous experiment and the effect of the
drugs on the intestinal handling of fluid following toxin
challenge was noted and compared to that of the control segments
of gut.
J
Perfusate was collected at the end of each hour of perfusion
and stored at -15 C until such time as extraction could be carried out.
Results and Discussion
The volume secreted or absorbed during each hour of perfusion,
following the one hour initial 'incubation' period when the loop
was clamped off from the inflow and outflow cannulae, by the
intestinal loops was measured. The mean volume for each group of
animals during each hour was calculated. Individual animals showed
a considerable variation in their sensitivity to cholera toxin, but
it was evident that toxin-challenged loops showed a marked difference
in behaviour to the control, unchallenged loops. The former showed
secretory activity whereas the latter absorbed water and electrolytes
from the solution which was perfused through the intestinal lumen.
The results are summarized in figures 14 to 17 and Tables 14 to
17.
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(a) Animals treated with intravenous indomethacin
I. Animals receiving Indomethacin 10mg/kg
Five animals were treated with indomethacin in a dose of
10mg/kg. Three animals received a single intravenous dose
prior to toxin challenge whilst the other two were given a
supplementary 10ng/kg dose two hours after toxin challenge. As
those latter cats did not exhibit a different pattern of response
to animals given the single prophylactic dose, the results were
treated together. The mean fluid output per hour in this group
of animals was 4-.9ml/hour in the toxin loop. The control, non-toxin
loop exhibiting an entirely different pattern of behaviour during
the perfusion period; this loop reabsorbed fluid. The mean
hourly absorption was 7.6 ml per hour. Neither of these values
differs significantly (p1) 5%) from the pattern of fluid movement
observed in the corresponding loops of animals which were not
subjected to either indomethacin or aspirin treatment (Experiment 8;
Results Section). These animals shoved a mean secretion of 4-«5 ml
in toxin challenged loops and a mean absorption of 7.0 ml in the control
loops.
(2) Animals receiving 50 mg/kg Indomethacin
A single intravenous injection of 50 mg/kg bodyweight indom¬
ethacin failed to suppress the secretory stimulus exerted by cholera
toxin on the terminal ileum. Toxin treated loops showed a mean
secretion of nil fluid per hour, whereas the control loops were
found to absorb fluid to the extent of 5.8 ml per hour. The
absorption figure is lower than the mean value for reabsorption in
other control loops. The control loops in the animals receiving
this high dose (50 mg) indomethacin, became engorged with blood and
damaged so that observations could not be extended beyond the first
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four hours of perfusion. The low mean absorption figure thus
reflects in part this trauma. The individual loops did show
a wide variation in absorption capacity but up to four hours did
not differ significantly in their ability to absorb fluid as
compared to other control, non-toxin treated loop3 in other animals.
The mean absorption figure was not significantly different from
the mean absorption figure of non-drug, non-toxin treated intestinal
loops (p > 5%).
(3) Animals receiving! 100 mg/kg Indomethacin
One animal received this high dose of indomethacin. The
animal's blood pressure fell markedly following this dose and
remained depressed throughout the experimental period. Nevertheless,
no inhibitory effect on fluid production was observed. The toxin
challenged loop showed a net fluid output of 11, 3, 3, 2 and 6 ml
in the five hours of perfusion. The control loop reabsorbed
fluid. Only 3 measurements could be made owing to the loop becoming
fragile and haemorrhaging. These three hour absorption volumes
were 8, 5 and 5 ml respectively. The mean secretory volume per
hour was 5.0 ml per hour and the absolution amounted to 6 ml per
hour. Neither of these is significantly different to the results
obtained for the corresponding loops in Experiment 8 where no
drug treatment was employed (p> 5$).
(b) Animals treated with locally applied indomethacin 600 ug/loop
In this group of animals both loops were exposed to cholera toxin
but one loop received a local intraluminal injection of indomethacin
600 jig/loop twenty minutes prior to toxin challenge. The dose was
selected on the grounds that it was A orders of magnitude greater
than that found to give 50% inhibition of prostaglandin synthesis in
dog spleen by Flower and his associates (Flower et al, 1971). It
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Table 14. The response of cholera toxin. challenged loops and
Control intestinal loops in cats to indomethacin oretreatment
(10 mg/kg by intravenous route)
Indomethacin 10mg/kg. I.V. Injection
Toxin-challenged loop
Control Loop














1 8 + 6.7 3.4 -12.2 + 4.0 2.3
2 3.3 + 0.6 0.3 -6.3 + 9.2 5.3
3 6.0 + 3.4 1.7 -9.1 + 5.5 2.8
A 0•x—+i0•0^ - 0.6 -6.7 + 5.5 3.2





6 5.0 (1 obser¬
vation)
-
Mean change 4.9 ml/hr -7.6 ml/hr
Table 15. The response of cholera toxin-challenged and control loops in
\ •
the terminal ileum in cats following systemic pretreatment with
indomethacin 50mg/kg





mean + S.D.(ml) S.E.M.
Change in Volume
mean + S.D. (ml) S.E.M.
1 8.7 + 3.8 2.2 -8.0 + 1.0 0.6
2 5.7 + 1.2 0.7 -7.3 i 4.9. . 2.8
3 2.7 + 2.1 1.2 0•+
l
0•CA1 2.9
4 3.0 + 1.0 0.6 -5.0 + 4.0 2.3
5 2 (1 observation) -
6 A (1 observation) -
Mean change A*A ml/hr -5.8 ml/hr
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FIGURE 14.
The effect of indomethacln 10mg kg i.v.






















Points represent mean values (see table 14.) +. S.E.M.
FIGURE 15.
The effect of indomethacin 50mg kg Lv.
















Points represent mean values (see table 15) + 3.E.M.
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,;as therefore likely to inhibit the biosynthesis of prostaglandins
even If absorption was poor and the intestinal prostaglandin synthetase
was particularly insensitive to jyhis inhibitory agent. There was however
no depression in fluid output by either loop. The average output per
hour was 5tnl in the ease of the loops troated with toxin alone and U.2ral
in the toxin loops protreated with indomothacin. Neither of these figures
is significantly different from the values obtained in other experiments
in which indomethacin was employed, nor are they significantly lower
or higher than those in toxin-treated loops of animals receiving no
inflammatory agent.
Although fluid output appeared to be depressed during the second
hour of perfusion.in the indomethacin-trented loops, this difference
was not statistically significant ( p= 11% ).
All statistical analysis and evaluation of the significance of these
results was done by means of the Student's 't' test with the Bessel
correction applied to allow for the small numbers in each sample.
It was noted that in all the experiments in which indomethacin was
used to modify the secretory response of the small intestine to cholera
toxin'there appeared to be a decrease in the fluid secreted during the
second hour of intestinal perfusion. The depression in the volume output
was not statistcally significant. The values for p were 7% and 61%
respectively in animals pretreated with intravenous indomethacin in
doses of 10 mg/ kg body weight and 50 mg/ kg body weight. A much larger
sample would have to be examined in order to determine whether this
apparent trend were of any real significance . That the higher dose of
indomethacin had less of a depressant effect on fluid output than did
the lower one would however seem to argue against this.
(c) Animals treated with intravenous aspirin ( 25mg/kg ).
The mean output of fluid in the aspirin-treated group of L cats was
5.8ml/hour. The volume absorbed in the control loops was 6.8ml/hour. From
these results it is clear that aspirin in the dose used did not interfere
with fluid absorption nor did it inhibit the effect of cholera toxin. The
results are summarized in Figurel7 and in Table 17.
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Table 16. The effect of local indomethacin (600 gg) on fluid
output in cat intestinal loops stimulated by cholera toxin. Except
where otherwise indicated the results are the mean of 3 observations






ml + S.D. S.E.tf,
Change in Vol. output
ml + S.D. S.E.M.
1 8.5 + 1.5 0.9 7.3 ± 4.6 2.7
2 5.7 + 2.1 1.2 • i
l+ M • v-n 1.4
3 . 0
1+ . o 1.5 2.8 + 1.0 0.6
4 5.0 + 1.0 0.6 3.4 1 3.7 2.1
5 1.6 + 2.1 1.2 1.5 (mean of 2
observations)




Mean/hr 5.0 ml/hr 4.2 ml/hr
Table 17. The effect of aspirin (25 m?/kg) injected intravenously




Toxin Treated Loop (n = A) Control Loop (n == 4)
Volume output
mean + S.D. (ml) S.E.M.
Volume output
mean + S.D. (ml) S.E.M.
1 11.3 + 3.8 (n = 3) 2.1 -12.3 + 4.7 2.4
2 6.8 + 1.7 0.8 -6.0 + 8.6 4.3
3 3.0 + 3.2 1.6 -5.0 + 2.2 1.1
A VO • 1+ —x • •<2 0.9 -3.7 + 2.1 (n = 3) 1.2
5 1 4.5 + 1.9 1.0 -7.0 + 6.2 (n = 3) 3.6
Mean output 5.8 ml/hr
I
-6.8 ml/hr
* (n = 4). The number of observations for each hour of perfusion was


















1 2 3 4 5 6
perfusion time (hours)
The effect of indomethacin 600/jg/loop on
intestinal handling of perfusate.
FIGURE 16.
Points represent mean values (see table 16) + S.E.M.
change in
volume (ml).
The effect of aspirin 25mg/kg i.v. on




Points represent mean values (see table 17) + S.E.M.
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Conclusion
Neither indomethacin in doses of 10, 50 or 100 mg/kg given
intravenously nor 600 yug indomethacin injected directly into the
lumen of the small intestine loop were capable of inhibiting the
effect of cholera toxin on the gut. Aspirin in the dose used
(25 mg/kg) failed to antagonize the secretory response to cholera
toxin. It would thus appear that as in the rabbit, prostaglandin
synthesis inhibitors are not able to suppress the choleraic syndrome
in experimental animals. Since prostaglandin biosynthesis would be
considerably reduced by these drugs, this gives further support
to the hypothesis that prostaglandins are not essential factors
in the secretion of water and electrolytes in experimental cholera.
Comment cn published paper. see Appendix.
Note that the data presented graphically in the published paper
are expressed in terms of percentage changes in the volume of fluid output
whereas those data presented in this thesis are expressed in terms of absolute
volumes of fluid in relation to the perfusion time. The latter form of present¬
ation is preferable on the grounds that it is more likely to avoid errors
associated with variations in the perfusion volumes.
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Experiment 10
The secretion of fluid in the upper small intestine of the cat
and the effect of indomethacin pretreatment on the fluid output
Since this work on cat perfused loop was undertaken, it has
been reported by Fink and Kata (Fink and Katz, 1972) that
aspirin inhibits fluid secretion in the upper small intestine
stimulated by cholera toxin. It was therefore decided to see if
the difference between this report and the work outlined in
Experiments 9 and 10 was attributable to a regional variation in
the sensitivity of the small intestine to cholera toxin and anti¬
inflammatory drugs. The effect of indomethacin 10 mg/kg given
by intravenous injection was investigated.
Methods
Two kittens were used in this series of experiments. One,
weighing 1.2 kg, was used as a control animal and received no drug
treatment; the other, which weighed 2 kg, was pretreated with
indomethacin administered as a single intravenous injection of
10 mg/kg 10 minutes before toxin challenge. The experimental
procedure was exactly the same as in the previous cat loop perfusion
experiments except that the intestinal loops were made in the upper
small intestine. The first of the two loops was made just below
the point of entry of the pancreatic duct. The loops were 32 cm long
and 35 cm long in the case of the toxin-challenged loops in the
untreated animals and drug-treated animals respectively. The control
loops were 37 cm long in the animal given indomethacin intravenously.
The intestinal lumen was perfused for 4 hours in the animal
receiving no drug treatment but for 3 hours only in the indomethacin-
treated cat, after the initial 1 hour incubation period of the toxin
in the intestinal loop. The dose of cholera toxin used was 1 g in
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10 rnl salt solution, as in previous experiments, and the control
loops were injected with equal volumes of control salt solution
(Pierce et al, 1971).
Results
(a) Upper small intestine loop perfusion. No drug treatment.
The cat which received no drug treatment was observed to secrete
fluid in response to cholera toxin challenge. ^he mean hourly
output was 3.75 ml per 32 cm length of intestine, which corresponded
to a rate of fluid production of 0.1 ml/cm/hour. The control loop
in this animal reabsorbed fluid. The extent to which the perfusing
solution was absorbed was 8.8 ml per hour (mean of 4 hour measurements).
This corresponded to a rate of absorption of 0.2 ml/cm intestine/
hour.
(b) Upper small intestine loop perfusion. Indomethacin pretreatment.
Fluid secretion was also observed by the toxin-challenged
loop of the animal given indomethacin 10 mg/kg by intravenous
injection 10 minutes prior to toxin administration. The mean fluid
output in the 3 hour observation period was 4.0 ml/hour for the
35 cm long loop. The rate of fluid production averaged 0.1 ml/
cm gut/hour. The control loop reabsorbed fluid during this
experimental period. The mean volume reabsorbed per hour was
10.3 ml per- hour which corresponded to a rate of 0.3 ml/cm gut/hour.
Conclusion
The rate of fluid production in the indomethacin-treated cat
and the untreated animal in response to cholera toxin were almost
identical. The control loop in the indomethacin-treated animal
showed a slightly higher rate of fluid absorption than did the
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corresponding loop in the cat which received no drug. It would,
therefore, seem unlikely that regional differences in response to
indomethacin of the small intestine influence the ability of
cholera toxin to stimulate fluid secretion in the intestine. The
results confirm the observations made with terminal ileal loops in
cats (Experiments 8, 9; Section i, Part 2).
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Experiment 11. The prostaglandin release from the small intestine
in catvS following cholera toxin challenge and the effect of anti¬
inflammatory drug pretreatment on this release
It did not appear likely that prostaglandins were essential to
the mechanism whereby cholera toxin stimulates fluid loss in cat
small intestine. Nevertheless it was important to investigate
the release of prostaglandin-like material into the fluid of
toxin-treated animals receiving drugs and those not on therapy
as it was possible that prostaglandin production might not be
depressed by the doses of drug used. If the doses were effective
then there should be a difference in this output and this would
be additional evidence refuting the suggestions made regarding
prostaglandin participation in cholera (Bennett, 1971). On
the other hand if no difference was seen it would suggest that
the doses were indeed not sufficiently great and that one could
not exclude prostaglandins as mediators of experimental cholera in
cats. A single passage perfusion system decreased the likelihood
that prostaglandin release might not be detected because of
intestinal metabolism of released prostaglandins (see Experiment 3).
The prostaglandin release from the small intestine in cats following
cholera toxin challenge and the effect of anti-inflammatory drug
pretreatment on this release was investigated.
Methods'
The material used in this study was the perfusates collected in
the two preceding experiments. The fluid which had been stored at
-15°C was allowed to thaw at room temperature and was pooled
according to the drug used, the dose and the route of administration
of the drug. The material collected from the one animal that
received 100 mg/kg indomethacin by intravenous injection was pooled
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with those of three cats which were given 50 mg/kg indomethacin
intravenously. Thus five batches of samples were obtained
for both toxin-challenged and control loops. These were coded as
follows: the 10 mg/kg cat samples were designated 1(10 C) and
I (10 T) for the control and toxin loop respectively; the 50 mg/kg
samples - I (50 C) and I (50T)j the 600^ug/loop locally administered
indomethacin - I (600 LC) and I (600 L T); the 25 mg/kg aspirin
A (25 C) and A (25 T). The control experiment fluid was termed
C ex C and C ex T for the control and toxin loop samples
respectively.
Because the initial volume of the samples was so large it
was more convenient to concentrate the organic matter in the fluid
and eliminate as much of the inorganic salts as possible. This
was achieved by using XAD-Amberlite columns. The prostaglandin
content of the samples is concentrated in a small volume of organic
solvent and can be extracted much more easily. The technique
has been used by Davis (1971) to concentrate large volumes of
prostaglandin-containing salt solutions.
Standard XAD-Amberlite columns were set up to determine the
optimum system for prostaglandin recovery and concentration from
salt solution used to perfuse the intestinal loops in the cat
experiments.
Standard XAD-Amberlite columns
H-PG3 (0.2 yuc) was added to A litres salt solution (Pierce
et al, 1971) and the pH was adjusted to pH 7.A if necessary using
citric acid or sodium bicarbonate. A long, wide bore glass column
(105 cm x 2.5 cm) was packed with 275g XAD-Amberlite in ethanol.
The XAD-Amberlite was washed with 200 ml ethanol and then with
3 litres distilled water. The salt solution was then poured down
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the column and the flow rate was adjusted to 25 ml per minute.
Once the sample had all been applied to the column, 500 ml
distilled water was passed down the column. This was followed
by 150 ml ethanol and then by a further 300 ml and finally by
two fractions of methanol, each 200 ml volumes. The four eluate
fractions v/ere collected separately and evaporated to dryness.
The residue of each was dissolved in 1 ml methanol and a 100 yil
aliquot was taken for scintillation counting. The percentage
recovery of PG3 in each fraction was calculated and the total
recovery from the column was obtained. The results are shown
in Table 18 in the results section.
The procedure was repeated using H-PGA( (0.2^uC) and
similar recovery determinations were made. The results are
contained in Table 18.
XAD-Amberlite Column Concentration of Fluid Samples
The procedure was essentially the same as that for the standard
3columns. Prior to passing the samples down the column, HPGE
(0.2-0.3 ^Ci) was added to the bulked material for each group of cats
and the pH of the sample was adjusted to pH 7.4- as before. The
flow rate was 25 ml/min. and the volumes of the various solvents
was the same as in the standard columns. The eluates were
evaporated to dryness, redissolved in 1 ml methanol and aliquots
removed for radioactivity recovery determinations. Fractions eluted
ahead of the major peak of radioactivity were discarded as were all
fractions containing less than 10% of the total tritium label added to
the column. Those fractions which were immediately behind the
main peak were also rejected unless they contained more than 10%
of the label. If they contained more than 1/10 of the total
radioactivity?they were pooled with the main peak and the combined
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fraction was evaporated to dryness in preparation for subsequent
extraction and thin layer chromatography.
Extraction of concentrated samples
The dried methanol fractions were dissolved in 25 ml 67$ ethanol
O
and partitioned with 10 ml heavy petroleum spirit (B.Pt.60-80)
and the petroleum phase was discarded. The ethanolic solution
was evaporated to dryness and then dissolved in 20 ml distilled water.
The pH was adjusted to pH 4-«5 with citric acid and the sample was
then partitioned against ethyl acetate. The ethyl acetate was
washed with U ml distilled water and evaporated under reduced
pressure.
Thin Layer Chromatography
Thin layer glass plates were prepared as described previously
in Section 1, Experiment 1. The solvent systems used were the A1
system of Green and Samuelsson (1964.) and the HD11 solvent system
described by Davis in 1971. This latter solvent was made up of
25 parts toluene to 15 of dioxane and 0.5 parts acetic acid. The
plates were allowed to run to a height of 15 cm on each of the two
runs. The first solvent run was in the A1 solvent and the second
was in the HD11 system. Standard prostaglandins were run on a
separate plate and the position of the PGE^ in the plates with
the samples was compared to that of the standard plate FGE^. From
this it was possible to estimate the position of the PCS] and the PGA^
3
on the sample plates. The standard plate contained H-PGA^ and
3
H-PGE.J. The amount of each prostaglandin added was O.ljiCi.
The prostaglandin zones were scraped from the plates and the
remainder of the plate was divided into 2 cm bands which were also
scraped off the plates. All of these fractions were eluted with
2.5 ml methanol. The methanol was evaporated to dryness and the
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samples vere dissolved in 1 ml distilled water for fractions to be
assayed against FGE^ on the rat fundal strip or in 1 ml 0,9%
saline in the case of samples to be assayed on the kitten blood
pressure preparation.
Biological Assay
The preparations used to estimate the prostaglandin content
of the samples were the rat fundal strip and the kitten blood pressure
assay. Both of these procedures are described in Section 1,
Experiment 1. The rat fundal strip was sensitive to 2.5 n^;
PGE^ i.e. to a final concentration of 0.5 ng/ml ^ was
possible to detect 20-25 •ag PGA^/kg in the kitten used.
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XAD Experiments
Results* (A) XAD Chromatography.
(a) Standard XAD Columns.
Table 18. The recovery of "^H-PGE^ and "^H-PGA^ in eluates of
XAD-Amberlite Columns.
Sample Volume 4 litres pH = 7.4
Flow Rate 25 ml/rnin.
Initial Volume distilled water - 500 ml.
Fraction
# Recovery in Eluates
PGE1 PGA1
1. 150 ml Ethanol 2.4# 0.2#
2. 300 ml Ethanol 85.3# 82.0#
3. 200 ml Methanol 0.4# 0.8#
4. 200 ml Methanol 0.3# 0.3#
Total radioactivity recovered 88.4# 83.3#
The results of the standard XAD-columns are summarized in Table 18.
The majority of the standard PGE^ and PGA^ was recovered in fraction
2, the 300 ml Ethanol fraction - 85.3# of the PGE1 added appeared
in this fraction. The corresponding fraction of the column run
with standard PGA^ contained 82.0# of the PGA^ added. The total
recovery from the columns was 88.4# and 83.3# for PGE^ and PGA^
respectively.
(b) Samples run on XAD-columns
The recoveries obtained with the samples obtained from the




























recovered 6.8$ 4.7$ 0.3$ 0.3$ 11.4$ 1.1$ 4$ 3.9$ 1.2$ 1$
Fraction 2








covered 0.9$ 0.6$ 6.9$ 3.8$
2.4$
0.5$ 0.7$ 0.6$ 1.8$ -
Fractions
used for
TLC & total -
$ in combin¬
ed fractions
2 2 2 & 3 2 & 3 2 2 2 2 2 & 3 2 & 3
91.1$ 90$ 92.8$ 96.9$ 86.2$ 93.4$ 93.9$ 94.2$ 97$ 99$
Actual $
Recovered
P.G. 77.6$ 82.9$ 85.4$ 77.5$ 85.8$ 90.4$ 93.9$ 79.4$ 69.7$ 72.7$
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*
As in the case of the standard prostaglandins, the recovery of
t
prostaglandin-like material was high. The range of recoveries in
the 300 ml Ethanol fraction was 76 to 95% of the total amount
recovered from the columns as estimated from tracer amounts of
1
PGE1 added to the samples prior to XAD chromatography. The total
recoveries varied between 72% and 100% of the total tritium label
added. The samples used for further investigation contained
69% to 9U% of the total 3-H-PGE^ tracer added. The mean value was
81.5%,
B. Prostaglandin Release in Cholera Toxin-Challenged Intestinal
loops and the effect of anti-inflammatory drugs on this release.
The mean prostaglandin recovery from XAD chromatography was
81.5$. Recovery from silica cjel plates was normally in the region
of 65%• Thus the actual recovery of prostaglandin material after
both procedures was on average 53% of the total amount in the sample.
(a) Control Animals - No anti-inflammatory drug treatment.
The PGE^-like activity detected in the toxin-challenged loop
fluid from the animals receiving no drug treatment amounted to
30 ng equivalents while no detectable PGA^ activity was found
by biological assay by the kitten blood pressure method of
estimation. The control loop also did not appear to contain
any prostaglandins of the A series but the PGE^-like activity
amounted to 20 ng PGE^-equivalents. The limit of detection for
PGA.J was 90ng PGA^. Thus the samples contained less than 180 ng
total PGA^-like activity.
(b) Indomethacin Treated Animals. 1/Animals receiving intravenous
indomethacin 10 mr/kg, 50mg/kg and 100mg/kg
No results were obtained from the group of animals treated
with indomethacin 10 mg/kg owing to the loss of the pooled sample
- 144 -
following thin layer chromatography.
The samples from the animal given 100 nig/kg indomethacin
were pooled with the appropriate samples in the cats which had
received 50 mg/kg indomethacin by intravenous injection. The
prostaglandin output was depressed compared to the group of
animals not given antiphlogistic agents. The toxin and non-toxin
challenged loops both showed depressed levels of prostaglandin
output. '-'■'here was no apparent difference in the PGE^-like activity
between these samples. The total PGE^ output was estimated to be
5 to 10 ng POE^ equivalents. Again no PGA^ activity could be
detected. The limit of the assay was 90 ng PGA^ equivalents.
The sample was therefore shown to contain less than 1S0 ng PGA^
equivalents.
(c) Local Indomethacin Treatment
The results obtained in this experiment were somewhat
surprising. The control, toxin-challenged, non-indornethacin
%
treated loop fluid was found to contain 125 ng PGE^ equivalents.
This was greatly in excess of the amount released into fluid in
toxin treated loops in the control series of experiments (Experiment
8), reported above in Section (a). No PGA^-like activity was found.
The indomethacin-treated loop was not observed to release either
PGE2 or PGA^-like material. The limits of the assay systems employed
were 25 ng, in the case of PGE2 equivalents and 180 ng PGA^ equivalents.
(d) The Effect of Aspirin 25 my/kg on Prostaglandin Release
Aspirin treatment did not appear to suppress the prostaglandin
release in the toxin treated intestinal loop. A total of 150 ng
PGE2 equivalents was detected on the rat fundal strip in this sample.
The corresponding control loop fluid contained less than 25 ng PGE2
equivalents in total. No PGA activity could be detected in either
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fluid sample. The amount of PGA^-like activity released was less
than 180 ng PGA^ in both cases.
Conclusion
Indomethacin administered systemically in a dose of
50 rag/kg was observed to depress prostaglandin synthesis by about
fifty per cent when compared to untreated control animals.
Locally applied indomethacin (600 ug/loop) markedly
/
inhibited prostaglandin output in toxin treated loops. The
depression of prostaglandin E-like output was at least 80% with
this dose. Aspirin (25 mg/kg) did not abolish prostaglandin
release in toxin-treated intestinal loops. Control loop synthesis
was depressed however.
The significance of these results is discussed in the
General Discussion of Part 2 of this Thesis.
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Experiment 12. The determination of plasma levels of Indonethacin
Although the results presented so far tend not to support the
hypothesis that cholera toxin effects are mediated via prostaglandins,
it is important to establish the non-involvement of these hormones as
conclusively as possible. Hence it was desirable to show that
plasma levels of indoraethacin achieved in the course of experiments
were sufficient to suppress prostaglandin production in the small
intestine. Marked inhibition of prostaglandin biosynthesis would,
if the synthesis were an essential step in the chain of events
initiated by cholera toxin and resulting in fluid secretion in
cholera, be expected to be associated with a definite inhibition of
the fluid output. Thus the plasma levels of indomethacin were
determined in cats following the intravenous administration of single
doses of 10 mg and 50 mg/kg.
Methods
(a) Animal Experiments
Three kittens (1.5 - 1.S kg) and 2 young cats (1.2 and 2.0 kg)
were anaesthetized with pentobarbitone sodium 4-0 mg/kg given intra-
peritoneally. Anaesthesia was maintained by the slow intermittent
infusion of pentobarbitone sodium solution (6 mg/ml). Tracheostomy
was performed. The right common carotid artery was cannulated and
the blood was recorded via a Statftham pressure transducer connected
to a Grass polygraph. Cannulae were inserted in the right external
jugular vein and one of the femoral veins for the infusion of
anaesthetic solution and the injection of indomethacin respectively.
The ipsilateral femoral artery was cannulated for the withdrawal
of blood samples for indomethacin determinations. Indomethacin
in doses of 50 mg/kg and 10 mg/kg was dissolved in 0.1 ml
polyethylene glycol and the volume was made up to 2.5 ml with 0.9^
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saline for slow intravenous injection via the femoral vein. Blood
samples were taken at varying time intervals after the drug was
injected, the first sample being withdrawn within 5 minutes of the
injection. All blood samples were collected in citrate anticoagulant
(pH 7.4) containing dextrose (24.5 g/l). Fluid replacement was
given in the form of injections of dextrose solution (2.5 ml) after
blood sampling.
(b) Extraction of Blood Samples + Indomethacin Measurement
The citrated blood was centrifuged at 2,000 rpm at 4°C
20 minutes and the plasma was carefully pipetted off using a
Pasteur pipette. The plasma volume was measured and the pH
adjusted to pH 5.0 with dilute hydrochloric acid. The sample
was then extracted into 25 ml heptane - 3% isoamyl alcohol mixture,
by vortexing the sample together with the organic solvent for 2
minutes, centrifuging, and separating off the upper organic phase.
Twenty millilitres of this heptane mixture was then vortexed with
5 mlOVCN sodium hydroxide solution for a further five minutes.
The organic material was discarded after centrifugation find 4 ml
of the alcoholic solution was carefully pipetted off with a Pasteur
Pipette and the fluorescence of the sample was determined using an
KPF 2A spectrophotofluorimeter (activation maximum 295 nju; fluorescence
maximum 335 mu, Slit width 6 nyi).
An alternative method was used to measure the concentration of
indomethacin in samples in two experiments. In these experiments
the sample was extracted into the heptane-isoamyl alcohol mixture
but was then returned into 5 ml 0.1 M phosphate buffer pH 8.0. As
in the previous method only 20 ml of the heptane-alcohol mixture
was treated with the inorganic solution. The 20 ml of organic
material was vortexed for 2 minutes with the buffer and then centrifuged.
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A 4 ml aliquot of the phosphate buffer solution was removed by
pipetting and 2 ml fractions were transferred to quarts cuvettes
for optical density measurements on the Unicam SP800 spectrophoto¬
meter. The optical density at 265 mji was determined.
(c) Standard Curves
Standard curves were constructed for indomethacin measurements
using both the Unicam SP800 spectrophotometer and the MPF2A
spectrophotofluorimeter. Known amounts of indoraethaein were
added to phosphate buffer (0.1 M, pH 8.0) and to 0.1N ssdium
hydroxide solution and fluorescence and optical density were
measured. Fluorescence and optical density values were found
to be proportional to the concentrations of indomethacin added
over the concentration range investigated (0 yig - /+0 jig
indomethacin per ml solution).
(d) Recovery Experiments
Known amounts of indomethacin were added to untreated plasma
and the samples were extracted as outlined above. The recovery




Standard curves were constructed for indomethacin in phosphate
buffer using optical density measurements, and indomethacin in 0.1N
sodium hydroxide solution, using fluorescence determination. The
curves obtained are shown in Figures 18 and 19 respectively. These
curves were used to calculate plasma levels of the drug in plasma
samples obtained from cats and kittens injected intravenously with
indomethacin in doses of 10 and 50 mg/kg.
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Figure 18. Standard curve of indomethacin fluorescence as determined
using the MPF-2A spectrophotofluorimeter. Indomethacin concentration







Fjp.ure 19. Standard curve of indomethacin absorbance at 265 nju
using the Unicara SP800 spectrophotometer. Indomethacin concentration




The recovery of indomethacin from plasma was found to be
dependent on the concentration of the drug present in plasma to
some extent. As the concentration increased, so the percentage
recovery improved. In the concentration range investigated in
the in vivo experiments the recovery ranged from 62.4.% to 78.1$.
The mean recovery was 71.5$ for a concentration range of 0 to
25 jtig/ml indomethacin in plasma. With concentrations of 4-0
to 100 yug/ml the mean recovery was observed to be 94.4$. These
results are summarized in Table 20. The sample containing no
indomethacin was used as the blank or zero value and nil deter¬
minations were made relative to this.
(c) The plasma levels of indomethacin following single intravenous
injections of 50 mg/kg and 10 mg/kg indomethacin.
1. The plasma levels of indomethacin in animals given 10 mg/kg drug
Three kittens received single intravenous injections of 10 mg/kg
indomethacin. The plasma levels were determined over a two hour
period. The plasma half life of the drug was found to be forty
minutes. The peak plasma concentration was 12.5 «g/ml. The
calculated peak plasma level of the drug was 13.3 yUg/ml, assuming
total body water distribution of the drug, total body water volume
equivalent to 70$ of total body mass and density of 1g/ml. The
results are shown graphically in Figure 20.
2. The plasma levels of indomethacin in animals given 50 mg/kg
indomethacin
Plasma levels of indomethacin were determined in two cats
following the intravenous injection of a single dose of 50 mg/kg
indomethacin. The peak plasma levels were observed to be 65 yUg/ml
by extrapolation to zero time. The calculated plasma concentration
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2 5 3.9 «g/ml 78.0%
3 10 7.03 jug/ml 70.3%
4 12.5 7.8 ,ug/ml 62. 4>
5 15.0 10.6 ug/ml 70.3%
6 20.0 13.9 ug/ml 69.7%
7 25.0 19.5 /ig/ml 78.1%
8 40.0 40.8 pg/ml 102.0%
9 70.0 65.5 jug/ml 93.5%
10 90.0 81.2 yug/ml 91.3%
11 100.0 90.6/ug/ml 90.6%
Mean recovery samples (2-7) : 71•5%
" " " (8-11) : 94.4%
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Conc'~l(/ug/ml)
Figure 20. Plasma levels of Indomethacin following
single intravenous injections of the drug in doses
of 10mg/kg in three kittens.
Figure 21. Plasma levels of Indomethacin following
intravenous injection of 50mg/kg Indomethacin
in two cats.
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was 66.6 ug/ral. The plasma half life of the drug was 40-45 minutes.
This showed good agreement with the results obtained in the group
of animals receiving 10 mg/kg indomethacin. The results are
contained in figure 21.
Discussion
The method used to extract indomethacin from plasma gave
relatively good recoveries^ In the concentration range liable
to be encountered in the in vivo experiments) «. The plasma half
life of the drug is quite short but is similar to that reported
by Eucker and his associates (Hucker et al, 1966) for guinea-pigs.
No estimation of blood metabolites was undertaken. The extraction
into heptane at pH 5.0 was found by Hucker -to eliminate the
necessity of such determinations (Hucker et al, 1966). The plasma
levels of indomethacin during the intestinal loop perfusion
experiments in the case of animals receiving 50 mg/kg indomethacin
were relatively high, even after 5 hours the levels were likely to
be 0.5 ^ug/ml. In the case of the animals receiving single doses
of 10 mg/kg indomethacin the levels were much lower at this time of
the order of 0.1 jxg/ml plasma. The 2 animals receiving additional
doses of the drug were likely to have much higher plasma levels
of the drug. With the 10 mg/kg doses given at 2 hours and 4 hours
after toxin challenge the five hour plasma levels were likely to be
in the region of 3-3.5 yug/ml.
Conclusion
Indomethacin has a relatively short half life in plasma,
being 40-45 minutes. The levels in in vivo experiments following
single intravenous injections of the drug rapidly decrease. With
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single doses of 50 mg/kg the plasma levels of the drug are however
appreciable after 5 hours. In animals given 10mg/kg doses, single
injections result in low levels of the drug remaining in plasma at
the end of a 5 hour perfusion period. Repeated dosage at 2 and
A hourljr intervals results in blood levels of the drug being
maintained at a level of 3 to 3*5 /ml plasma.
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ExperimentJi. The in vitro synthesis of prostaglandins by cat
terminal small intestine and its inhibition by indonethacin
In the previous series of experiments it was found that the
peak plasma levels of indomethacin achieved by intravenous doses of
indoraethacin (10 mg/kg, and 50- mg/kg) lay between 10yug and
65 Wg per ml (Experiment 12)-. In order to exclude the possibility
that these concentrations were unable to inhibit prostaglandin
synthesis and therefore resulted in the failure of indomethacin
to modify cholera toxin-induced fluid secretion in the small
intestine, in vitro investigations were undertaken. The in vitro
synthesis of prostaglandins by cat intestinal mucosa was measured
and the effect of indomethacin, 3*3 yug/ml and 20yUg/ml, on this
synthesis was studied.
Methods
Terminal small intestine was removed from cats. The tissue
was collected in ice-cold normal saline (0.95° saline). The outer
muscle layeB w&te carefully stripped off and discarded. The remainder
of the tissue was washed carefully with saline {0.9%) and cut into
small pieces with scissors^ The tissue was weighed and added to
conical flasks containing ice-cold Tyrode's solution. The volume
of Tyrode used was 10 ml per gram tissue. The flasks and contents
were incubated at 37°C for 60 minutes in a Gallenkampf shaking
water bath. The tissues were gassed with oxygen throughout the
incubation period. In experiments in which indomethacin was used
to inhibit prostaglandin biosynthesis, the drug was added to the
Tyrode prior to the addition of the chopped mucosa. Indomethacin
was prepared as a stock solution in polyethylene glycol-Tyrode
solution (0.2: 6.8, v/v) containing 2.5 mg/ml indomethacin. A
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1 ml aliquot was removed and the concentration of this was adjusted
to 1 mg/ml with ice-cold Tyrode solution. An appropriate
volume of this solution was added to the conical flasks to give
\
final concentrations of 3.3 jig/ml and 20 ^lg/ml. Incubation
was then carried out as in control experiments. Prostaglandin
synthesis was terminated after 1 hour by acidifying the incubates
to pH 3.5 - 2 with 10% acetic acid and plunging the flasks and
contents into an ice bath.
Extraction of Prostaglandins
The acidified supernatants were extracted three times with
l£ volumes of ethyl acetate. The ethyl acetate phases were
pooled, evaporated to a small volume (circa 20 ml), under reduced
pressure, and washed with 5 ml distilled water The
washed ethyl acetate phase was evaporated to dryness and desiccated.
The residue was redissolved in 25 ml 67% ethanol and this was
partitioned twice with 10 ml heavy petroleum spirit (B. Pt 60-80°C).
The petroleum spirit was discarded and the ethanolic phase was
evaporated and desiccated. The residue was stored at -15°C
overnight prior to thin layer chromatography.
Thin Layer Chromatography
Thin layer chromatography of the samples was carried out as
previously described (Experiment 5, Section 1, Part 2). Zones
corresponding to standard tritiated PGE2 and PGF^tracers were
scraped from the plates and eluted with 2 x 5 ml methanol. The
methanol eluates were evaporated to dryness, desiccated and then
redissolved in 1.0 ml distilled water for biological assay.
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Biological Assay
Samples were assayed in terms of standard and ^
on the rat fundal strip preparation as previously described
(Experiment 5, Section 1, Part 1).
Results
(a) Control tissue synthesis of prostaglandins
The synthesis of prostaglandins of the E and F series was
observed in chopped cat ileal mucosa incubated in Tyrode's
solution at 37°C for one hour. The net production of PGE,
assayed in terms of PGE^ equivalents on the rat fundal strip,
was 34-7 ng/g (mean of 5 experiments), while that of PGF
compounds, assessed biologically in terms of authentic PGF^^ ,
was 156 ng/g (wet weight) mucosa (mean of 5 experiments).
The range of PGE synthesis observed was 277-485 ng/g wet weight
mucosa, whereas that for PGF^was much less - 126-170 ng/g wet
weight mucosa.
(b) Synthesis of prostaglandins in the presence of 3.3 ml and
20 ml indomethacln
Indomethacin in concentrations of 3.3 ^g/ml and 20 jug/ml
was added to incubates of mucosal tissue. The prostaglandin output
was then determined after incubation. The mean content of PGE^-like
material fell from the control value of 347 ng to 64 ng/g wet
weight tissue in samples pretreated with 3.3 yug/ml indomethacin
(2 experiments) and to 44»0 ng/g in tissues treated with 20yUg/ml
indomethacin. These drug concentrations also reduced the PGF^ -like
activity in the supernatant. The levels of PGF were below the
2t\
limit of detection on the rat fundal strip. The upper limit for
PGF2^ in the 3.3 jug/ml indomethacin samples was 17 ng/g wet weight
- 159 -
tissue and 23.0 ng/g wet weight mucosa in the 20 jig/ml indomethacin
experiments. The percentage reductions in the means were 81.5#
and 89.2# for PGE^ and PGF2c\ * anc* ^7.3# and 86.3# for PGE^ and
PGF^^ in the 3«3yUg/ml and 20yug/ml indomethacin treated tissues
respectively.
The results of these experiments are outlined in Table 21.
Conclusion
Indomethacin in doses of 3.3 jig/ml and 20 jig/ml is capable
of inhibiting prostaglandin production by cat ileal mucosa tissue.

















2.6 g 720ng 81.6$ 330ng 77.8% 277.0 126
2.7 g 765ng 85.6$ 440ng 8A. 6% 283.3 163
2.8 g 1350ng 22.8% 500ng 120.1$ 4-85.7 160
3.3 g 1210ng 61.6$ 560ng 71.5$ 366.7 170
3.3 g 1035.5ng 67.6% 536ng 69.3$ 313.8 162














































2.8 Ind.3.3 I80ng 87.4$ 47.5 74.7$ 64.3 17.0ng
2.5 Ind. 20 110ng 57.5 44.0 23.0ng
Ind. 3.3 jig/ml 81.5$ inhibn. PGE2 & 89.2$ F^
20.0 ^ug/till 87.3/o " " & 86.3$ synthesis.
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General Conclusion
Little evidence was found to support the hypothesis that
cholera toxin stimulated fluid and electrolyte secretion in the
terminal ileum in rabbits and cats via a mechanism involving an
obligatory prostaglandin mediated step.
Prostaglandins of the E and A series were detected in
purified extracts of fluid aspirated from the ligated intestinal
loops in rabbits but there was a marked correlation between
the amounts of PGE-like and PGA-like material released and the
extent of tissue damage in the intestinal wall.
Indomethacin administered prophylactically to rabbits in
doses of 10 to 4-0 mg did not inhibit the secretory response of the
ileum to cholera toxin but did result in a diminished prostaglandin
release. This coincided with the absence of haemorrhagic
necrosis in the ligated loops at 24 hours after toxin administration.
In untreated animals haemorrhagic necrosis was invariably present
at this point (Experiments 1,2). It was therefore concluded that
indomethacin prevented the onset of pathological, necrotic changes
in the intestinal wall which were associated with prostaglandin
biosynthesis but did not interfere with cholera toxin-induced
fluid output in the rabbit ileum.
The residual prostaglandin release was not attributable to
the bacterial toxin itself; no prostaglandin-like material correspond¬
ing to prostaglandins of the E, F or A series being detected in
extracts of crude toxin (Experiment 1a). Horton and Collee
(unpublished observations) were also unable to detect prosta¬
glandins by biological assay of purified extracts of V. cholerae
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12r (Ogawa) toxin.
A further reduction in prostaglandin release was observed
when the perfused ileal loop model was substituted for the
less sophisticated ligated loop model (Experiment 3). No
prostaglandin-like activity was detected in intestinal pe rfusates
following challenge of the intestinal mucosa with purified cholera toxin
prepared from V. cholerae 225B or with crude toxin elaborated
by V. cholerae 12r (Ogawa). It was evident that prostaglandin
release was due to distension of the intestinal wall by fluid
which accumulated in the ligated intestinal loop in experiments
of short duration (8-12 hours) and that the enhanced prosta¬
glandin output observed at 22-24 hours after toxin administration
was a reflection of the degree of haemorrhagic necrosis experienced
by the intestinal wall.
These conclusions were further supported by experiments in
which local application of indomethacin was used in order to
prevent prostaglandin biosynthesis. Large doses of indomethacin
(3 mg per loop) did not inhibit the secretory response of the
mucosa to cholera toxin (Experiment 4)*
In vitro studies confirmed these observations. Incubation
of chopped ileal tissue with purified V. cholerae 225B toxin
did not enhance prostaglandin biosynthesis in this tissue.
No increase in the PGE or PGF content of the incubate supernatant
was detected by biological assay of purified extracts on the
rat fundal strip (Experiment 5). Indomethacin in doses of
glandin synthesis in cholera toxin treated intestine and control,
untreated tissue. It was therefore concluded that neither
in vitro nor in vivo exposure of rabbit intestinal mucosa to
equally effective in suppressing prosta-
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cholera toxin stimulates the production of prostaglandin compounds.
These results indicate that prostaglandins are unlikely to
be mediators of the fluid secretion initiated by cholera toxin in
rabbit experimental models of cholera.
Subsequent experiments conducted in cats confirmed these
findings in this species also. The terminal ileum of young cats
and kittens respond to cholera toxin challenge by secreting fluid
and electrolytes. The mean volumes secreted ranged from l> to 6 ml per
20 cm per hour. Unchallenged loops reabsorbed between 5 and 8 ml
fluid in this period (Experiment 8). Indomethacin in doses of
10 to 100 mg per kg body weight given intravenously, and in a
dose of 600 jig per loop administered to the loop itself, and aspirin
25 mg per kg also given by intravenous injection did not depress
the secretory activity or reabsorptive capacity of the toxin-
treated and control loops respectively (Experiment 9). The release
of prostaglandin-like material into the perfusates collected in the
course of these experiments was estimated. It was observed that
indomethacin given both locally and systemically depressed prosta¬
glandin output between 50 to 80^. Aspirin 25 mg/kg did not
j
abolish the release of prostaglandin-like material in toxin--
challenged loops. As the fluid secretion was not impaired even
although the prostaglandin output was markedly affected following
adrninistrati on of the prostaglandin synthesis inhibitor, indomethacin,
it is clearly demonstrated that in vivo, cholera toxin aoes not
operate^through a prostaglandin-like mediator when inducing fluid
secretion.
Experiments were also performed using sections of jejunum
in cats. As in the ileal region of the intestine it was not
possible to inhibit fluid secretion in toxin-challenged loops by
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systemic pretreatment with indomethacin in a dose of 10 mg/kg
body weight (Experiment 10).
The plasma levels of indomethacin were measured following
single intravenous injection of doses of 10 mg and 50 mg/kg body
weight. The peak plasma levels were 13 yug and 65 jig per millilitre
respectively. The plasma half life was also determined and
was found to be 40 to 45 minutes (Experiment 12).
It was further demonstrated that in vitro prostaglandin
biosynthesis could be markedly inhibited on incubation of chopped
intestine with concentrations of indornethacin as low as 3.3 yhg
per ml. At this dose level inhibition of PGE-like synthesis
was 81.5$ while the corresponding value for PGF-like compounds
was 89.2$. Levels of 3.3 jig per ml and greater were maintained
for 90 minutes following single indomethacin injections of 10 mg/kg,
and for the entire experiment where multiple injections of
indomethacin were employed. The single 50 mg per kg dose ensured
that plasma levels in excess of 3.3yUg per ml were maintained for
at least 3 hours. Thus it was clearly demonstrated that plasma
levels of indomethacin encountered in in vivo experiments were
capable of significantly reducing prostaglandin production by
intestinal tissue.
In summary, it was clearly demonstrated that cholera toxin
did not cause fluid secretion in the small intestine of either cats
or rabbits by stimulating prostaglandin production. Three lines
of approach were used: firstly, the in vivo release of prosta¬
glandins in ligated and perfused rabbit intestinal loops and cat
perfused loops was examined; secondly, the effect of local and
systemic administration of a potent prostaglandin biosynthesis
inhibitor, indomethacin, in fluid production and prostaglandin release
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was studied; thirdly the in vitro biosynthesis of prostaglandins
and the effect of toxin and indomethacin on this synthesis was
determined. All the evidence obtained indicated that cholera
toxin did not stimulate prostaglandin synthesis and that treatment
with prostaglandin synthesis inhibitors did not suppress the
secretory response of intestinal tissue to cholera toxin, at
dose levels which markedly inhibited prostaglandin biosynthesis.
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Experiment 1. Section 2
The prostaglandin content of E. coli crude heat stable enterotoxin
prepared from B. coli strain BAA
As in the case of experiments performed using crude toxin
e,
material prepared from V. cholera/, it was necessary to eliminate
L
a contribution from E. coli enterotoxin itself to the prostaglandin
content of intestinal fluid and supernatant in tissue incubation
studies. The prostaglandin content of crude E. coli enterotoxin
used to infect piglets and calves was therefore investigated.
Methods
E. coli Strain B4A heat-stable, crude enterotoxin was
supplied by Dr. R. Bywater (Royal (Dick) Veterinary School,
Edinburgh). 60 ml volumes of the toxin were subjected to
prostaglandin extraction procedures. Three batches- of BAA toxin,
prepared on separate occasions were used. The techniques used
for extraction were those previously described in Experiment 1,
Section 1, Part 2. Method B, Figure 6b was used. Standard
tracer tritiated PGE-j aQd FGA^ were added to the sample prior to
extraction. O.l^iCi of each was added. Control sterile broth
was also subjected to the extraction procedure.
Thin Layer Chromatography
Residues obtained after extraction of the samples of enterotoxin
were subjected to thin layer chromatography. A double solvent run
development procedure was used. The solvent systems used were the
F VI solvent system for the initial run and GCM solvent system for
the subsequent development of the samples. The 67^ ethanol residue
was applied as a narrow band to the ready prepared Merck 20 x 5 cm
plates coated with a layer of Silica gel G 0.25 mm thick. The
plates were then run in the solvent systems described and the solvent
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front in both cases was 15 cm from the origin. Before the plates
were developed for the second time the origin zone of the first
run was scraped off and the plates vere then run from the new
baseline. The removal of the origin zone ensured that the majority
of the pigment contained in the extract which was retained at the
origin, v:as eliminated and this gave much cleaner samples than would
otherwise have been obtained. Standard tracer PGF^ /was incorporated
into the samples prior to thin layer chromatography and thus the
appropriate prostaglandin zones could be scraped off the plates and
eluted with methanol. The scraped zones were vortexed with 5 ml
methanol and centrifuged. The supernatant was decanted off. This
procedure was carried out twice and the methanol eluates were pooled,
evaporated to dryness and desiccated. The samples were then
bJL
dissolved in 1 ml methanol. A 0.1^aliquot was used for
prostaglandin recovery estimations and Biological Assay was
performed on the remaining 0,9 ml of the sample.
Recovery Determination
The 0.1 ml aliquots of the methanol samples obtained after
thin layer chromatography were added to 10 ml toluene scintillant.
The radioactive content of the samples was determined by
scintillation counting using a Nuclear Chicago scintillation
counter. The percentage recovery of the PGF^and PGA^ activity
added (O.l^uCi of each had been added) was determined.
Biological Assay
(a) Biological assay of the PGE^ and zones obtained after TLC
using the rat fundal strip allowed estimations of the PGE^-like
and PGF_ -like content of the enterotoxin extract to be made.
2>a
Standard solutions of PGE^ and PGF^were used. The preparation
was sensitive to 0.5 ng/ml PGS^ and 3 ng/ml FGF^ . The technique is
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described infection 1, Part 2, Experiment 5.
(b) The kitten blood pressure assay preparation was used to
estimate the PGA content of crude enterotoxin. The assay
had a lower limit of sensitivity of 30 ng PGA^ in the animal
used on this occasion. This was equivalent to 25 ng PGA^/kg
body weight.
Results
(a) Recovery of Exogenous Prostaglandins
The percentage recovery of PGF2 activity added to the
samples prior to TLC was 85-88$ while that of FGE2 was 57-67$
PGA^ recovery was 65 - 72$. The higher recovery of PGF^ ^ is
partly due to the addition of this compound immediately prior to
thin layer chromatography and not, as in the case of the PGE2
and PGA^, before beginning the sample extraction procedure.
(b) Prostaglandin Content of E. coli toxin
In two of the three samples no prostaglandin-like activity
was detected either on the rat fundal strip or on the kitten
blood pressure preparation. In the third sample 10 ng PGE2~like
activity and 100 ng PGF_ -like activity was detected. In this
<■°\
sample no PGA^-like activity was present. The limit of detection
of FGE2 was 10 ng PGE^, that of PGF^ ^was 25 ng and 60 ng PGA^ per
60 ml for all of the three samples of toxin solution.
(c) Prostaglandin Content of Sterile Broth
As in the case of the toxin samples, no prostaglandin-like
activity was detected in 2 of the 3 sterile broth samples.
These corresponded to the enterotoxin batches in which no prosta¬
glandin activity was detected. In the third 12 ng PGE2 and
100 ng PGF2 activity was found. No PGA^-like activity was
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found in any of the three samples. The limit of detection was
60 ng PGA. The sample with PGE^ and PGF^-like activity was
prepared at the same time as the E. coli toxin batch which contained
prostaglandin-like activity. The activity per ml was 0.2 ng
of PGS and 1.7 ng/ml of PGF„ in the toxin and sterile broth which
were biologically active.
Discussion
I WO of the three batches of toxin and sterile broth
contained no detectable prostaglandins of either the E, F or
A series. The third batch of sterile broth and toxin contained
PGE and F-lik9 activity. The PGE activity in the sterile broth
was marginally greater than that of the toxin, while there was no
difference betxveen the PGF content of the two.
The reason, for the activity in this third sample of sterile
broth is not clear. It is curious that the activity in the toxin
prepared using that sterile broth contained an equal amount of
prostaglandin-like activity. It therefore suggests that some
contaminant was present, which was carried through the extraction,
purification and separation techniques. The result of the third
batch of toxin and sterile broth does not contradict the findings
of the other two experiments as the prostaglandin-like activity
contained in the toxin solution was no greater than that in the
sterile, broth used to prepare toxin solutions.
Conclusion
The prostaglandin content of E. coli toxin prepared from
strain B44 is no greater than that of sterile broth. Sterile
broth is unable to stimulate fluid production in the small
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intestine of piglets or calves. Therefore the possession of
prostaglandin-like activity by the toxin is unlikely to be
responsible for the fluid losses observed in E. coli induced
diarrhoea. The contribution made to the prostaglandin content
of fluid secreted by the small intestine following E. coli
enterotoxin administration is negligible. The maximum
contribution was 0.2 ng PC-E,,, 1.7 ng PGF^and 1 ng PGAlike
activity when 1 ml toxin was used for challenge.
Experiment 2 ~ 171 ~
The prostaglandin content of fluid washings from healthy and
E. coli-infected piglets
As in cholera, E. c oli infection results in diarrhoea.
The animals selected for this study were neonatal piglets which
were infected with E. coli heat-stable enterotoxin. Intestinal
washings samples were supplied by Dr. R. Bywater of the Royal
(Dick) Veterinary School, Edinburgh University. Intestinal
washings were also obtained from healthy, non-infected control
piglets. The prostaglandins present in washings from both
healthy and infected animals were investigated.
Methods
Samples were collected and transferred on ice from the Royal
(Dick) Veterinary School to the Department of Pharmacology, and
were either extracted immediately or stored at -15°C overnight,
when extraction was performed the following day.
Extraction
The technique used to extract the prostaglandin-like material
in tho samples was that outlined in Figure 6B, Experiment 2,
Section 1, Part 2 : Method B. The 67$ ethanol residue was then
subjected to thin layer chromatography. Radioactive tracer
3-H-PGE2, PGF^and PGA^, 0.1 pCi of each was added to the samples
prior to extraction. The amount of non-radioactive prostaglandin
added was less than 4- ng.
Thin Layer Chromatography
Thin layer chromatography procedure was as described in
Experiment 1, Section 2: The methanol eluates of the PGE, PGF,
and PGA containing zones were evaporated to dryness and redissolved
in 1 ml methanol. At this point the samples were split: 0.1 ml
was used to determine the percentage recovery of prostaglandin-like
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material in the sample by scintillation counting techniques;
0.9 ml sample was used for biological assay.
Scintillation Counting and Recovery Determinations
These procedures have been described previously in Experiment
1, Section 2.
Biological Assay
Samples were assayed using the rat fundal strip and kitten
blood pressure preparation as in Experiment 1, Section 2.
Results
The results of both control and infected animals are contained
in Table 21A.
(a) Uninfected Animal Intestinal Washings
Samples were obtained from 2 animals. The samples contained
3.3 ng and 0.9 ng per ml PGE2-like activity. The PGF^-like
content was 5.7 ng/ml and 7.3 ng/ml in these samples. No PGA-like
activity was detected. The limit of detection of 50 ng total
and 60 ng total respectively for these samples which corresponded
to limits of 2.5 ng and 16 ng per ml for the respective samples.
The average output was 2.1 ng/ml and that of PGF^was 6.5 ng/ml.
(b) Infected Animals' Intestinal Washings
Four samples were obtained from infected animals. The
prostaglandins detected were PGE and PGF series compounds.
As in the uninfected animals no PGA-like activity was found. The
mean PG22 output was 4.0 ng/ml and the range of values was 1.8 ng/ml -
8.0 ng/ml. In two samples no PGF^-like activity was found. The
limits of detection for these samples were 1.9 ng/ml and 7.3 ng/ml.
In the two remaining samples the PGF0 concentrations were observed to
be 12.1 ng/ml and 4.0 ng/ml. The mean output, using the limits of
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Table 21A. The prostaglandin content of intestinal washings from













Control 19.0 ml FGF2* 85.1$ 110ng 5.7 ng/ml
Control 3.7 ml KF2* 61.4$ 26ng 7.3 ng/ml
Average values 73.4$ 6.5 ng/ml
Control 19.0 ml pge2 65.156 61.5ng 3.3 ng/ml
Control 3.7 ml pge2 (25.056) (6556) 3.2ng 0.9 ng/ml
Average value's 45.1$ 2.1 ng/ml
Control 19.0 ml pga2 69.1$ 50ng 2.5 ng/ml
Control 3.7 ml pga2 130.756 60ng 16.0 ng/ml
Average values 99.7% 9.3 ng/rnl
Toxin 13.0 ml pgf2„ 74-2 25 1.9 ng/ml
Toxin 4«0 ml pgf2k 76.7 48.2 12.1 ng/ml
Toxin 6.8 ml rer2* 88.8 50 7.3 ng/ml
Toxin 10.0 ml raF2^ AO 4 ng/ml
Average values 6.3 ng/ml
Toxin 13.0 ml pge2 87.6 23 1.8 ng/ml
Toxin 4-.0 ml pgb2 (17.6) (57.6) 11.7 2.9 ng/ml
Toxin 6.8 ml pge2 84.2 55 8.0 ng/ml
Toxin 10.0 ml pge2 33 3.3 ng/ml
Average values 4.0 ng/ml
PGA^ none detected 65ng 1.9 ng/ml
O
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sensitivity as the output in samples where no prostaglandin
was detected, was 6.3 ng/ml.
Discussion
The PGF_ -like output by control, non-infected and infected
animals did not differ significantly. ■'•'he PGE2 output mean
figures do show a higher mean value for the infected animals
than in the two non-infected animal average. 1'he range of
values in both cases was large and statistical analysis showed
that the difference was not significant (p>5%). The student
' t' test was used for this evaluation. No conclusion about the
PGA output could be made by the assay used. It is possible that
with more sensitive techniques, for example radio-immunoassay, that
PGA output might be detected. The recoveries of PGE in the 3*7
ml control sample and 4*0 ml toxin sample were unusually low but
the PGA recovery was remarkably high, in both cases exceeding 100%.
It was found that the tracer prostaglandin E had in fact
deteriorated and approximately 45-50% of it had been converted to
PGA^. In the determination of PG32 and PGA2 levels in both
of these samples, this factor was allowed for. The standard
PGE^ solution was purified by Sephadex LH-20 chromatography by
C. Hensby and on thin layer chromatography of the PGE eluate from
the column, only one peak of activity was detected. This material
was then eluted from the thin layer plate and used as standard
tracer PGE^ in subsequent experiments. It was 99»9% pure.
Conclusion
Intestinal washings from control and toxin infected animals do
not appear to differ in their prostaglandin content. Thus E. coli
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Prostaglandin production by healthy and E. coli enterotoxin
infected intestinal tissues
Small intestine from healthy and infected piglets was removed
during experiments by Dr. R. Byvater. The tissue was immersed
in the cold Tyrode and transferred on ice. All samples were kept
on ice as far as was possible prior to incubation. The tissue
was freed from any mesentery fat and blood vessels, dried with
blotting paper and weighed. It was chopped with scissors and
then homogenised in 25 ml ice cold Tyrode solution using a Waring
blender, at maximum speed for 2 minutes. The homogeniser tube was
surrounded by a jacket of ice during the homogenization process.
The homogenate was then transferred to conical flasks and the
volume adjusted so that the weight to volume ratio of the tissue
to Tyrode solution was 1:10 - (g:ml). The flask and contents
were then incubated at 37°C in a Gallenkampf shaking vater bath
for 45 minutes and the tissue was gassed with oxygen during the
incubation period. The reaction was terminated by plunging the
conical flasks containing the intestinal homogenate into ice baths
and acidifying the incubate to pH 4.0 - 4*5 with 10$ acetic acid.
Extraction
Standard 3~H~PGE2, 3~H-PGF2^and 3~H-PGA2, 0.1 yUCi of each,
were added to the acidified material. The amount of non-radioactive
prostaglandin contained in these radioactive tracers was less than
4 ng in the 100 ^.1 aliquot added to the samples. The samples were
then extracted using Method B, Section 1, Part 2, Experiment 2.
The 67$ ethanolic residue was subjected to thin layer chromatography.
Thin Layer Chromatography
Thin layer chromatographic separation of the prostaglandin F,
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E and A-like activity in the extracts was performed by using the
double development technique using FVI solvent system in the initial
run and the GCM solvent system in the second solvent development
of the samples, as described previously (Experiment 5, Section 1,
Part 2). The zones corresponding to the PGE, F and A standards
were scraped from the plates and eluted with 2 x 5 ml methanol.
The methanol fractions were pooled, evaporated to dryness and
redissolved in 1 ml methanol. Aliquots were removed for recovery
estimations (0,1 ml), for Gas Chromatography-1-b.ss Spectrometry
analysis (0.4- ml) and the remainder (0.5 ml) was used for
Biological Assay.
Biological Assay
The PGE and PGF fractions of samples were assayed using the
rat fundal strip preparation (Experiment 5, Section 1, Part 2)
while the PGA content of the eluates from thin layer chromatography
PGA zones were estimated using the kitten blood pressure preparation
(Experiment 5, Section 1, Part 2).
Recovery Estimations
The recovery of exogenous prostaglandins was determined by
calculating the percentage recovery of tritium labelled prosta¬
glandins added to the samples prior to extraction. Scintillation
counting techniques were employed. The technique is described
in Experiment 1, Section, 2. This gave an indication of the
recovery of endogenous prostaglandin in the samples.
Gas-Ghromatoyraphy-Mass Spectrometry
(a) PGF^Samples
The 0.4 ml aliquot from the thin layer plates was evaporated
to dryness in a 10 ml glass, pear shaped flask. Deuterium carrier
D^-PGF.^(5 fig) was added to each of the samples. This was
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sufficient for 5 injections. The biological extracts and deuterium
tr
carrier prostaglandin were methylated in the pear shaped flask
by adding excess of freshly prepared diazomethane in diethyl ether
methanol (9:1) and allowing it to react for 15 minutes. The
solvent was evaporated off with a fine jet of air and the residue
was desiccated by evacuation at reduced pressure. The sample
was then dissolved in 0.5 ml methanol and transferred to an
Eppindorf tube and the original flask was washed with 2 x 0.25 ml
aliquots of methanol which were also added to the Eppindorf tube.
The solution was evaporated down with a fine jet of air before
and between each addition of methanol washings, and was finally
evaporated to dryness and desiccated. A 50 pi volume of bis-
(trimethylsilyl)-trifluoroacetamide (B3TFA)-3igma Chemicals - was
added to each sample and these were then allowed to stand at room
temperature overnight. 10yUl amounts of each sample were injected
on to the gas chromatographic column without removal of the B3TFA.
Analysis was performed using an LKB 9000 gas chromatograph-
mass spectrometer. The column (3.0m x 1.5 mm i.d.) was packed
with 3% OVI on a Supelcoport pretreated with dimethylchlorosilane.
The column temperature was 24-0-260°C. The carrier gas was helium
and the flow rate was 30 ml per minute. The mass spectra were
recorded at an electron voltage of 27.5 mV and 22.5 mV.
Mass spectra of authentic PGF^prepared as the methyl ester/
trimethylsilyl trifluoroacetamide (Me/TMS) derivative in the same
manner as the samples, were taken. Mass spectra of the samples were
taken at the appropriate retention time.
(b) PGE^ and PGA„ sanrales
^ ^
The PGA^ and P^E^ samples reserved for gas chromatography-
mass spectrometry were treated with 0.5 ml O.IN potassium
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hydroxide in methanol. The samples were allowed to stand for
1 hour at room temperature. The samples dehydrate to the
corresponding FGA compound under these conditions and this then
isomerizes into the more stable FGB conformation.
After the reaction was thought to have gone to completion, 20 ml
distilled water new- added to the flasks containing the samples
and the acidity was adjusted to pH 4-.0 with hydrochloric acid.
The samples were then partitioned with AO ml ethyl acetate twice.
The ethyl acetate phases were pooled and evaporated to dryness at
reduced pressure. The residue was desiccated and then redissolved
in 0.5 ml methanol and transferred to clean, dry Eppindorf tubes.
The original flasks were rinsed with 0.25 ml methanol two times and
the washings were added to the appropriate samples. The solvent
was vaporized off with a fine jet of air and the residue was
desiccated. The Me/TMS derivative was prepared as described in
the previous section as for FGF^, samples. The Me/TMS derivative
of 1 yUg authentic was prepared and this was injected on to the
column, and the retention time was noted. The Me/TMS derivative
of the extracted material was then injected on to the column and
mass spectra were taken at the appropriate retention time for FGB,,.
Results
(a) Biological Assay
The results of the biological assay are summarized in Table 21B.
The intestinal homogenates from healthy and infected piglets were
observed to synthesize prostaglandins of the F and the E series.
No FGA-like activity was detectable in any of the samples. The
limit of the assay was 90 ng PGA^-like activity for each sample.
The mean production of PGF„ -like material by healthy piglets was 108ng/g
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Table 21J3. The synthesis of prostaglandins of the F and £
series by pig small intestine taken from healthy and Escherischia
coli infected piglets, in vitro. The presence of PGF^^ was













5.2 g 1.6 yllg 307.7 ng/g 460 ng * 88.5 ng
Control
4.3 g 1.53 fig 355.3 ng/g 550 ng * 127.9 ng
Control
3.2 g 1.2 /tig 363.6 ng/g - -
Control
11.3 g 4.3 yog 4.24.3 ng/g
MEAN
Control 363 ng/g 108.2 ng/g
Infected
3.3 g 0.8 jig 242 ng/g 400 ng * 121.2 ng/g
Infected
3.2 g 1.33 fig 415 ng/g 500 ng * 156.2 ng/g
Infected




7.3 ng 1.6 fig 219.3 ng/g
am
MEAN 328.7 ng/g 133.7 ng/g
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while that of infected intestinal tissue vas 139 ng/g. The
difference was not statistically significant (p/'5/0 when
assessed by the paired student 11' test method. The mean
rate of synthesis was 363«0ng/g in healthy intestinal
homogenates and 328 ng/g in horaogenates from E. coli-infected
piglets. The difference between the rates of synthesis was not
statistically significant (p/5^).
(b) Gas Chromatcgraphy-Kass Spectrometry
The presence of PGF^in extracts from E. coli-infected and
healthy piglet homogenates was confirmed by gas chromatography-
mass spectrometry. The ratio of protium to deuterium peaks were
greater in the biological extracts than in the deuterated prosta¬
glandins alonej thereby indicating the presence of PGF^in the
samples. Peaks were present in the mass spectra of the samples at
the following m/e values - 58/+, 569, 513, 494, 4-23 and 397 and
it was the ratio of these peaks that was used to determine whether
PGF^was present or not. The line diagram for one of these samples
is shown in figure 22.
The presence of PGE^ and could not be confirmed by mass
spectrometry owing to the lack of purity of the samples. It was
impossible to distinguish the peaks corresponding to standard
in the spectra of the samples from the background contaminants and dirt.
Conclusion
The synthesis of PGF^in toxin-treated and healthy piglet
f
intestine were not significantly different. The synthesis of PGE^
was also not observed to differ in the tissue exposed to E. coli
toxin and uninfected intestine. No PGA^ synthesis was observed
in either healthy or infected intestine. The presence of PGF^^
vas confirmed by gas chromatography-mass spectrometry.
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Figure 22. Mass spectrum of a sample of piglet intestine synthesi
of following heat-stable E. coli toxin challenge. Only peaks
.corresponding to standard PGF^ and not those due to deuterated
carrier are shown in the spectrum of the test sample, and
compared with those of authentic non-deuterated FGF^standard
in order to simplify the spectrum.
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Experiment L
The effect of prostaglandins on water glucose and electrolyte
movement in the small intestine
From the in vitro studies of prostaglandin synthesis in
E. coli with infected and healthy piglet intestine and the lack of
significant enhancement of prostaglandin output in intestinal
washings, it did not seem likely that prostaglandins were involved
in the E. coli-induced diarrhoea (Experiments 2 and 3, Section 2).
The evidence was however by no means conclusive. More direct
attempts were made to investigate the possible role of prostaglandins
in the secretory mechanisms initiated by enterotoxin. If prosta¬
glandins are indeed mediators of the diarrhoea, then these compounds
should be able to stimulate fluid production by the intestinal
mucosa. This approach was attempted with a series of 9 animals.
Prostaglandins of the E and A series were employed.
Methods
Nine piglets were anaesthetized with pentobarbitone sodium
injected into the anterior vena cava. A dose of 25 mg/kg was used.
A midline incision was made and the intestine was carefully withdrawn
from the abdominal cavity. Loops of approximately 10 cm in length
were made in the upper, middle and small intestine and were cannulated
with soft multiperforate cannulas. The loops were then washed with
warmed 0.9a saline solution.
The animals were divided into the following experimental groups,
(a) Group (A). There were four piglets in this group. In these
animals the intestinal loop was challenged with PGA^ after the first
control period. PGE^ was given after the second control observations
(2 animals) or at 50 minutes after PGS^ measurements had been made
(2 animals).
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Group B. This group was made up of three piglets. Each piglet was
challenged with PGE^ intraluminally after the initial control period
and subsequently with PGA^ after the second control measurements
were taken.
Group C. Of the two animals in this group one animal was treated
with only PGE^ and the other received PGA^ intraluminally. Two
prostaglandin "test" periods were studied in these animals.
The experimental procedure used was the same, irrespective
of the group of animals. Test solution similar to that described
by Bywater (1973) was prepared and contained sodium chloride
(4*772 g/l), sodium bicarbonate (2.135 g/l), potassium chloride
(0.2985 g/l), phenol red 50 flg/ml, glucose (lOg/l), 22Na (2
juCi/l) and D20(1:100 w/v). A 1.5 ml volume of this was
injected into the washed loop and the initial sample was taken
to be equivalent to this test solution in composition as the volume
injected was too small to allow for initial samples to be taken as in
previous calf experiments (Bywater, 1973; Thesis Section 2,
Experiment 6). The test solution was allowed to remain in contact
with the intestinal mucosa for 10 minutes. The loops were then
drained of fluid. PGE^ or PGA^ in doses of 20 jxg and 4.0yUg per
loop were then injected into each loop. The prostaglandin was
dissolved in test solution in both cases. Prostaglandin A test
solution contained 40 jug PGA^ per 1.5 ml volume while the prosta¬
glandin E test solution contained 20 yug PGE^ in 1.5 ml. The loops
were drained after ten minutes and a forty minute recovery period
ensued. A second control observation was made in 3 animals, in the
remaining 6 animals the second prostaglandin was injected in the
appropriate test solution and a further ten minute intestinal
absorption pattern was determined in each piglet. In animals which
- 135 -
were subjected to an intermediate control observation, the second
prostaglandin was administered immediately after these control
readings were taken. The prostaglandin given was in accordance with
the experimental schedule outlined above. Again the absorption
values were determined after a ten minute mucosal contact time.
A further forty minute recovery period was allowed to elapse
and the final control study was made.
Aliquots of the samples collected from each loop were removed
for water, sodium, chloride, potassium and bicarbonate net flux
determinations.
The techniques used to determine sodium and water fluxes were
those described by Bywater for ligated calf intestinal loops
(Bywater 1973b). Net movement was obtained by determining the
difference between the insorption and exsorption values.
Bicarbonate determinations were by microdiffusion as
described in Conway (1962) - Microdiffusion Analysis and
Volumetric Error, U edition, Crosley Lockwood.
Chloride ion determinations were performed using an EEL
chloridemeter and potassium was estimated by flame photometry.
Results
There was no apparent difference in the effect seen with
prostaglandin E compounds injected after the first control period
and after the forty minute recovery period. The same was also true
for PGA injections. The results of all the PGE and PGA treated
loops were therefore pooled separately. The results are
summarized in Figures 23a - f and are tabulated in Tables 22a - f.
- 136 ~
♦. *
(a) The Effect of Prostaglandin on Met Water Movement
The results are contained in Figure 23a and Table 22a. Negative
values indicate reabsorption and positive values secretion of water.
In all of these loops the initial control value is somewhat
exaggerated^ -this being due to the blood leakage which occurs
and interferes with the phenol red estimation used to calculate the
water volume. The upper and middle intestine does however appear
to show a secretory pattern when challenged with PGA^. The position
of PGE^ and PGA^ are interchangeable and thus PGA^ can be compared
with the more characteristic second and final control values. In
later stages blood leakage had ceased to be a likely source of error.
PGE^ did not appear to modify the pattern of fluid reabsorption in
the upper and middle small intestine. Neither prostaglandin
modified the intestinal handling of water in the lower small intestine
as far as could be determined. The colon is characterized by its
marked ability to reabsorb water. The local administi'ation of PGA^
(4-Oyng) and PGE^ (20^ug) did not alter this reabsorptive pattern
when compared to the second and final control mean values. Paired
't1 test of the PGA results in loop B indicated that the difference
was not statistically significant (p)5$)« PGE^ did not appear to
induce any change in the intestinal handling of water either in the
small bowel or in the colon when administered as a single intraluminal
injection of 20yug.
(b) The Effect of Prostaglandins on Net Glucose Flux
The results are summarized in Figure 23b and Table 22b. The
initial control values are remarkably high and should not be regarded
as valid. The second and final control values are much lower and
are more representative of glucose absorption in normal intestine.
In the upper and middle and lower small intestine PGS^ and PGA^




Values represent the mean of n observations (see Table 22a) + S.E.M.
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In figures 23a - e the values plotted represent the mean values + S.E.M.
The positions of PGE^ and PGA^ results are interchangeable with respect
to the 1st and 2nd and 2nd and 3rd control observations. Details of all
of the mean values + S.E.M. for these figures are given in tables 22a - e.
- 187a -
Figure 23(b).
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Table 22a. The net flux of water in the piglet gastro-intestinal
tract and the effect of local intraluminal injection of PGA^ (AOyUg)
and PGE.J (20 jxg) on these fluxes. Loops A-C are situated in the
upper, middle and lower small intestine respectively. Loop D is in
the spiral colon. The results indicate the mean flux + standard
deviation of the net water fluxes. The number of observations (n)
made for each loop and the standard error of the mean used to construct
the graphs, are indicated below the mean values for each loop. The
flux was measured as net movement of millilitres of fluid per
centimetre length of intestine during the 10 minute observation period.













































































Table 22b. The net flax of glucose in piglet small intestine. The
Loops A - D are situated in the upper, middle, lower small
intestine and spiral colon respectively. The effect of PGA^
(40yUg) and PGE^ (20yUg) on the net glucose flux was investigated.
The results given are the means of several observations, indicated
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In these regions of the intestine the rpean control value was
<
^ <•
higher than that of the PGA - treated intestine* The values were,
going from upper to lower intestine 0.13 + 0.20, 0.10 + 0.19,
0.14. + 0.61 mg/cm/10 minute period for the control tissues and 0.01
* 0.1$, -0.02 + O.48 and -0.31 ± 0.23 in the PGA^ challenged loops
respectively. The differences were not statistically significant
(p/>5^.). The colon does not absorb glucose normally and prosta¬
glandins did not appebr to modify the behaviour of this region
of intestine.
(°) The Effect of Prostaglandins on Net Sodium Flux
Prostaglandin-treated and control observations are summarized
in Figure 23c and in Table 22c. No marked alteration in the
intestinal handling of medium was observed following the administration
•
v
of prostaglandins in the colonic loop, loop D. In the upper small
intestine PGA^ appeared to enhance sodium absorption. This result
was not statistically significantly different from the second
control (p.) 570. The mean values in question are 2.60 + 2.13
mEq/cm/lO minute and -1.97 + 5.07 mEq/cn/10 minute for PGA^ and
second control respectively. In the middle and lower small
intestine both .PGA^ and PGS^ seemed to increase the mean absorption
but again this was not significant (p)5/0. In the colon there
was essentially no difference between the prostaglandin sodium net
movement figures and the control'measurements. The mean values
(+ SD) for the three control readings were 1.75 ± 2.53, 2.23 (2
observations only), and 1.09 + 1.85 mSq/cm/10 minutes. PGA^ sodium
value was 1.57 ± 2.3 mSq/cm/10 minutes and that for the corresponding
PGE.J period was 1.45 + 2.19 mEq/cn/'lO minutes.
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Figure 23(c).
The Effect of Prostaglandin E,. and on Net Sodium Flux
SODIUM ABSORPTION
















































Table 22c. The net sodium flux across piglet small intestine.
Loops A - C are situated in the upper, middle and lower small
intestine. Loop D is in the spiral colon. The number of
observations n, are given below the mean value + standard
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Table 22d. The net flux of potassium ions across the small
intestine and spiral colon in piglets. Loops A - C are situated
in the upper, middle and lower small intestine while Loop D is in
the colon. The results are the means of several observations
(n) + standard deviation. The effect of PGA^ (AOyUg) and PGE^
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The Effect of Prostaglandin and on Net Potassium Flux
POTASSIUM ABSORPTION






















pmoles /cm /10 mln.









(d) Potassium Ion Movement (net) and.prostaglandins
The effect of prostaglandins, PGS^ arid PGA^, on the net movement
of potassium ions across the small intestine and colon mucosa
are depicted in Figure 23d and are contained in Table 22d. As
in the case of sodium ions there was no significant alteration
in the pattern of potassium ion movement in either the small
bowel or in the colon in the presence of PGA^ and PGE^.
(®) The Effect of Prostaglandins onxNet Chloride Flux
Neither PGS. nor PGA. caused significant alteration in
/ 1 1
the chloride ion flux in the colon. No marked changes occurred
in response to PGS^ (20 yug) administration in the small intestine.
With PGA.J (4.0yag), there appeared to be a trend to enhance
middle small intestine absorption of chloride ions. The mean
PGA( stimulated chloride net flux was 2.43 ± 2.42yuEq/cm/10 minutes.
The second control net flux for chloride ions was 0.25 + 1.12
cm/10 minutes and the final control was 0.56 + 1.79yuEq/cm/
10 minutes. The difference is not statistically significant (p> 55®) •
No striking changes were produced by either PGS^ or PGA^ in the
upper and lower small intestine with the intraluminally injected
doses of 40 ^ug PGA.J and 20yzg PGE^. The results ai-e shown in
Table 22e and Figure 23e.
(f) Prostaglandins and Bicarbonate icnHovement
The effect of prostaglandins on bicarbonate"ifin movement in
the small intestine and colon can be seen in Table 22f and Figure 23f.
Only in the control and prostaglandin values from this ion does any
pattern appear to emerge. The initial control value in all the
intestinal loops tends to be depressed b^ thp administration of PGS^
and PGA^. PGA in the lower small intestine seems to cause a more
marked trend to secretion of bicarbonate ions than in the upper and middle
- 195 -
Firare 23(e)
The Effect of Prostaglandin 5^ and on Net Chloride Flux
CHLORIDE ION ABSORPTION
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Figure 23(f)»
The; Sffect Rf Prostarl?.ndin and on Net Bicarbonate Flux
BICARBONATE ION ABSORPTION



























































Table 22e. The net flux of chloride ionsyuEq per centimetre of
intestine daring the ten minute observation period. Loops A - C
are situated in the upper, middle and lower small intestine. Loop
D is in the spiral colon. The number of observations (n) made
to determine the mean + S.D. of each set of values is indicated
together with the standard error. The effect of PGA^ (40yUg) and
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Table 22f. The net flnx of bicarbonate ions across the piglet small
intestine and the effect of PGA^ (40yig) and PGE^ (20yug) given
by local intraluminal injection on the net ion flux. The results
given are the mean values + the standard deviations of several
observations. The number (n) is indicated below the mean,
together with the S.E.M. Loops A - C are situated in the
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small intestine. The second control value shows a net secretion
at all points along the small intestine. In the upper small
intestine 0.2 + 0.7^uEq bicarbonate per cm per 10 minutes is secreted.
The corresponding values for the middle and lower small intestine
are 0.3 i O.^yuEq and 0.17 + 1.16per cm per 10 minute
observation period. The third and final control value shows a
return to absorption of bicarbonate ions. The mean absorption
of bicarbonate ions was 0.12 +, 0.56, 0.56 + 0.39 and 0.35 ±1*5yUiSq
bicarbonate per centimetre length of intestine during the ten
minute study period. The middle and lower small intestine appear
to be more sensitive to the effects of PGE^ than does the upper
small intestine but the range of values encountered do preclude
any definite statement on this possibility.
No significant alteration in net bicarbonate ion movement
was observed in the colon.
Discussion
It was anticipated that with the high doses of prostaglandin
used and even allowing for substantial metabolism of these compounds
by the intestinal mucosa, that some marked changes in net ion flux
across the intestinal mucosa would be observed. It would seem
that the piglet intestinal mucosa is either capable of metabolizing
the prostaglandin presented to it from the luminal side of the
mucosal cell very rapidly and effectively, or possibly is particularly
insensitive to the effects of intraluminally administered prosta¬
glandins. The only ion flux which may be considerably altered by
prostaglandins appears to be the bicarbonate ion flux. (The
significance of these findings in relation to the actions of E. coli
toxin on ion and water movement will be discussed together with the
remainder of the results in this section and in conjunction with the
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calf perfusion results).
Bywater and Jeffries (unpublished observations) have
investigated the effects of heat-stable Escherischia coli toxin
preparations on water, glucose and electrolyte movement in the
small intestine of healthy neonatal piglets both in vivo and
in vitro. Using the everted intestinal sac model it has been
observed that the uptake of glucose by the intestinal mucosa is markedly
depressed by exposure of the tissue to E. coli heat-stable toxin.
Secondary to this effect, is the reduction in water absorption
by the mucosa. In vivo, preliminary investigations using a
perfused intestinal loop model have confirmed these results.
The net movement of sodium, potassium, chloride and bicarbonate
ions was also studied in this latter model. Neither potassium,
nor chloride nor bicarbonate ion fluxes showed any alteration from
their usual pattern following toxin administration. The absorption
of sodium was slightly depressed but this was not statistically
significant and was probably a reflection of the depression of
the glucose-dependent sodium transport pathway which operates in
the gastro-intestinal mucosal cells (Bywater and Jeffries,
unpublished observations).
Thus it is evident that prostaglandins do not imitate the
effects of heat-stable E. coli toxin in the small intestine. PGE^
and PGA.J did not produce a significant reduction in glucose
absorption, in the doses used, but did promote bicarbonate ion
secretion; the toxin depressed glucose uptake but caused no
alteration in the net bicarbonate ion movement across the mucosa
of the small intestine.
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Conclusion
Prostaglandins stimulate bicarbonate ion secretion in
piglet small intestine. Neither PGA^ nor PGE^ in the doses used
shoved any modification of intestinal handling of water, glucose,
sodium or potassium or chloride. It was therefore concluded that
prostaglandins of the E and A series are unlikely to be mediators
of the secretory activity stimulated by Escheri chia coli toxin
in the small intestine.
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Experiment 5
The intra-arterial infusion of prostaglandins in calves
The effect of Escherichia coli heat stable toxin on
ion and water flaxes in the small intestine and colon of calves
has been extensively investigated by Bywater and Jefferies (in
preparation). It was possible that prostaglandins might be able
to simulate the effects of E. coli toxin on ion movement in the
small intestine and colon. Pierce and his associates demonstrated
that prostaglandins administered intra-arterially in dogs are capable
of stimulating fluid secretion in the small bowel (Pierce et al,
1971). Cholera toxin stimulates copious fluid production in the
calf intestine (Bywater, unpublished observations).
Methods
Four calves weighing 30-40 kg and 5-10 days old, were
anaesthetised with pentobarbitone sodium 25 mg/kg injected
intravenously. The trachea was intubated and the animals were
allowed to breathe oxygen/carbon dioxide (95>s5 per cent). The
/
abdomen was opened and lengths of intestine at approximately
15 p. 100, 40 p 100, 65 p 100, and 90 p 100 of the distance from
the pylorus to the ileo-caecal valve were selected. The positions
were confirmed at the end of the experiment. A 15 cm length of
intestine was tied off with silk ligatures. The loops were
cannulated at their upper ends with a multiperforate 15 cm
long cannula which was passed through the centre of a nylon bobbin.
The bobbin was then secured with a silk ligature at the upper end
of the loop. Animals received a continuous intravenous infusion
of isotonic saline at a rate of 10 ml/min. via the jugular vein.
A fine cannula was inserted into one of the smaller branches
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of the superior mesenteric artery close to the intestinal wall,
in the gut mesentry, and was passed retrogradely until the tip
lay just below the point at which the superior mesenteric artery
branched from the aorta. The position of this cannula was
confirmed at death. During control observation periods 0.9%
saline was infused into the superior mesenteric artery at a rate
of 1-1.5 ml per minute. During test, prostaglandin observations,
prostaglandin dissolved in 0.9% saline were infused via the
arterial cannulae at a rate of 1-1.5 ml per minute. The rate
was maintained constant using a Braun infusion pump system
for both the control and test infusions.
The lumen of each loop was washed with warm saline and a
15 ml of an isotonic test solution was injected into each of the
loops to be studied. The test solution contained sodium chloride
(4-.772 g/l), sodium bicarbonate (2.135 g/l), potassium chloride
'(0.2985 g/l) glucose (lOg/l) and either polyethylene glycol 4.000
(7.5 g/l) or phenol red (50 jig/ml). 22Na (2 jxOi/l) and D20 p.
100 w/v were added to the solution. The solution was mixed rapidly
with the residual saline in the loop and an initial sample of 0.2 ml
was removed for duplicate estimations of polyethylene glycol or
phenol red. This procedure was adopted in order to determine
the amount of residual saline in the intestinal loops. After a
fifteen minute period the loops were drained and. the control
sample was taken.
Prostaglandin administration
(l) PGF2^ PGF2^2 yUg/ml - 25 yug/ml was infused at a rate of 1-1.5
ml per minute for 50 minutes in 3 calves into the superior mesenteric
artery. Measurements of the ion fluxes and water movement were
taken in the last 15 minutes of the perfusion period.
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(2) PGE^. ^ ~ 50 yug/ral was infused at a rate of 1 ml/
minute for 50 minutes in 4 calves via the superior mesenteric artery.
As in the case of PGF^ion and v/ater fluxes were estimated during
the final 15 minutes of the infusion period.
(3) PGA^. PGA.J 2 yug - 25 ytig/ml was infused at rates of 1 to 1.5 ml
per minute for 40,or 50 minute periods via the superior mesenteric
artery in 3 animals and any changes in ion flux and water absorption
were measured during the last 15 minutes of perfusion.
A 60 - 90 minute control period was observed between each
prostaglandin infusion. The last 50 minutes of this control
period was used to infuse 0,9% for the,same length of time as the
prostaglandin solution and to record control, non-prostaglandin—
treated intestinal loop ion and v/ater movement in the loops.
Again a 15 minute observation period was employed.
Ion and V/ater Flux Determinations
The methods used to determine potassium, sodium chloride
and bicarbonate ion fluxes are described in Experiment 4, Section 2.
The method used to estimate v/ater movement is also described in
Experiment 4 for phenol red containing samples. In the experiment
in which polyethylene glycol was used to estimate the volume and
correct the ion concentrations, the polyethylene glycol was
estimated by the turbidometric method of Hyden (1956) and modified
by Smith (1959) and by Bywater (1973b). Deuterium oxide was
measured as described by Bywater (1973b). The net ion and water
movements were estimated and used to compare the effects of
prostaglandin infusion with Escheri/chia coli toxin results
(obtained by Bywater and Jefferies).
Results
The effects of infusing prostaglandins into the superior
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mesenteric artery for 4-0 to 50 minutes in doses of 2-50 jug/'ml
at rates of 1-1.5 ml per minute are summarized in Tables 23-25.
The results are also shown in histogram form in Figures 24- to 26.
Only net fluxes were investigated.
(a) PGP,, 'infusion
Intra-arterial infusion of PGF^ in doses of 2-25 yug/ml/rainute
did not appear ,to induce any significant alteration in the ion and
wat&h flux across the mucosa of the small intestine in calves.
(b) PGA infusion
The"""administration of PGA^ did not significantly alter the
net flux of water across the small intestine at any level. The
flux of sodium ions in the upper and middle small bowel did not
appear to be modified in any way. In the lower small intestine
there appeared to be a depression of sodium absorption but the
difference between PGA^ treatment and control observations was
not statistically significant. The effects were measured in 3
animals only. Potassium flux was not modified by PGA. treatment
nor were the chloride or bicarbonate net fluxes.
(c) PG5^ infusion
As in the experiments in which PGA^ and PGF^were infused,
little alteration in net ion and water fluxes were elicited by
PGE^. No enhanced or diminished net movement of potassium, water,
sodium or chloride was encountered. Bicarbonate ion flux was however
altered. Three of the four loops A (15$ duodenum-ileocaecal valve
distance), C (65$ duodenum-ileocaecal valve interval), and D (90$
of duodenum-ileocaecal valve distance) were observed to show an
enhanced bicarbonate secretion. The mean output of bicarbonate ions
in control observation periods by these loops was 15.69 + 15.71
15 minutes/100 2minutes/100 Cm and
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Calf. Superior Mesenteric Artery Perfusion Experiment
Table 23. . The effect of intra-arterlal PGB^. infusion on net ion
and water fluxes in the small intestine of calves
; 1
PGEg perfusion
Nfet H^O Flux rwC / .

































































Net Chloride Flux ji//"SW.'n
c on -614.41 ± 457.98 -556.61 + 360.98 -147.99 + 261.12 271.59 + 288.2c
P.G.t^ -60.23 ± 1204.1 -370.03 + 825 -488.05 + 701.83 235.45 ± 260.36
. S.E.M. 144.83; 491.59 114-15; 336.82 82.57; 286.53 91.16; 106.5
t N.S. N.S. N.S. N.S.
Net Bicarbonate Flux yi>-,
c©n 15.69 + 15.71 9.58 + 23.4 -4.77 + 13.43 -5.39 + 9.57
P.G.fc-^ -0.13 + 11.65 -5.22 + 16.11 -34.87 + 26.55 -15.58 + 6.0
S.E.M. 4.80; 4.76 8.91; 6.58 5.83; 10.84 3.03; 2.45
t 5% N.S. 5% 5%
* N.S. = not statistically significant at the 5% level.
- 206 -
Table 24. ?he effect of intra-arterial infusion of PGF^ on net ion
■ and water fluxes in the calf small intestine
The effect of PGF„ , infusion on Net Ion Fluxes.
«-®v










































































































Table- 25. The effect of intra-arterjal infusion of PGA^ on
on net ion and water flaxes in the calf small intestine
The Effect of PGA infusion on Net Ion Fluxes











































































































The Effect of PG3„ Infusion on Water and Sodium Flux
THE EFFECT OF PGE INFUSION ON NET WATER AND ION FLUXES
H20 FLUX ml / 100cm / ISmin.













The values plotted represent the mean change in net flux of n
observations + S.E.M. (Table 23)•
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Figure 2U - coatd.
The Effect of FG'X Infusion on Net Potassium Chloride and
Bicarbonate Flux




































The Effect of Infusion on Net Water and Sodium Flux
THE EFFECT OF PGF?0C INFUSION ON WATER AND NET ION FLUXES
H20 FLUX ml / 100cm / I5min
































The values shown represent the mean change in net flux of n
observations + S.E.M. - see Table 2A for details.
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Figure 25 - contd.
The Effect of Infusion on Net Potassium Chloride and
Bicarbonate Flux
THE EFFECT OF PGF0tL INFUSION ON NET ION FLUXES
K* FLUX/j moles/100cm2/ 15min



























CL~ FLUX /i moles / 100cm2/ 15min.














The Effect of PGA^ Infusion on Net Water and Sodium Flux































The values shown represent the mean change in net flux of n
observations + S.E.M. - see Table 25 for details.
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Figure 26 - contd.
The Effect of PGA^ Infusion on Net Potassium Chloride and
Bicarbonate Flux.





-5.39 + 9.57 yuSq/15 tainutes/100 era respectively. The
corresponding values after prostaglandin E0 administration were
-0.13 ± 11.65, -34.37 + 26.55 and -15.53 + 6.CyuEq/l5 minutes/
2 rf
100 era . The fourth loop, loop B, at 4Cfc of the distance between
the duodenum and the ileocaecal valve did show a similar pattern
of response to PGS^ but the results obtained in control and
prostaglandin-treated intestinal loops were not statistically
significantly different (p >5/»). The values were 9.58 + 28.4
^uEq and -5.22 + 16.11 jaEq/15 minutes/100 cm in the untreated
and prostaglandin treatment segments of intestine.
Discussion
Neither PGA^ (2-25 /ig/ml infused at a rate of 1 ml/minute
for 50 minutes) nor (2~25 ^g/ml infused for 50 minutes at
a rate of 1 ml/minute) were found to modify the intestinal
handling of water and electrolytes. ^^2 a-'-one (2~^G /^gA'T f°r
50 minutes at an infusion rate of 1.15 ml/minute) when given via
the superior mesenteric artery was observed to alter net ion flux
across the intestinal mucosa. The ion affected was the bicarbonate
ion. "'"n ^0ses ase<T enhanced the exsorption or secretion
of this particular ion.
These results with prostaglandins contrast sharply with
those obtained by Bywater and Jeffries who, using a similar calf
model, studied the effects of heat stable Escheri/chia coli toxin
'On the movement of ions and water across the intestinal mucosa.
In these investigations the toxin depressed water absorption in the-
upper small intestine and stimulated net secretion of fluid in the
lower half of the small bowel. Sodium ions were secreted in the
upper intestine in healthy calves and this output was not augmented
- 212 -
by toxin administration. In the lower gut, however, sodium ions
were normally absorbed and this movement was reversed by heat-
stable toxin. The secretion of potassium ions was enhanced by
challenging the intestine with E. coli toxin but this response
was only elicitable in the terminal ileum. The pattern of
chloride ion movement followed that of sodium ions in toxin
treated intestine.Tbus net secretion was found in the lower small
bowel in infected animals but not in healthy control calves. The
net movement of bicarbonate ions was not sensitive to E. coli heat-
stable toxin. All of these responses differed from those
observed following prostaglandin infusion. These results are
shown in Figures 27 to 31 which were provided by Dr. Bywater of the
Royal (Dick) School of Veterinary Studies (Edinburgh).
Conclusion
PGE^ (2-50 Jug/ml) administered by intra-arterial infusion
via the superior mesenteric artery stimulated bicarbonate ion
secretion in the small intestine in calves. PGA^ (2-25yug/ml)
and P^F^^ (2-25yug/ml) did not modify bicarbonate ion movement in
the small bowel. Neither PGE^, PGF^^ nor PGA^ influence the net
fluxes of water, sodium, potassium or chloride ions across the
intestinal mucosa in healthy calves. It was therefore concluded
that prostaglandins were unlikely to be the mediators of E. coli
heat-stable toxin-induced fluid and electrolyte secretion in
the small bowel.
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Figure 27. The effect of E. coll toxin on net water movement
in calf intestine. Values represent mean change + S.E.M. The
statistical significance is indicated where appropriate in this and
subsequent figures (Figures 28 - 31) • cw 'tvc.
U *—urwz^jvdrcJ. <X8>
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General Conclusion (Section 2)
The evidence presented in this section of the thesis
suggests that like cholera toxin, Escherichia coli heat stable
toxin initiates fluid secretion and electrolyte loss in the
small intestine by a mechanism independent of prostaglandin
production and mediation.
Intestinal washings from infected and healthy piglets
did not show any marked difference in prostaglandin content.
Thus no overflow mechanism involving prostaglandin biosynthesis
and release appeared to be operational (Experiment 2).
Escheri/bhia coli toxin itself was devoid of prostaglandin-
like activity (Experiment 1) thus no direct prostaglandin step
was involved in the initiation of secretory responses. The
synthesis of PGE^ and PGF^was no greater in intestinal tissue
taken from E. coli toxin infected animals than in samples of
calves (Experiment 3)» This suggested that prostaglandin
biosynthesis in the intestine did not play an integral part in
the intestinal reaction to toxin administration. These results
were further supported by experiments in which prostaglandins
(PGE.J and PGA^) were administered intraluminally to piglets.
In these experiments no net secretion of fluid was observed.
Bicarbonate ion secretion was enhanced. These effects did not
resemble those seen following toxin administration either in vivo
or in vitro to piglet intestine (Experiment 5).
Prostaglandins are not likely to be mediators of the
effects of E. coli heat-stable toxin in neonatal calves. Intra¬
arterial infusion of PGE2>PGA and PGF^did not mimic the effects
of toxin administration on fluid and electrolyte loss in the
small bowel (Experiment 6).
- 217 -
It is therefore concluded that Escherichia coli heat —
stable toxin does not initiate fluid secretion in the gastro¬




In the introduction it was suggested that there were two
possible mechanisms whereby cholera toxin and other bacterial
toxins might initiate fluid secretion in the small intestine via
a prostaglandin or prostaglandin-like mediator (see Introduction,
Figure A)• The first pathway implicated a prostaglandin of
bacterial origin. The second was dependent on host biosynthesis
in response to the toxin stimulus. It has been possible to
demonstrate that neither of these hypotheses is valid and that
prostaglandins or prostaglandin-like compounds are not implicated
in either experimentally-induced cholera or E. coli diarrhoea.
Toxin and Prostaglandin
The prostaglandin content of cholera enterotoxin and heat-
stable Escherichia coli enterotoxin was determined. No prosta¬
glandins were detected in cholera toxin prepared from Vibrio
cholerae strain 569B (Wyeth lot 002 toxin). The lower limits of
the assays were 12.5 ng, 25 ng and 90 ng per gram solid weight of
toxin for PGS2' PGF^ and PGA^ equivalents respectively. The dose
of toxin used to initiate choleraic fluid loss in cats was 1 g
while the amount used in the rabbit perfused ileal loop model
was 100 mg solid weight toxin. Thus the total prostaglandin
administered to rabbit intestine was no more than 1.25 ng PGE^-,
2.5 ng PG?2o(-, and 9.0 ng PGA^-like material. No prostaglandin-
like activity was found in two of the three batches of E. coli
toxin prepared from E. coli strain BAA and the respective medium
controls. The limits of detection were 10 ng PG32 equivalents, 25 ng
PGF2(X equivalents and 60 ng PGA^ equivalents per 60 ml toxin solution
and sterile broth. 1? The third sample of toxin solution contained
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10 ng PGS^-like and 100 ng PGF^-like material bat no PGA^-like
activity was detected. The corresponding control medium was
also observed to contain anc* activity amounting
to 12 ng and 100 ng per 60 ml fluid respectively. No PGA^-like
substances were found. The limit of assay for PGA^-like material
in both the sterile broth and active toxin solution was 60 ng per
60 ml fluid. The volume of toxin used to challenge intestinal
loops was 1.5 ml in piglet experiments. Thus the maximum total
dose of prostaglandin administered was 0.3 ng PGS^ equivalents,
2.6 ng PGF^ equivalents and 1.5 ng PGA^- equivalents. Sterile
v.
broth does not induce fluid secretion in the small intestine and
thus it could be concluded that the amounts of prostaglandin
administered in the active toxin solution were insufficient to
account for the fluid and electrolyte loss caused by the toxin.
It was considered unlikely that PGF^^ or a PGF-like
compound might have been responsible for fluid production due to
bacterial toxin infections as PGF^^had been observed to enhance
plasma protein loss from canine jejunum in association with the
extrusion of electrolytes and water (Pierce et al, 1971).
Choleraic fluid and E. coli diarrhoeic fluid are not rich in
protein matter (Weaver et al, 194-8; Pierce et al, 1971; Pierce
& Wallace, 1972). The situation encountered in the intestine
following local bacterial enterotoxin administration resembles
the excretory activity of the kidney in that only salt and water
is lost from the organ (see e.g. Davson & Eggleton, 1968). PGE
and PGA compounds stimulate fluid and electrolyte extrusion by the
kidney (Herzog, Johnston & Lauler, 1967; Davis, 1971; Fulgraff,
Brandenbusch & Meiforth, 1972, 1973)* Thus it seemed that the
most likely candidates as mediators of the effects of the
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enterotoxins were prostaglandins of the E and A series.
The absence of such compounds in cholera toxin preparations
confirmed the work of Horton & Collee (unpublished observations).
Similar findings have since been reported by Bedwani (personal
communication) who was unable to detect any PGE^-like activity
in extracts of crude Wyeth lot 001 cholera toxin and in highly
purified toxin. In all of these investigations biological assay
was used to estimate prostaglandin-like activity.
Pierce and his associates (Pierce et al, 1971) demonstrated
that microgram quantities of prostaglandins of the E, F and A
series were required to elicit a secretory response from the
intestinal mucosa when given by either intra-arterial or local
intraluminal infusion to dogs. Thus it is highly unlikely that
the prostaglandin-like activity detected in any of the toxin
preparations used to stimulate fluid production in experimental
animals could have been responsible for the secretory stimulant
properties of the toxin solutions.
It was also difficult to reconcile the long duration of the
effects of cholera toxin with the brevity of those of prostaglandins
In the intestine it has been observed in vivo and in vitro that
the stimulation of fluid secretion and adenyl cyclase activity
by PGE^ is rapidly terminated following the removal of this
compound. Removal of cholera toxin does not result in a rapid
cessation of enhanced activity (Pierce et al, 1971; Kimberg et al,
1971; Al Awqati & Greenough, 1972). The evanescent nature of
the intestinal secretory stimulant activity of Escherichia coli
toxin was compatible with this hypothesis however (Guerrant, Ganguli
Casper, Moore & Pierce, 1973).
The absence of appropriate polyunsaturated fatty acids in
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cholera toxin filtrate (Kaur et al, 1970) and the fact that
purified cholera toxin is a high molecular weight protein
(Finkelstein, 1972) also argued against a direct prostaglandin
link. Furthermore it was impossible to give a logical and valid
explanation of results like those of Kimberg and his associates
who demonstrated that PGE^ and cholera toxin were both able to
elicit maximal stimulation of adenyl cyclase activity equivalent
to that observed in the presence of PGE^ and toxin alone respectively,
wh?n the tissue had been previously exposed to the other agent
(Kimberg et al, 1971). Sharp and Hynie have claimed to have
enhanced the response of adenyl cyclase activity to PGE^ by
cholera toxin pretreatment (Sharp and Hynie, 1971) but the actual
prostaglandin-elicited part of the response was not significantly
greater than that observed in the absence of the active toxin.
Had toxin activity been directly associated with prostaglandin
compounds, then an inhibitory effect of each of these substances
on the other would have been expected.
Furthermore, it is possible to dissociate the stimulant
properties of cholera toxin and Escherichia coli toxin from those
of PGE compounds by investigating adenyl cyclase systems other than
those found in the gastro-intestinal tract. Both cholera toxin
and Escherichia coli toxin preparations stimulate fat cell adenyl
cyclase activity (Curlin & Chen, 1971; Hewlett & Greenough, 1972;
Greenough, Pierce & Vaughan, 1970; Hewlett, Guerrant, Evans &
Greenough, 1974-) but do not inhibit the lipolytic actions and
increase in adenyl cyclase activity induced by other hormones, e.g.
adrenaline (Katz & Greenough, 1972; Hev/lett et al, 197/+). In
contrast prostaglandins inhibit adenyl cyclase activity which is
hormonally induced (Steinberg, 1967; see Reviews of Horton, 1972
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and Karim, 1972) but do not stimulate lipolysis directly in
isolated fat cells. Furthermore the time course of adenyl
cyclase activation by bacterial toxins is different to that of
prostaglandin-induced activity, there being marked discrepancies in
the latency of onset, duration and rapidity of termination of .
effects (see Sharp, 1973).
Finally it has been.demonstrated by Pierce (1973) that
there are separate intestinal mucosal cell receptors for cholera
enterotoxin and E. coli heat-stable enterotoxin. Gangliosides,
and natural cholera toxoid inhibit the binding of active cholera
toxin but not that of E. coli toxin. The possession of discrete
receptor sites by the mucosal cell for each of these toxins implies
that a common direct pathway reliant on prostaglandin-like moieties
in the toxins unlikely to be responsible for the fluid loss
and that there are probably two activating mechanisms in the cell
wall, one for each toxin.
Thus there is little or no evidence to support the statement
that toxin release of prostaglandin-like substances is responsible
for the secretory stimulant properties of either Vibrio cholerae
or Escherichia coli enterotoxins.
Escherichia coli toxin. Cholera toxin and Intestinal prostaglandins
Much of the data in the literature could however be reconciled
with the second postulated mechanism of prostaglandin-dependent toxin-
induced fluid production. The relevant part of Figure 4 is
reproduced in Figure 3Zfor clarity. The inability of PGE^-induced
maximal adenyl cyclase activity to approach the levels of enhanced
activity achieved with cholera toxin and S. coli toxin (see Kimberg
et al, 1971j Kimberg, Field, Gershorn and Henderson, 1974; Evans
















inability of sufficient quantities of prostaglandin to escape
metabolism and reach the adenyl cyclase regulator sites. Penetration
would not be a problem for intracellularly synthesized prostaglandin.
The difference in time course of adenyl cyclase activation and
duration of effects between cholera toxin and E. coli toxin were
also explicable. Cholera toxin consists of a binding and an
activator subunit. E. coli heat-stable toxin on the other hand is
a relatively low molecular weight compound (see Introduction). It is
Figure 2L
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+ membrane
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possible that the prolonged latency observed with cholera toxin is
attributable to the delay in the release of the activator fraction
and initiation of prostaglandin biosynthesis. This latter process
may well be an indirect protein«*dependent step, the protein itself
requiring to be synthesized de novo as cycloheximide interrupts the
toxin-initiated processes which culminate in fluid secretion (Serebro
et al, 1969,* Grayer et al, 1970; Moritz et al, 1972). Tenuazoic
f
acid, also a protein synthesis inhibitor (Moritz S: Womelsdorf, 1973)
has similar effects.. Cuatrecasas has shown that the binding of
cholera toxin to cell membranes is a two stage reaction: there is an
initial rapid attachment of the toxin to the membrane surface; this
is followed by a slower reaction in which some change in the toxin
configuration relative to the membrane receptor occurs which is
irreversible, stabilizes the toxin-receptor binding and results
in the intracellular extrusion of the activator subunit (Cuatrecasas,
1973a)• Similar studies have not been performed using E. coli
toxin. It has however been shown by Hewlett, Guerrant, Evans and
Greenough (1974) that washing of isolated fat cells following
exposure to E. coli toxin limits the toxin-induced stimulation of
adenyl cyclase activity and glycerol release. This together with
the work of Pierce suggests that E. coli toxin may only be weakly
bound to the mucosal cell membrane and initiate secretory activity
from that membrane site rather than by a more direct intracellular
action similar to cholera toxin. Leitch and Glinkson observed
changes in the lipid content of mucosal cell membranes (see
Introduction). Phospholipids are storage sites for prostaglandin
precursors. The fate of the phospholipid released from the membrane
has yet to be established. The loss of these compounds during
exposure of the intestinal mucosal cell to cholera toxin might
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indicate that prostaglandin biosynthesis was indeed taking place
within the mucosal cell.
The discrepancy between the doses of intra-afterially infused
prostaglandins and of intraluminally administered compounds required
to induce fluid secretion in canine small bowel could in part be
accounted for in terms of the above hypothesis. Firstly the adenyl
*
cyclase responsible for ion and water extrusion is not located in
the brush border membrane but in the lateral and basal membraies
(see Sharp, 1973). Thus there is a much greater ease of access
to these sites for intra-arterial prostaglandins than for intra¬
luminally ^applied compounds, which have to overcome uptake and
metabolism processes in sufficient quantities in addition to
actually reaching the target adenylate kinase.
No explanation could however be given for the results obtained
on maximal stimulation of adenyl cyclase activity by PGE^ or cholera
toxin (Kimberg et al, 1971) nor for Sharp and Hynie's results
(Sharp & Hynie, 1971). That these two reports did not concur
with the remainder of the evidence in support of this hypothesis
was insufficient grounds for rejecting the hypothesis outright.
However direct evidence of prostaglandin participation was required
in order to prove it.
The results obtained in this investigation from direct
observations on the release, and biosynthesis of prostaglandin-
like compounds did not support the theory of prostaglandin-mediated,
toxin-induced fluid loss in the small bowel. Prostaglandin-like
material was present in fluid secreted into the lumen of ligated
ileal loops in rabbits and was characterized by solvent extraction,
purification and silicic acid column or silica gel thin layer
chromatography followed by biological assay. Intestinal washings
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from E. coli toxin^infected piglets were also found to contain
prostaglandin-like activity. In the rabbit PGE-like and PGA-like
material was detected both in samples collected 8 to 12 hours
after toxin administration and in those obtained at 22 to 24 hours
after challenge. The amounts present in the 22 to 24- hour samples
greatly in excess of those in samples from the experiments of
shorter duration. This markedly enhanced release corresponded
in time with the development of extensive haemorrhagic necrosis
of the ligated, toxin-treated loop wall and with considerable
distension of the loop itself.
When a perfused ileal loop model was used instead of this
ligated loop model it was apparent that the prostaglandin release
induced in the ligated loop was mainly attributable to the trauma
experienced by the intestinal tissue. Prostaglandin E and F-like
compounds were present in low concentrations both in washings
from E. coli toxin-infected animals and in control, healthy
uninfected piglets. This suggested that the prostaglandin release
was largely due to the washing procedure itself. However, in
these experiments in which toxin-challenged and control tissues
produced prostaglandins it is impossible to differentiate the
prostaglandin which is synthesized as a result of tissue injury
and that which represents an overflow from the intracellular
secretory processes. Such an overflow mechanism would be
expected to contribute picogram amounts of prostaglandin to the
total output. Thus in the absence of a detecting system which
permits differentiation of prostaglandin output from the various
sources, it is unlikely that in vivo direct measurement of release
can afford much conclusive evidence either in favour or against the
hypothesis.
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This problem can be overcome to a certain extent by
investigating the synthesizing capacity of toxin-treated tissue.
If, as it was postulated, the toxins are responsible for augmenting
prostaglandin biosynthesis intracellularly it should be possible to
measure thte difference between control and infected tissue output in
in vitro situations where the trauma is more easily controlled and
can be adjusted so that toxin-treated and control tissues are
studied in identical conditions. The difference in output in
this situation then represents the effect of the toxin per se.
\
This approach was used with both cholera toxin and E. coli-treated
intestinal tissues, appropriate controls also being carried out.
It was observed that highly purified cholera toxin had no effect
on prostaglandin output by intestinal tissue. Thus it would seem
that little change in the ability of the gut to synthesize
prostaglandins is wrought by the pure form of toxin. Bedwani
has since confirmed this observation (Bedwani, 1974). Crude
cholera toxin was, in his hands, found to stimulate prostaglandin
output slightly but the effect wa3 also observed with crude boiled,
inactive cholera toxin. Thus it is apparent that impurity of the
toxin itself can sometimes lead to enhanced prostaglandin biosynthesis.
Kimberg, Field, Gershorn & Greenough (1974) have confirmed that
prostaglandin output is not augmented by purified choleragen.
There was no significant difference in the levels of PGE (converted
to PGB) and PGF^^as determined by radio-imraunoassay.
The incubation period used for these investigations was
3 hours. The increase in adenyl cyclase following cholera toxin
administration is not immediate, the latent period being approximately
1 hour (Field et al, 1969; Chen, Rohde & Sharp, 1972) but the
effects are long lasting. Thus by using this 3 hour period it
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should have been possible to detect some change in the amount of
prostaglandin being produced if these substances were responsible
for the rise in adenyl cyclase activity. Because control samples
were also studied the effect of metabolism of prostaglandins in
the cell was not investigated^ "tdhe argument being that metabolism
in the cells must have been proceeding at similar rates in toxin-
treated and control tissues if a net effect on adenyl cyclase
activity and in vivo fluid secretion was observed. Escherichia
coli toxin on the other hand does not have a long action on either
adenyl cyclase activity or fluid output (Guerrant et al, 1973).
Activity falls back to control levels very rapidly after toxin
is removed from contact with the intestine and even in the
continued presence of toxin, the levels of adenyl cyclase activity
fall to control levels after approximately 6 hours. In the
in vitro investigations with this toxin a one hour period was
used, thereby ensuring that a period in which enhanced adenyl
cyclase activity and fluid secretion would be expected to occur,
was being investigated. The lack of effect of the E. coli heat-
stable toxin therefore indicated that a prostaglandin-
dependent mechanism was not likely to be responsible for the
pathological effects of the toxin.
Thus the evidence from in vitro investigations confirmed the
results of in vivo experiments and gave additional weight to the
conclusions drawn from these experiments. It now seemS very
*
unlikely that prostaglandins were of prime importance in toxin-
induced fluid secretion.
An alternative approach to the problem was to study the
effects of prostaglandin synthesis inhibitors on the secretion of
fluid in the small bowel in response to toxin administration.
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Two such compounds were selected namely^indomethacin and aspirin.
It was observed that systemic administration of indomethacin in
doses of 10 to 100 mg per kg body weight and local application of
a 600 yug dose to the small intestine in cats failed to d epress the
secretory response of the intestine to subsequent challenge with
crude cholera toxin. Indomethacin given chronically over a 3 day
period, or as acute doses also failed to prevent fluid production
in rabbit models. The doses used were 10 to 20 mg per kg in acute
experiments while in chronic treatment schedule doses of 4-0 mg
per day were employed. Aspirin in doses of 25 mg per kg did not
modify fluid secretion in the terminal ileum of cats, when
administered intravenously before toxin challenge. Systemic
administration of indomethacin in doses of 1 to 5 rag per kg body
weight in dogs has been observed to abolish renal prostaglandin
output (Herbaczynska-Cedro and Vane, 1972). Davis (Davis, 1972)
made similar observations in rabbits following intravenous injections
of 10 rag/kg body weight. In guinea-pigs, a species which has a
plasma half life for indomethacin of twenty minutes (Hucker et al,
1966), a dose of 20 rag per day of indomethacin can prolong the
oestrous cycle in guinea-pigs (Poyser, 1972) which also suggested
that prostaglandin biosynthesis was being inhibited. Oral
administration of indomethacin (img) and aspirin (10 mg/kg) has
been claimed by Somova (1972) to reduce prostaglandin output in
hypertensive cat and rat kidneys to the levels observed in
normotensives. Ferreira, Herman & Vane (1972) demonstrated
that indomethacin in doses of 1-10 -ug/ml inhibited prostaglandin
release from isolated strips of rabbit jejunum. Thus it was
highly unlikely that the doses used to treat cats and rabbits





Bedwani has confirmed that indomethacin does not abolish the
secretory stimulant properties of cholera toxin in rabbits
in vivo (Bedwani, personal communication). It was reported
by Fink and Katz (1972) that aspirin given as a single intravenous
injection in a dose of 25 mg per kg body weight in cats is capable
of inhibiting the secretion of fluid by the jejunum following
exposure to cholera toxin. The toxin used in these studies
(Fink and Katz's work) was Wyeth lot 001 toxin. As demonstrated
by Bedwani, it was highly unlikely that the prostaglandin content
or release of prostaglandin caused by the toxin could have been
responsible for the fluid losses encountered (Bedwani, personal
communication). As previously stated, Pierce and his associates
demonstrated that the concentration of prostaglandins, whether
PGE.J or PGA^, required to induce fluid production in the jejunum
in dogs was of the order of micrograms per minute (Pierce et al,
1971). The only factors which might have influenced the results
and hence the discrepancy between Fink and Katz's work and the
observations reported in this thesis was the strain of cat and
perhaps the insensitivity of the jejunum to indomethacin versus
it3 sensitivity to aspirin.
That the jejunum should be less sensitive to the effects of
indomethacin than to those of aspirin seems rather unlikely. In
the wide range of synthetase inhibitors investigated to date, there is
not one in which aspirin appears to be a more effective prostaglandin
synthetase inhibitor than indomethacin. Even with brain synthetase
which is remarkably sensitive to paracetamol, the same order of
potency is adhered to for indomethacin and aspirin (see Flower, 1974).
Thus it appears that species differences are most likely to be
responsible for the observed effects of indomethacin in the cat.
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A further report of inhibition of choleraic fluid production by
anti-inflammatory agents vas made by Jacoby and Marshall (1971).
The species investigated was the rat. Increase in stomach and
duodenal weight were used as the index of fluid secretion. The
results of these experiments were not very convincing however.
There have been at least two reports of the failure of
indomethacin to inhibit the effects of cholera toxin in other
experimental situations. In fat cells, Illiano and Cuatrecasas
were unable to prevent cholera toxin-induced lipolysis by
incubating isolated fat cells with indomethacin in concentrations
up to 100 yug per ml. Similar inability to modify the lipolytic
response was seen with sodium salicylate in concentrations as
great as 200yUg/ml (illiano & Cuatrecasas, 1971; Cuatrecasas,
1973c). In this model it should be remembered that prosta¬
glandins do not stimulate lipolytic activity but antagonise the
effects of other hormones (see earlier part of discussion).
The work of Bourne (1971) also supports the conclusions drawn
from the results presented in this thesis. Bourne showed that
indomethacin did not inhibit cholera toxin-induced stimulation of
adenyl cyclase activity in neutrophil cells. These results are
comparable to the recent observations made by Kimberg and his
associates on rabbit mucosal adenyl cyclase activity (Kiraberg
et al, 1974).
The negative findings reported in this thesis were supported
by the demonstration of the ability of levels of indomethacin
circulating in cat plasma to inhibit in vitro prostaglandin
biosynthesis by 80$ or more, the dose of indomethacin injected
being either 10 mg/kg or 50 mg/kg. Thus the case against prosta¬
glandin mediation of the secretory effects of cholera toxin was
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strong. Similar studies have not been undertaken in either the
calf or pig. It has, however, been observed that indomethacin,
•when applied locally to piglet intestine, does not inhibit fluid
secretion elicited by E. coli toxin (McLaughlin, personal communic¬
ation) and thus it does seem likely that prostaglandins are not
primary instigators of fluid production in E. coli diarrhoea either.
It was apparent from the results of the in vivo prostaglandin
release experiments, the in vitro prostaglandin biosynthesis
studies and the inability of indomethacin to inhibit fluid
secretion in the in vivo rabbit and cat experimental models of
cholera, that cholera toxin did not depend on a prostaglandin—
mediated step to initiate fluid and electrolyte secretion into
the intestinal lumen. The evidence against Escherichia coli
enterotoxin fluid loss being attributable to prostaglandin release
was also strong, and was further supported by additional studies
on ion and water fluxes in the small intestine following prosta¬
glandin administration. It was established that E. coli toxin
did not produce the same qualitative effects on ion and water
movement as prostaglandins in the intestine of piglets and calves.
This therefore eliminated the possibility that E. coli toxin did
operate through a prostaglandin (or prostaglandin-like) moiety.
In piglet small intestine E. coli heat-stable toxin depresses
glucose uptake^ and effects on water and sodium fluxes are thought
to be secondary to the depression of glucose uptake (Bywater &
Jefferies, unpublished observations). PGA^ and FGE^ on the other
hand had pronounced effects on bicarbonate ion movement. The
effect of PGE^ was much more marked than that observed with PGA^.
At these dose levels glucose absorption was slightly but not
significantly depressed. Prostaglandins have been observed to
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inhibit glucose uptake in the small .intestine of man (Matuchansky
& Bernier, 1973) but the dose of PGE^ required is substantial -
McColl (1972) observed a similar effect with FGE^, and F^
in rat small intestine in vivo. In these experiments the dose
Cholera toxin does not influence glucose absorption either in
human intestine in vivo (Pierce et al, 1968) or in vitro (Iber
et al, 1969). Indeed glucose solutions antagonize the effects
of cholera diarrhoea in the small intestine. In rabbit intestine
glucose absorption is not impaired by cholera toxin (Love, 1969)
whereas E. coli toxin has been observed to depress glucose uptake
(Whipp & Moon, 1972). Thus there would appear to be a
fundamental difference between the effects of heat-stable E. coli
toxin and cholera toxin. This is, however, likely to be a
species related phenomenon as calf intestinal uptake of glucose
is not sensitive to heat-stable E. coli toxin (Bywater, 1970).
In the calf experiments prostaglandins were administered via
the superior mesenteric artery. Neither PGE^ nor PGF^produced
any marked effect on electrolyte and water transport. PGA^ however
was found to enhance bicarbonate ion secretion. This prostaglandin
did not cause any significant change in any other parameter measured
in these experiments.
It was notable that prostaglandins of the E series were
more active than those of the A series in stimulating bicarbonate
ion secretion in the small intestine following intraluminal
administration whereas PGA^ was active in intra-arterial infusion
in contrast to PC-E^. Although species differences may account for
these findings it would be interesting to determine whether the
being 0.9 minute infused into the jej unum. Coupar and
required was 1.4. x 10 this' is equivalent to approximately
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intraluminal-intra-arterial difference might not reflect alteration
of PGE compounds during uptake by the intestinal mucosa. Furthermore
in vitro cholera toxin has been shown to stimulate chloride ion
secretion and reduce sodium absorption, an effect mimicked by
prostaglandins (A1 Avqati & Greenough, 1973; Field, Fromm, A1
Avqati & Greenough, 1972). In vivo it is the bicarbonate ion which
is the major component of anion secretion (Love, 1966). Recent
work of Powell, Binder and Curran (1973) does suggest that chloride
ion secretion in vitro may be dependent on the addition of toxin
in vivo as in these in vitro experiments where tissues were not
exposed to cholera toxin in vivo, bicarbonate ion secretion was
observed. In human intestine bicarbonate ion, the residual ion
flux, is also enhanced (Rohde & Anderson, 1973)* It therefore
seems feasible that, since prostaglandins can enhance bicarbonate
ion secretion in vivo, the control of bicarbonate ion secretion
may be due to the balance of prostaglandin activity in the
intestinal mucosa. Prostaglandins have been shown to be present
in the mucosal layer of the intestine and as yet no function has
been attributed to them in this situation.
Having thus excluded prostaglandins as mediators of cholera
toxin and E. coli heat-stable toxin-induced fluid secretion, the
problem still remains as to what does act as a mediator within
the mucosal cell. Polypeptides are found in the mucosa of the
small intestine. Barbezat and Grossman (1971) have shown that
vasoactive intestinal peptide (VIP), gastric inhibitory peptide (GIP)
and glucagon all stimulate fluid secretion in canine jejunum.
Glucagon stimulates adenyl cyclase activity in rat fat cells
(Butcher & Baird, 1970). This ability is shared by both V. cholerae
and E. coli toxins (Hewlett, Guerrant, Evans & Greenough, 1974) but
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neither of these toxins abolishes the sensitivity of fat cell
adenyl cyclase to hormones (Vaughan, Pierce & Greenough, 1970;
Katz Sc Greenough, 1972). In fact it was demonstrated by Hewlett
and his associates that adrenaline sensitivity was actually
increased (Hewlett et al, 1974.) • Adrenaline and glucagon in
fat cells activate the same receptor (Birnbaumer Sc Rodbell,
1969). Thus it seems doubtful whether endogenous hormone
production could be responsible for the effects of either
enterotoxin.
It may be that fragments of the toxin themselves are the
mediators. Raskova (1974-) has suggested that cholera toxin
modifies the regulator unit which is responsible for basal activity
and not the hormone sensitive unit. If this hypothesis is
valid then not only would it account for the additive effects
seen with cholera toxin and prostaglandins (Kimberg et al, 1971)
but it would also explain the apparently anomalous findings of
Sharp and Hynie (1971). Recent work by Kantor, Tao and Kiefer
(cited in Kantor, Tao Sc Gorbach, 1974-) suggests that a similar
situation may exist for Escherichia coli toxin and PGE^, as
kinetic evidence has been obtained which indicates that there are
separate receptor sites on intestinal adenyl cyclase for each of
these agents.
It is also clear from the results presented in this thesis
that the wide scale use of aspirin and other prostaglandin synthesis
inhibitors as a means of treating cholera (Bennett, 1971) and
other similar bacterial diarrhoea is unlikely to be successful.
Recently the alkaloid of Berberis Anistata has been found to
reduce the diarrhoeic effects of Vibrio cholerae and non-vibrial
organisms (Dutta 2c Panse, 1962; Purokit & Sabhadra Rao, 1969;
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Lahiri & Datta, 1967). It is thought to produce its effects
by altering the fatty acid composition of the infective organism
and by stimulating protein and lipid synthesis (Kodak, Kodak &
Venkataraman, 1970). It could well be that the development of
synthetic compounds based on this alkaloid could provide a potent,
rapidly effective drug against vibrio cholerae and other similar
organisms like Escherichia coli.
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THE FAILURE OF INDOMETHACIN TO MODIFY THE RESPONSE
OF CAT SMALL INTESTINE TO CHOLERA ENTEROTOXIN
Department of Pharmacology, University of Edinburgh, 1, George Square, Edinburgh EH8 9JZ
M. J. DLUGOLECKA: The failure of indomethacin to modify the response of cat
small intestine to cholera enterotoxin. Pol. J. Pharmacol. Pharm. 1974, 26, 93—100.
In a series of 21 cats in which the terminal small intestine was challenged with
cholera toxin, the effect of two prostaglandin synthesis inhibitors and anti-inflam¬
matory drugs were studied. Neither indomethacin in doses of 10, 50 and 100 mg/kg
by intravenous injection nor in a dose of 600 jig/loop when administered locally,
nor aspirin intravenously injected in a dose of 25 mg/kg were able to abolish the
response of the intestine to the toxin. It is concluded that prostaglandins are not likely
to be mediators of the fluid loss observed in the terminal small intestine.
Preliminary experiments in rabbits have indicated that indomethacin
chronically administered prior to cholera toxin challenge does not inhibit
fluid accumulation in ligated intestinal loops but is capable of preventing
haemorrhagic necrosis. This report concerns experiments in the cat using
perfused intestinal loops similar to those of Fink and Katz [5] in cats and
of Pierce et al [9] in dogs. In the present study animals were pretreated with
either indomethacin or aspirin. The effect of these drugs on the response
to cholera enterotoxin in the small intestine is reported.
METHODS
Twenty-one young cats and kittens weighing 1-3—3-75 kg were used in these experiments.
Anaesthesia was induced with pentobarbitone sodium, 40 mg/kg and maintained by continuous
intravenous infusion of pentobarbitone sodium in saline (6 mg/ml) at rates varying between 0 075—
6 6 ml/hr. The anaesthetic solution contained heparin 100 iu/ml. Tracheostomy was performed and
animals artificially ventilated if respiration became unsatisfactory. The right common carotid artery
was cannulated for blood pressure recording on a Grass polygraph. The right femoral vein or
external jugular vein was cannulated to administer the anti-inflammatory drugs. All vascular cannulae
were primed with heparin 100 iu/ml before use.
A mid-line abdominal incision was made and the terminal small intestine exteriorized. Three
loops were created by means of ligatures, in the small intestine. The last of these loops extended
to a point 15—20 cm proximal to the ileocaecal junction. Both the first and third loops, each of
approximately 20 cm in length, were cannulated at their upper and lower ends. The intervening loop,
which was only 5—8 cm long, was left intact and served to separate toxin-treated and control loops.
The cannulae were secured with Mersilk ligatures and all blood vessels to the loops were left functio¬
nal. The integrity of the blood supply was ascertained at the beginning and end of each experiment.
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Salt solution prepared as in Pierce et al [9] was heated to 37°C in a heated coil water bath delivered
at a rate of 10—1-7 ml/min. In all loops fluid flowed from the cephalic to the caudal end of the loop.
Fluid was collected by downward drainage into 100 ml reservoirs. Perfussion of the loops was begun
one hour after toxin administration and continued for some five hours. The volume delivered in any
given hour, and the fluid output were measured. The percentage increase or decrease in fluid output
were measured. The percentage increase or decrease in fluid output as compared to input was
calculated.
One gram crude cholera toxin, Weyth 002 toxin, was dissolved in 5 ml salt solution used for per¬
fusion and injected into the test loop. Control loops were inoculated with 5 ml salt solution. In each
pair of experiments the positions of the test and control loops relative to the unperfused loop were
altered in a cross-over design, so that an equal number of readings for test and control experiments
for a particular region of the small intestine was obtained. The loops were held clamped off from
the inflow'and outflow cannulae for one hour.
Indomethacin was dissolved in 0-2 ml polyethylene glycol 200 and the volume for injection made
up to 2-5 ml with 0-9% saline when administered intravenously. When the drug was locally applied
into the lumen of the intestinal loops, the drug was dissolved in polyethylene glycol only. The doses
of indomethacin used were 10 mg/kg, 50 mg/kg and 100 mg/kg intravenously and 600 ug/loop
locally.
Acetylsalicylic acid either in the form of Alkaseltzer tablets or powdered acetylsalicylic acid were
dissolved in alkaline salt solution and injected intravenously. The dose used was 25 mg/kg in all
four experiments.
Intravenously administered drugs were given by slow injection over a two minute period some ten
minutes prior to toxin challenge. Local indomethacin was delivered to the loop twenty minutes
before toxin challenge or control solution was introduced into the loop.
RESULTS
The percentage change in fluid output compared with the amount of fluid
delivered to each loop was calculated for each hour of perfusion. The results
are given in Figures 1—6. Fig. 1 compares the responses of toxin-treated and
control loops in animals receiving no anti-inflammatory drugs. Whereas
toxin challenged loops showed a net secretion of fluid, the control loops
showed a decrease in fluid output indicating that reabsorption of fluid had
occured throughout the five hours perfusion period. The greatest difference
between the two loops is seen during the first hour of perfusion.
In all subsequent experiments fluid output from toxin-treated and control
loops was measured after treatment with either indomethacin or aspirin.
If these drugs were capable of antagonising the effects of cholera enterotoxin,
then the secretory pattern of test and control loops should have been identical.
The results are given in Figures 1—6.
Animals treated with intravenous indomethacin (Fig. 2-4).
In eight experiments indomethacin 10 mg/kg (5 animals) and 50 mg/kg
(3 animals) injected intravenously had no significant effect on fluid output
from toxin-treated or control loops. One animal received 100 mg/kg indome¬
thacin. This higher dose caused a pronounced fall in arterial blood pressure
but even in this experiment no significant effect on the action of cholera entero¬
toxin was observed.
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CONTROL EXPERIMENTS
% change ( no drug treatment)
i n v/ol ( Im o
the behaviour of salt solution treated loops (lower graph).
INDOMETHACIN 10rnq/kg iv.
Fig. 2. The effect of indomethacin 10 mg/kg by intravenous injection on the responses of toxin-treated
loops (upper graph) and salt-solution treated loops (lower graph) in cat small intestine.
Animals treated with local indomethacin (Fig. 5).
In three cats indomethacin (0-6 mg) was introduced into one toxin-treated
loop. The other loop also received toxin but no anti-inflammatory drug.
Again no significant effect on fluid output was detected following treatment
with indomethacin.
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INDOMETHAC IN mg/kg i.v.
°/0 change
Fig. 3. The response of toxin-treated loops (upper graph) and salt solution treated loops following










Fig. 4. The effect of 100 mg/kg indomethacin given by intravenous injection on cat small intestine
exposed to cholera toxin (upper graph) and salt solution (lower graph).
Animals treated with aspirin intravenously
In cats (4 animals) aspirin in doses of 25 mg/kg also failed to modify fluid
secretion in the toxin treated loops (Fig. 6).
Readings from loops which were seen to be dehydrated or to which the
blood supply had become impaired were discarded. In some cases this resulted
in only one reading for the five hour values, e.g. Fig. 3 control loop.
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Fig. 5. The effect of locally administered indomethacin 600 pig/loop on the response of cat terminal
small intestine to challenge with cholera toxin (continuous-line graph) compared to toxin-challenge
alone (broken-line graph).
ASPIRIN 25mg/ kg iv.
perfusion time
(hours)
Fig. 6. The effect of 25 mg/kg aspirin administered intravenously on toxin-challenged loops (upper
graph) and salt solution treated loops (lower graph) in cat small intestine.
Figs 1—6. The results of the control series of experiments are given on Figure 1. Those for the drug
treated animals are summarized in Figures 2—6. Numbers in brackets indicate the number of obser¬
vations made for each point on the graphs. The mean value for each point together with the standard
deviation is plotted. The percentage change in fluid output compared to input is plotted against
time for each series of experiments. In Figures 1—4 and Figure 6 the upper graph gives the results
of the toxin treated loops and the lower graph those of the salt solution-treated loops. In Figure 5
the broken line gives the results of the toxin treated loops. Drug and toxin-treated loops results
are depicted in the continuous line graph.
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DISCUSSION
From these results it is concluded that the anti-inflammatory drugs, indome-
thacin and aspirin in the doses used were without significant effect on the
secretion of fluid in the gut in the presence of cholera toxin.
The most significant period for monitoring the effects of potential anti-
cholera drugs following toxin challenge is probably during the time of clamping
off the gut and the first hour of perfusion. During the "incubation" interval
the toxin-treated loop is observed to accumulate fluid whereas the untreated se¬
ction of the intestine reabsorbs the fluid initially introduced into the lumen
and does not produce any of its own accord. The secretion continues, in the
case of the toxin-treated loop, for a period of several hours but effects from
exteriorization and dehydration together with the trauma of continuous
perfusion of fluid are not significant in the initial stages of the experiment.
The intestine retains its capacity to reabsorb fluid, as is seen from the behaviour
of the control loop. In order to exclude the possibility that lack of an adequate
blood supply might contribute to the failure to observe any effects of the
anti-inflammatory drugs, results from any loop found to have an impaired
blood supply were rejected.
These results are in direct opposition to the results published by Fink and
Katz [5], These workers found that aspirin 25 mg/kg i.v. inhibited fluid secre¬
tion in the upper small intestine in the cat. A similar effect of anti-inflammatory
drugs has been described by Jacoby and Marshall [7] in rat stomach and
upper small intestine.
In both these experiments the investigators were studying a region of the
alimentary tract specialized for secretory activity. The results presented in
this paper, however, reflect the influence of drugs on that region of the small
intestine associated mainly with reabsorption. It may well be that the discre¬
pancy between these results and the results of the two other groups of workers
is attributable to this basic physiological difference in epithelial cell type.
Bennett [1] has advocated the use of prostaglandin synthesis inhibitors
in the treatment of human cholera, having suggested that prostaglandins
might be involved as mediators of the toxin-induced diarrhoeas. Protaglandins
have been shown to cause diarrhoea in man. In 1969 Horton et al [6] and
Misiewicz et al. [8] reported that oral PGEx caused massive diarrhoea of a
watery nature and Cummings et al [3] described the production of diarrhoea
in human subjects following intravenous infusion of prostaglandin F2a.
It has also been suggested that the diarrhoeas associated with medullary carci¬
noma of the thyroid, carcinoid syndrome and ganglioneuroma may be at¬
tributable to the release of prostaglandins [10, 12].
Indomethacin and aspirin are prostaglandin synthesis inhibitors [4, 11].
Therefore, if prostaglandins were involved in the production of diarrhoea
in cholera, one would have expected to see a change in the pattern of fluid
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loss. There was no such alteration in these experiments. This, therefore,
suggests that protaglandins are not involved in the changes which occur
in the terminal ileum induced by cholera toxin. It also indicates that, even
if prostaglandins are implicated in the secretion of fluid in the upper small
intestine, these anti-inflammatory agents will not necessarily prevent the
symptoms of cholera since they do not reverse the inhibition of fluid reabsorb-
tion, nor the fluid secretion in more distal regions of the small intestine.
In a further paper evidence will be presented to support the belief that
prostaglandins are not involved in the ileal responses to cholera toxin in the
cat, and that doses of indomethacin and aspirin which failed in vivo to modify
cholera toxin effects are capable of inhibiting in vitro synthesis of prostaglandins.
Bourne [2] suggested that the ability of aspirin and other prostaglandin
antagonists to inhibit the actions of cholera toxin was due to the fact that
other groups of workers were using suboptimal doses of toxin. The toxin
used in the experiments presented in this paper is more potent on a weight
basis than that used by Fink and Katz [5], (Toxin report sheet. Nat. Inst.
Allergy and Infect. Dis.— Dr J. Seal). These results may, therefore, be in part
attributable to this factor in addition to regional differences in the intestinal
cell morphology.
The questions of doses of toxin and sensitivity of different areas of intes¬
tine to anti-inflammatory drugs require further investigation in order that
these points may be clarified.
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DISCUSSION TO PAPER OF DR DLUGOLECKA
Bennet has suggested that cholera toxin stimulates the release or synthesis of prosta¬
glandins, which in turn stimulate the c-AMP synthesis and diarrhea results. Several authors
have used PGE inhibitors and demonstrated some inhibition of intestinal fluid secretion.
These findings would suggest the major role of PG in cholera induced diarrhea. The findings
of Dr Dlugolecka speak against this interpretation.
According to our findings concerning both cholera toxin and E. coli enterotoxin (which
also stimulates adenylcyclase activity) actions and from data in the literature it seems not to
be probable that the main action of both toxins is mediated by PGE only.
All adenylate cyclase preparations stimulated by cholera toxin keep the sensitivity to
hormone stimulation. However the absence of substantial increase by hormone stimulation
in cholera toxin treated tissues suggest that the activation of the enzvme by toxins and
hormones is of different nature. It seems that both cholera toxin and E. coli enterotoxin
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enlarge that part of the regulatory unit of adenylate cyclase, which is responsible for basal
activity and not the unit senstive to hormone stimulation. However this part might be in
vivo stimulated by liberated PG due to other actions of cholera toxin and E. coli
enterotoxin.
This view is supported by differences in the action of cholera toxin and prostaglan¬
dins (time, course, intensity, effect from serosal and mucosal site, possibility to reduce the
effect by washing and stimulation in brush cell preparation).
M. J. Dlugolecka
BRAK MODYFIKOWANIA ODPOWIEDZI JELITA CIENKIEGO KOTA
NA ENTEROTOKSYNIJ CHOLERY PRZEZ INDOMETACYNE
Streszczenie
Badano wplyw dw6ch inhibitorow syntezy prostaglandyn i zwi^zkow przeciwzapalnych u 21 ko-
t6w, ktdrych koncowa cajsc jelita cienkiego byla poddana dzialaniu toksyny cholery.
Ani indometacyna (10, 50 lub 100 mg/kg i.v., b^dz 600 jig na p^tle lokalnie), ani aspiryna
(25 mg/kg iv) nie znosily odpowiedzi jelita na toksyn?. Wydaje sif, ze prostaglandyny nie s^ prawdo-
podobnie mediatorami utraty ptynu obserwowanej w koncowym jelicie cienkim.
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